doi,title,authors,author_corresponding,author_corresponding_institution,date,version,type,license,category,jatsxml,published,server,doc_name
10.1101/2020.01.29.20019489,Genomic determination of relative risks for Clostridioides difficile infection from asymptomatic carriage in ICU patients,"Worley, J. N.; Delaney, M. L.; Cummins, C. K.; Dubois, A.; Klompas, M.; Bry, L.",Lynn Bry,Brigham & Women\'s Hospital,2020-01-30,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/01/30/2020.01.29.20019489.source.xml,10.1093/cid/ciaa894,medrxiv,10.1101__2020.01.29.20019489_doc.txt
10.1101/2020.02.04.20020438,The impact of traffic isolation in Wuhan on the spread of 2019-nCov,"Jin, G.; Yu, J.; Han, L.; Duan, S.",Shiwei Duan,Ningbo University,2020-02-05,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2020/02/05/2020.02.04.20020438.source.xml,,medrxiv,10.1101__2020.02.04.20020438_doc.txt
10.1101/2020.02.21.20026179,"2019 Novel Coronavirus can be detected in urine, blood, anal swabs and oropharyngeal swabs samples","Peng, L.; Liu, J.; Xu, W.; Luo, Q.; Deng, K.; Lin, B.; Gao, Z.",Zhiliang Gao,The 3rd Affiliated Hospital of Sun Yat-sen University,2020-02-25,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/02/25/2020.02.21.20026179.source.xml,,medrxiv,10.1101__2020.02.21.20026179_doc.txt
10.1101/2020.02.25.20021568,Deep learning-based model for detecting 2019 novel coronavirus pneumonia on high-resolution computed tomography: a prospective study,"Chen, J.; Wu, L.; Zhang, J.; Zhang, L.; Gong, D.; Zhao, Y.; Hu, S.; Wang, Y.; Hu, X.; Zheng, B.; Zhang, K.; Wu, H.; Dong, Z.; Xu, Y.; Zhu, Y.; Chen, X.; Yu, L.; Yu, H.",Honggang Yu,Renmin Hospital of Wuhan University,2020-03-01,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/03/01/2020.02.25.20021568.source.xml,,medrxiv,10.1101__2020.02.25.20021568_doc.txt
10.1101/2020.02.25.20027755,Application and optimization of RT-PCR in diagnosis of SARS-CoV-2 infection,"Jiang, G.; Ren, X.; Liu, Y.; Chen, H.; Liu, W.; Guo, Z.; Zhang, Y.; Chen, C.; Zhou, J.; Xiao, Q.; Shan, H.",Hong Shan,Sun Yat-sen University,2020-02-28,2,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/02/28/2020.02.25.20027755.source.xml,,medrxiv,10.1101__2020.02.25.20027755_doc.txt
10.1101/2020.03.04.20030916,Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing,"Zhang, J.; Liu, J.; Li, N.; Liu, Y.; Ye, R.; Qin, X.; Zheng, R.",Rui Zheng,Shengjing Hospital of China Medical University,2020-03-10,2,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/03/10/2020.03.04.20030916.source.xml,10.1016/j.intimp.2020.106861,medrxiv,10.1101__2020.03.04.20030916_doc.txt
10.1101/2020.03.07.20032706,"Forensic genomics of a novel Klebsiella quasipneumoniae type from an NICU in China reveals patterns of genetic diversity, evolution and epidemiology","Perlaza-Jimenez, L.; Wu, Q.; Torres, V. V. L.; Zhang, X.; Li, J.; Rocker, A.; Lithgow, T.; Zhou, T.; Dhanasekaran, V.",Vijaykrishna Dhanasekaran,Monash University,2020-03-12,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/03/12/2020.03.07.20032706.source.xml,10.1099/mgen.0.000433,medrxiv,10.1101__2020.03.07.20032706_doc.txt
10.1101/2020.03.06.20032342,"Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China","Wang, Y.; Jiang, W.; He, Q.; Wang, C.; Wang, B.; Zhou, P.; Dong, N.; Tong, Q.",Nianguo Dong,"Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",2020-03-12,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/03/12/2020.03.06.20032342.source.xml,,medrxiv,10.1101__2020.03.06.20032342_doc.txt
10.1101/2020.03.12.20035048,Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19,"Zhang, B.; Zhou, X.; Zhu, C.; Feng, F.; Qiu, Y.; Feng, J.; Jia, Q.; Song, Q.; Zhu, B.; Wang, J.",Jun Wang Sr.,The First Affiliated Hospital of Shandong First Medical University,2020-03-16,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/03/16/2020.03.12.20035048.source.xml,10.3389/fmolb.2020.00157,medrxiv,10.1101__2020.03.12.20035048_doc.txt
10.1101/2020.03.11.20034546,Environmental contamination of the SARS-CoV-2 in healthcare premises: An urgent call for protection for healthcare workers,"Ye, G.; Lin, H.; Chen, L.; Wang, S.; Zeng, Z.; Wang, W.; Zhang, S.; Rebmann, T.; Li, Y.; Pan, Z.; Yang, Z.; Wang, Y.; Wang, F.; Qian, Z.; Wang, X.",Xinghuan Wang,"Zhongnan Hospital of Wuhan University, Leishengshan Hospital",2020-03-16,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/03/16/2020.03.11.20034546.source.xml,,medrxiv,10.1101__2020.03.11.20034546_doc.txt
10.1101/2020.03.21.20040360,Prognostic value of C-reactive protein in patients with COVID-19,"Luo, X.; Zhou, W.; Yan, X.; Guo, T.; Wang, B.; Xia, H.; Ye, L.; Xiong, J.; Jiang, Z.; Liu, Y.; Zhang, B.; Yang, W.",Xiaomin Luo,Renmin hospital of Wuhan University,2020-03-23,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/03/23/2020.03.21.20040360.source.xml,10.1093/cid/ciaa641,medrxiv,10.1101__2020.03.21.20040360_doc.txt
10.1101/2020.03.23.20039446,Aerosol and Surface Transmission Potential of SARS-CoV-2,"Santarpia, J. L.; Rivera, D. N.; Herrera, V.; Morwitzer, M. J.; Creager, H.; Santarpia, G. W.; Crown, K. K.; Brett-Major, D.; Schnaubelt, E.; Broadhurst, M. J.; Lawler, J. V.; Reid, S. P.; Lowe, J. J.",Joshua L Santarpia,University of Nebraska Medical Center,2020-06-03,3,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/06/03/2020.03.23.20039446.source.xml,10.1038/s41598-020-69286-3,medrxiv,10.1101__2020.03.23.20039446_doc.txt
10.1101/2020.03.22.20040071,A special case of COVID-19 with long duration of viral shedding for 49 days,"Tan, L.; Kang, X.; Zhang, B.; Zheng, S.; Liu, B.; Yu, T.; Yang, F.; Wang, Q.; Miao, H.",Hongming Miao,Third Military Medical University (Army Medical University),2020-03-27,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/03/27/2020.03.22.20040071.source.xml,,medrxiv,10.1101__2020.03.22.20040071_doc.txt
10.1101/2020.03.23.20041608,Multiple-Input Deep Convolutional Neural Network Model for COVID-19 Forecasting in China,"Huang, C.-J.; Chen, Y.-H.; Ma, Y.; Kuo, P.-H.",Ping-Huan Kuo,National Pingtung University,2020-03-27,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/03/27/2020.03.23.20041608.source.xml,,medrxiv,10.1101__2020.03.23.20041608_doc.txt
10.1101/2020.03.22.20040840,An alarming high prevalence of resistance associated mutations to macrolides and fluoroquinolones in Mycoplasma genitalium in Belgium: Results from samples collected between 2015-2018,"De Baetselier, I.; Kenyon, C.; Vanden Berghe, W.; Smet, H.; Wouters, K.; Van den Bossche, D.; Vuylsteke, B.; Crucitti, T.",Irith De Baetselier,Institute of Tropical Medicine,2020-03-27,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2020/03/27/2020.03.22.20040840.source.xml,10.1136/sextrans-2020-054511,medrxiv,10.1101__2020.03.22.20040840_doc.txt
10.1101/2020.03.23.20041970,Haplotype networks of SARS-CoV-2 infections in the Diamond Princess cruise ship outbreak,"Sekizuka, T.; Itokawa, K.; Kageyama, T.; Saito, S.; Takayama, I.; Asanuma, H.; Naganori, N.; Tanaka, R.; Hashino, M.; Takahashi, T.; Kamiya, H.; Yamagishi, T.; Kakimoto, K.; Suzuki, M.; Hasegawa, H.; Wakita, T.; Kuroda, M.",Makoto Kuroda,National Institute of Infectious Diseases,2020-03-27,1,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2020/03/27/2020.03.23.20041970.source.xml,10.1073/pnas.2006824117,medrxiv,10.1101__2020.03.23.20041970_doc.txt
10.1101/2020.03.27.20045575,Basic prediction methodology for covid-19: estimation and sensitivity considerations,"Britton, T.",Tom Britton,Stockholm University,2020-04-07,2,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2020/04/07/2020.03.27.20045575.source.xml,,medrxiv,10.1101__2020.03.27.20045575_doc.txt
10.1101/2020.03.24.20042689,"SARS-CoV-2 detection using digital PCR for COVID-19 diagnosis, treatment monitoring and criteria for discharge","Lu, R.; Wang, J.; Li, M.; Wang, Y.; Dong, J.; Cai, W.",Weihua Cai,"Nantong Third Hospital Affiliated to Nantong University, Infection Division",2020-03-30,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/03/30/2020.03.24.20042689.source.xml,,medrxiv,10.1101__2020.03.24.20042689_doc.txt
10.1101/2020.03.27.20043752,"Forecasting COVID-19 impact on hospital bed-days, ICU-days, ventilator-days and deaths by US state in the next 4 months","IHME COVID-19 health service utilization forecasting team,  ; Murray, C. J.",Christopher JL Murray,Institute for Health Metrics and Evaluation,2020-03-30,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2020/03/30/2020.03.27.20043752.source.xml,,medrxiv,10.1101__2020.03.27.20043752_doc.txt
10.1101/2020.04.02.20051284,Building an International Consortium for Tracking Coronavirus Health Status,"Segal, E.; Zhang, F.; Lin, X.; King, G.; Shalem, O.; Shilo, S.; Allen, W. E.; Grad, Y. H.; Greene, C. S.; Alquaddoomi, F.; Anders, S.; Balicer, R.; Bauman, T.; Bonilla, X.; Booman, G.; Chan, A. T.; Ori Cohen, O.; Coletti, S.; Davidson, N.; Dor, Y.; Drew, D. A.; Elemento, O.; Evans, G.; Ewels, P.; Gale, J.; Gavrieli, A.; Geiger, B.; Hajirasouliha, I.; Jerala, R.; Kahles, A.; Kallioniemi, O.; Keshet, A.; Landua, G.; Meir, T.; Muller, A.; Nguyen, L. H.; Oresic, M.; Ovchinnikova, S.; Peterson, H.; Rajagopal, J.; Ratsch, G.; Rossman, H.; Rung, J.; Sboner, A.; Sigaras, A.; Spector, T.; Steinherz, R.",Eran Segal,Weizmann Institute of Science,2020-04-06,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/04/06/2020.04.02.20051284.source.xml,10.1038/s41591-020-0929-x,medrxiv,10.1101__2020.04.02.20051284_doc.txt
10.1101/2020.04.01.20049478,Differential COVID-19-attributable mortality and BCG vaccine use in countries,"Shet, A.; Ray, D.; Malavige, N.; Santosham, M.; Bar-Zeev, N.",Anita Shet,"Johns Hopkins Bloomberg School of Public Health, USA",2020-04-06,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/04/06/2020.04.01.20049478.source.xml,,medrxiv,10.1101__2020.04.01.20049478_doc.txt
10.1101/2020.04.02.20050997,Acute liver injury and its association with death risk of patients with COVID-19: a hospital-based prospective case-cohort study,"Fu, L.; Fei, J.; Xu, S.; Xiang, H.-X.; Xiang, Y.; Tan, Z.-X.; Li, M.-D.; Liu, F.-F.; Li, Y.; Han, M.-F.; Li, X.-Y.; Zhao, H.; Xu, D.-X.",De-Xiang Xu,Anhui Medical University,2020-04-06,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/04/06/2020.04.02.20050997.source.xml,,medrxiv,10.1101__2020.04.02.20050997_doc.txt
10.1101/2020.04.10.20053207,"Homologous protein domains in SARS-CoV-2 and measles, mumps and rubella viruses: preliminary evidence that MMR vaccine might provide protection against COVID-19","Franklin, R.; Young, A.; Neumann, B.; Fernandez, R.; Joannides, A.; Reyahi, A.; Modis, Y.",Robin Franklin,University of Cambridge,2020-04-10,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/04/10/2020.04.10.20053207.source.xml,,medrxiv,10.1101__2020.04.10.20053207_doc.txt
10.1101/2020.04.10.20060616,"Chaos, Percolation and the Coronavirus Spread: the Italian case","Bonasera, A.; Bonasera, G.; Zhang, S.",Aldo Bonasera,Texas A&M University,2020-04-14,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/04/14/2020.04.10.20060616.source.xml,10.1140/epjp/s13360-020-00494-6,medrxiv,10.1101__2020.04.10.20060616_doc.txt
10.1101/2020.04.09.20058941,"Associations of clinical characteristics and antiviral drugs with viral RNA clearance in patients with COVID-19 in Guangzhou, China: a retrospective cohort study","Chen, X.; Zhang, Y.; Zhu, B.; Zeng, J.; Hong, W.; He, X.; Chen, J.; Zheng, H.; Qiu, S.; Deng, Y.; Chan, J.; Wang, J.",Jian Wang,"Guangzhou Eighth People\'s Hospital, Guangzhou Medical University, Guangzhou 510060, China",2020-04-14,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/04/14/2020.04.09.20058941.source.xml,,medrxiv,10.1101__2020.04.09.20058941_doc.txt
10.1101/2020.04.12.20062869,Cardiovascular Diseases Burden in COVID-19: Systematic Review and Meta-analysis,"Hessami, A.; Shamshirian, A.; Heydari, K.; Pourali, F.; Alizadeh-Navaei, R.; Moosazadeh, M.; Abrotan, S.; Shojaei, L.; Sedighi, S.; Shamshirian, D.; Rezaei, N.",Amirhossein Hessami,Mazandaran University of Medical Sciences,2020-07-10,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/07/10/2020.04.12.20062869.source.xml,10.1016/j.ajem.2020.10.022,medrxiv,10.1101__2020.04.12.20062869_doc.txt
10.1101/2020.04.13.20063529,Impact of population mask wearing on Covid-19 post lockdown,"Javid, B.; Balaban, N. Q.",Babak Javid,Tsinghua University School of Medicine,2020-06-02,3,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/06/02/2020.04.13.20063529.source.xml,10.1097/IM9.0000000000000029,medrxiv,10.1101__2020.04.13.20063529_doc.txt
10.1101/2020.04.12.20062828,Estimation of airborne viral emission: quanta emission rate of SARS-CoV-2 for infection risk assessment,"Buonanno, G.; Stabile, L.; Morawska, L.",Giorgio Buonanno,"Department of Civil and Mechanical Engineering, University of Cassino and Southern Lazio, Cassino, Italy",2020-04-17,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/04/17/2020.04.12.20062828.source.xml,10.1016/j.envint.2020.105794,medrxiv,10.1101__2020.04.12.20062828_doc.txt
10.1101/2020.04.12.20062794,Modelling and analysis of COVID-19 epidemic in India.,"TIWARI, A.",ALOK TIWARI,IIT BOMBAY,2020-04-21,2,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2020/04/21/2020.04.12.20062794.source.xml,10.1016/j.jnlssr.2020.11.005,medrxiv,10.1101__2020.04.12.20062794_doc.txt
10.1101/2020.04.16.20067355,Do Weather Temperature and Median-age affect COVID-19 Transmission?,"Kassem, A. Z. E.",Aly Zein Elabdeen Kassem,Institute of National Planning,2020-04-17,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/04/17/2020.04.16.20067355.source.xml,10.3389/fpubh.2020.554964,medrxiv,10.1101__2020.04.16.20067355_doc.txt
10.1101/2020.04.11.20062349,Phenotype of SARS-CoV-2-specific T-cells in COVID-19 patients with acute respiratory distress syndrome,"Weiskopf, D.; Schmitz, K. S.; Raadsen, M. P.; Grifoni, A.; Okba, N. M. A.; Endeman, H.; van den Akker, J. P. C.; Molenkamp, R.; Koopmans, M. P. G.; van Gorp, E. C. M.; Haagmans, B. L.; de Swart, R. L.; Sette, A.; de Vries, R. D.",Rory Dylan de Vries,"Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands",2020-05-29,2,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/05/29/2020.04.11.20062349.source.xml,10.1126/sciimmunol.abd2071,medrxiv,10.1101__2020.04.11.20062349_doc.txt
10.1101/2020.04.16.20068148,COVID-19-Associated Acute Disseminated Encephalomyelitis: A Case Report,"Zhang, T.; Rodricks, M. B.; Hirsh, E.",Tianshu Zhang,RWJUH Somerset,2020-04-21,1,PUBLISHAHEADOFPRINT,cc_no,neurology,https://www.medrxiv.org/content/early/2020/04/21/2020.04.16.20068148.source.xml,10.1007/s12028-020-01119-7,medrxiv,10.1101__2020.04.16.20068148_doc.txt
10.1101/2020.04.19.20071605,Spatial analysis of COVID-19 spread in Iran: Insights into geographical and structural transmission determinants at a province level,"Ramirez-Aldana, R.; Gomez-Verjan, J. C.; Bello-Chavolla, O. Y.",Ricardo Ramírez-Aldana,"Research Division, Instituto Nacional de Geriatría (INGER), Anillo Perif. 2767, San Jeronimo Lidice, La Magdalena Contreras, 10200, Mexico City, Mexico.",2020-10-14,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/10/14/2020.04.19.20071605.source.xml,10.1371/journal.pntd.0008875,medrxiv,10.1101__2020.04.19.20071605_doc.txt
10.1101/2020.04.21.20066258,No Clear Benefit to the Use of Corticosteroid as Treatment in Adult Patients with Coronavirus Disease 2019 : A Retrospective Cohort Study,"Wang, D.; Wang, J.; Jiang, Q.; Yang, J.; Li, J.; Gao, C.; Jiang, H.; Ge, L.; Liu, Y.",Yongming Liu,"The Third Peoples Hospital of Hubei Province, Jianghan University",2020-04-24,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/04/24/2020.04.21.20066258.source.xml,,medrxiv,10.1101__2020.04.21.20066258_doc.txt
10.1101/2020.04.22.20075598,Pooling of Nasopharyngeal Swab Specimens for SARS-CoV-2 detection by RT-PCR,"Torres, I.; Albert, E.; Navarro, D.",David Navarro,"Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.",2020-04-25,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/04/25/2020.04.22.20075598.source.xml,10.1002/jmv.25971,medrxiv,10.1101__2020.04.22.20075598_doc.txt
10.1101/2020.04.23.20077297,Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios,"Mukandavire, Z.; Nyabadza, F.; Malunguza, N. J.; Cuadros, D. F.; Shiri, T.; Musuka, G.",Godfrey Musuka,"ICAP at Columbia University, Harare, Zimbabwe",2020-04-29,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/04/29/2020.04.23.20077297.source.xml,10.1371/journal.pone.0236003,medrxiv,10.1101__2020.04.23.20077297_doc.txt
10.1101/2020.04.24.20078154,Predicting COVID-19 peaks around the world,"TSALLIS, C.; TIRNAKLI, U.",Ugur TIRNAKLI,Ege University,2020-05-04,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/05/04/2020.04.24.20078154.source.xml,10.3389/fphy.2020.00217,medrxiv,10.1101__2020.04.24.20078154_doc.txt
10.1101/2020.04.27.20080226,Review and methodological analysis of trials currently testing treatment and prevention options for the novel coronavirus disease (COVID-19) globally.,"Fragkou, P. C.; Belhadi, D.; Peiffer-Smadja, N.; Moschopoulos, C. D.; Lescure, F.-X.; Janocha, H.; Karofylakis, E.; Yazdanpanah, Y.; Mentre, F.; Skevaki, C.; Laouenan, C.; Tsiodras, S.",Paraskevi C. Fragkou,"4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece",2020-05-06,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/05/06/2020.04.27.20080226.source.xml,10.1016/j.cmi.2020.05.019,medrxiv,10.1101__2020.04.27.20080226_doc.txt
10.1101/2020.04.27.20082362,Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence Testing in Idaho,"Bryan, A.; Pepper, G.; Wener, M. H.; Fink, S. L.; Morishima, C.; Chaudhary, A.; Jerome, K.; Mathias, P. C.; Greninger, A.",Alex Greninger,University of Washington,2020-05-02,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2020/05/02/2020.04.27.20082362.source.xml,10.1128/jcm.00941-20,medrxiv,10.1101__2020.04.27.20082362_doc.txt
10.1101/2020.04.26.20081059,Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19,"Huang, M.; Li, M.; Xiao, F.; Liang, J.; Pang, P.; Tang, T.; Liu, S.; Chen, B.; Shu, J.; You, Y.; Li, Y.; Tang, M.; Zhou, J.; Jiang, G.; Xiang, J.; Hong, W.; He, S.; Wang, Z.; Feng, J.; Lin, C.; Ye, Y.; Wu, Z.; Li, Y.; Zhong, B.; Sun, R.; Hong, Z.; Liu, J.; Chen, H.; Wang, X.; Li, Z.; Pei, D.; Tian, L.; Xia, J.; Jiang, S.; Zhong, N.; Shan, H.",Hong Shan,"The Fifth Affiliated Hospital, Sun Yat-sen University",2020-05-04,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/05/04/2020.04.26.20081059.source.xml,10.1093/nsr/nwaa113,medrxiv,10.1101__2020.04.26.20081059_doc.txt
10.1101/2020.04.30.20081257,Single-cell Transcriptome Analysis Indicates New Potential Regulation Mechanism of ACE2 and NPs signaling among heart failure patients infected with SARS-CoV-2,"Xu, X.; Xu, D.; Li, H.; Ma, M.; Xu, Y.; Su, Y.; Ong, S.-B.; Hu, X.; Cai, M.; Zhao, M.; Chen, Y.",Xiaojiang Xu,"NIEHS, NIH",2020-05-15,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/05/15/2020.04.30.20081257.source.xml,10.3389/fcvm.2021.628885,medrxiv,10.1101__2020.04.30.20081257_doc.txt
10.1101/2020.04.29.20084327,Cross-talk between the airway epithelium and activated immune cells defines severity in COVID-19,"Chua, R. L.; Lukassen, S.; Trump, S.; Hennig, B. P.; Wendisch, D.; Pott, F.; Debnath, O.; Thürmann, L.; Kurth, F.; Kazmierski, J.; Timmermann, B.; Twardziok, S.; Schneider, S.; Machleidt, F.; Müller-Redetzky, H.; Krannich, A.; Schmidt, S.; Balzer, F.; Liebig, J.; Loske, J.; Eils, J.; Ishaque, N.; von Kalle, C.; Hocke, A.; Witzenrath, M.; Goffinet, C.; Drosten, C.; Laudi, S.; Lehmann, I.; Conrad, C.; Sander, L.-E.; Eils, R.",Roland Eils,"Center for Digital Health, Berlin Institute of Health (BIH) and Charite - Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-U",2020-05-05,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2020/05/05/2020.04.29.20084327.source.xml,10.1038/s41587-020-0602-4,medrxiv,10.1101__2020.04.29.20084327_doc.txt
10.1101/2020.05.04.20090043,SARS-CoV-2 transmission in different settings: Analysis of cases and close contacts from the Tablighi cluster in Brunei Darussalam,"Chaw, L.; Koh, W. C.; Jamaludin, S. A.; Naing, L.; Alikhan, M. F.; Wong, J.",Liling Chaw,"PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Brunei Darussalam",2020-07-10,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/07/10/2020.05.04.20090043.source.xml,10.3201/eid2611.202263,medrxiv,10.1101__2020.05.04.20090043_doc.txt
10.1101/2020.05.04.20090944,Acute Kidney Injury in Hospitalized Patients with COVID-19,"Chan, L.; Chaudhary, K.; Saha, A.; Chauhan, K.; Vaid, A.; Baweja, M.; Campbell, K.; Chun, N.; Chung, M.; Deshpande, P.; Farouk, S. S.; Kaufman, L.; Kim, T.; Koncicki, H.; Lapsia, V.; Leisman, S.; Lu, E.; Meliambro, K.; Menon, M. C.; Rein, J. L.; Sharma, S.; Tokita, J.; Uribarri, J.; Vassalotti, J. A.; Winston, J.; Mathews, K. S.; Zhao, S.; Paranjpe, I.; Somani, S.; Richter, F.; Do, R.; Miotto, R.; Lala, A.; Kia, A.; Timsina, P.; Li, L.; Danieletto, M.; Golden, E.; Glowe, P.; Zweig, M.; Singh, M.; Freeman, R.; Chen, R.; Nestler, E.; Narula, J.; Just, A. C.; Horowitz, C.; Aberg, J.; Loos, R. J. ",Girish N Nadkarni,"Icahn School of Medicine at Mount Sinai, New York, NY, USA",2020-05-08,1,PUBLISHAHEADOFPRINT,cc_no,nephrology,https://www.medrxiv.org/content/early/2020/05/08/2020.05.04.20090944.source.xml,10.1681/ASN.2020050615,medrxiv,10.1101__2020.05.04.20090944_doc.txt
10.1101/2020.05.05.20091355,Longitudinal peripheral blood transcriptional analysis of COVID-19 patients captures disease progression and reveals potential biomarkers,"Yan, Q.; Li, P.; Ye, X.; Huang, X.; Mo, X.; Wang, Q.; Zhang, Y.; Luo, K.; Chen, Z.; Luo, J.; Niu, X.; Feng, Y.; Ji, T.; Feng, B.; Wang, J.; Li, F.; Zhang, F.; Li, F.; Wang, J.; Feng, L.; Chen, Z.; Lei, C.; QU, L.; Chen, L.",Ling Chen,"Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences",2020-05-08,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/05/08/2020.05.05.20091355.source.xml,,medrxiv,10.1101__2020.05.05.20091355_doc.txt
10.1101/2020.05.05.20092551,A preliminary study on analytical performance of serological assay for SARS-CoV-2 IgM/IgG and application in clinical practice,"Zhou, Q.; Zhu, D.; Yan, H.; Quan, J.; Kuang, Z.; Zhang, W.; Huang, L.; Lei, T.; Liu, J.; Xiao, B.; Luo, A.; Sun, Z.; Li, L.",Linhai Li,"Department of Laboratory Medicine, General Hospital of Southern Theatre Command of PLA",2020-05-09,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/05/09/2020.05.05.20092551.source.xml,,medrxiv,10.1101__2020.05.05.20092551_doc.txt
10.1101/2020.05.04.20087072,St George's COVID shield for use by ENT surgeons performing tracheostomies,"Brar, S.; Daya, J.; Schuster-Bruce, J.; Krishna, S.; Daya, H.",Hamid Daya,"St George\'s University Hospital, London",2020-05-11,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,otolaryngology,https://www.medrxiv.org/content/early/2020/05/11/2020.05.04.20087072.source.xml,,medrxiv,10.1101__2020.05.04.20087072_doc.txt
10.1101/2020.05.07.20093674,Coronavirus Disease 2019 (COVID-19): An Evidence Map of Medical Literature,"Liu, N.; Chee, M. L.; Niu, C.; Pek, P. P.; Siddiqui, F. J.; Ansah, J. P.; Matchar, D. B.; Lam, S. S. W.; Abdullah, H. R.; Chan, A.; Malhotra, R.; Graves, N.; Koh, M. S.; Yoon, S.; Ho, A. F. W.; Ting, D. S. W.; Low, J. G. H.; Ong, M. E. H.",Nan Liu,Duke-NUS Medical School,2020-05-11,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/05/11/2020.05.07.20093674.source.xml,10.1186/s12874-020-01059-y,medrxiv,10.1101__2020.05.07.20093674_doc.txt
10.1101/2020.05.07.20094235,"Chaos, Percolation and the Coronavirus Spread: a two-step model.","Bonasera, A.; zheng, h.",Aldo Bonasera,texas A&M university,2020-07-08,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/07/08/2020.05.07.20094235.source.xml,,medrxiv,10.1101__2020.05.07.20094235_doc.txt
10.1101/2020.05.07.20090621,Prolonged viral RNA shedding after COVID-19 symptom resolution in older convalescent plasma donors,"Hartman, W. R.; Hess, A. S.; Connor, J.",Aaron S Hess,University of Wisconsin-Madison,2020-05-12,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/05/12/2020.05.07.20090621.source.xml,10.1111/trf.15927,medrxiv,10.1101__2020.05.07.20090621_doc.txt
10.1101/2020.05.08.20095448,Genetic drift and regional spreading dynamics of COVID-19,"Alberti, S.; Di Pietro, R.; Basile, M.; Antolini, L.",Saverio Alberti,University of Messina,2021-01-24,4,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/01/24/2020.05.08.20095448.source.xml,,medrxiv,10.1101__2020.05.08.20095448_doc.txt
10.1101/2020.05.07.20094839,Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009.,"Rojek, A.; Martin, G.; Horby, P.",Amanda Rojek,Royal Melbourne Hospital,2020-05-12,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/05/12/2020.05.07.20094839.source.xml,10.1186/s12916-020-01732-5,medrxiv,10.1101__2020.05.07.20094839_doc.txt
10.1101/2020.05.10.20049783,Attributable mortality of vancomycin resistance in ampicillin-resistant Enterococcus faecium bacteremia in Denmark and the Netherlands: a matched cohort study,"Rottier, W. C.; Pinholt, M.; van der Bij, A. K.; Arpi, M.; Blank, S. N.; Nabuurs-Franssen, M. H.; Ruijs, G. J. H. M.; Tersmette, M.; Ossewaarde, J. M.; Groenwold, R. H.; Westh, H.; Bonten, M. J. M.; Dutch VRE Bacteremia Investigators,  ; Danish Collaborative Bacteraemia Network (DACOBAN),  ",Wouter Carel Rottier,"University Medical Center Utrecht (Utrecht, NL)",2020-05-15,1,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2020/05/15/2020.05.10.20049783.source.xml,10.1017/ice.2021.216,medrxiv,10.1101__2020.05.10.20049783_doc.txt
10.1101/2020.05.12.20097105,SARS-CoV-2 spillover into hospital outdoor environments,"Zhang, D.; Yang, Y.; Huang, X.; Jiang, J.; Li, M.; Zhang, X.; Ling, H.; Li, J.; Liu, Y.; Li, G.; Li, W.; Yi, C.; Zhang, T.; Jiang, Y.; Xiong, Y.; Hu, Z.; Wang, X.; Deng, S.; Zhao, P.; Qu, J.",Dayi Zhang,Tsinghua University,2020-05-19,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/05/19/2020.05.12.20097105.source.xml,10.1016/j.hazl.2021.100027,medrxiv,10.1101__2020.05.12.20097105_doc.txt
10.1101/2020.05.12.20099044,Forecasting the COVID-19 Pandemic with Climate Variables for Top Five Burdening and Three South Asian Countries,"Karimuzzaman, M.; Afroz, S.; Hossain, M. M.; Rahman, A.",Azizur Rahman,Charles Sturt University,2020-05-19,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/05/19/2020.05.12.20099044.source.xml,,medrxiv,10.1101__2020.05.12.20099044_doc.txt
10.1101/2020.05.21.20108951,Effective Screening of SARS-CoV-2 Neutralizing Antibodies in Patient Serum using Lentivirus Particles Pseudotyped with SARS-CoV-2 Spike Glycoprotein,"Tandon, R.; Mitra, D.; Sharma, P.; Stray, S. J.; Bates, J. T.; Marshall, G. D.",Ritesh Tandon,University of Mississippi Medical Center,2020-05-23,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/05/23/2020.05.21.20108951.source.xml,10.1038/s41598-020-76135-w,medrxiv,10.1101__2020.05.21.20108951_doc.txt
10.1101/2020.05.22.20108498,"Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a","Batty, E. M.; Kochakarn, T.; Panthan, B.; Kumpornsin, K.; Jiaranai, P.; Wangwiwatsin, A.; Kotanan, N.; Jaruampornpan, P.; Watthanachockchai, T.; Rakmanee, K.; Sensorn, I.; Sungkanuparph, S.; Pasomsub, E.; Chookajorn, T.; Chantratita, W.",Thanat Chookajorn,Mahidol University,2020-05-25,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/05/25/2020.05.22.20108498.source.xml,10.1016/j.virusres.2020.198233,medrxiv,10.1101__2020.05.22.20108498_doc.txt
10.1101/2020.05.24.20100990,Performance evaluation of the point-of-care SAMBA II SARS-CoV-2 Test for detection of SARS-CoV-2,"Assennato, S. M.; Ritchie, A. V.; Nadala, C.; Goel, N.; Zhang, H.; Datir, R.; Gupta, R. K.; Curran, M. D.; Lee, H. H.",Helen H Lee,Diagnostics for the Real World EU Ltd,2020-06-09,3,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/06/09/2020.05.24.20100990.source.xml,10.1128/JCM.01262-20,medrxiv,10.1101__2020.05.24.20100990_doc.txt
10.1101/2020.05.18.20106187,Tensions between research and public health: modelling the risks and benefits of SARS-CoV-2 vaccine field trials versus human infection challenge studies.,"Heriot, G. S.; Jamrozik, E.; Selgelid, M. J.",George S Heriot,Monash University,2020-05-27,2,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/05/27/2020.05.18.20106187.source.xml,,medrxiv,10.1101__2020.05.18.20106187_doc.txt
10.1101/2020.05.24.20111971,Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Network.,"Casas Rojo, J. M.; Anton Santos, J. M.; Millan Nunez-Cortes, J.; Lumbreras Bermejo, C.; Ramos Rincon, J. M.; Roy-Vallejo, E.; Artero Mora, A.; Arnalich Fernandez, F.; Garcia Brunen, J. M.; Vargas Nunez, J. A.; Freire Castro, S. J.; Manzano, L.; Perales Fraile, I.; Crestelo Vieitez, A.; Puchades, F.; Rodilla, E.; Solis Marquinez, M. N.; Bonet Tur, D.; Fidalgo Moreno, M. d. P.; Fonseca Aizpuru, E. M.; Carrasco Sanchez, F. J.; Rabadan Pejenaute, E.; Rubio-Rivas, M.; Torres Pena, J. D.; Gomez Huelgas, R.",Juan Miguel Antón Santos,"Internal Medicine Department, Infanta Cristina University Hospital, Parla (Madrid), Spain",2020-05-26,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/05/26/2020.05.24.20111971.source.xml,10.1016/j.rceng.2020.07.003,medrxiv,10.1101__2020.05.24.20111971_doc.txt
10.1101/2020.05.26.20113464,The Potential Impact of Intensified Community Hand Hygiene Interventions on Respiratory tract Infections: A Modelling Study,"Pham, T. M.; Mo, Y.; Cooper, B.",Thi Mui Pham,Julius Center for Health Sciences and Primary Care of the UMC Utrecht,2020-05-27,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/05/27/2020.05.26.20113464.source.xml,,medrxiv,10.1101__2020.05.26.20113464_doc.txt
10.1101/2020.05.26.20114124,Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak,"Dingens, A. S.; Crawford, K. H.; Adler, A.; Steele, S. L.; Lacombe, K.; Eguia, R.; Amanat, F.; Walls, A. C.; Wolf, C. R.; Murphy, M.; Pettie, D.; Carter, L.; Qin, X.; King, N. P.; Veesler, D.; Krammer, F.; Dickerson, J. A.; Chu, H. Y.; Englund, J. A.; Bloom, J. D.",Jesse D Bloom,Fred Hutchinson Cancer Research Center,2020-06-30,3,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2020/06/30/2020.05.26.20114124.source.xml,10.1038/s41467-020-18178-1,medrxiv,10.1101__2020.05.26.20114124_doc.txt
10.1101/2020.05.27.20114744,Factors affecting healthcare workers' compliance with social and behavioural infection control measures during emerging infectious disease outbreaks: Rapid evidence review.,"Brooks, S. K.; Greenberg, N.; Wessely, S.; Rubin, G. J.",G James Rubin,King\'s College London,2020-05-29,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/05/29/2020.05.27.20114744.source.xml,10.1136/bmjopen-2021-049857,medrxiv,10.1101__2020.05.27.20114744_doc.txt
10.1101/2020.05.26.20113373,Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter interventional trial,"Perotti, C.; Baldanti, F.; Bruno, R.; Delfante, C.; Seminari, E.; Casari, S.; Percivalle, E.; Glingani, C.; Musella, V.; Belliato, M.; Garuti, M.; Meloni, F.; Frigato, M.; Di Sabatino, A.; Klersy, C.; De Donno, G.; Franchini, M.",Catherine Klersy,Fondazione IRCCS Policlinco San Matteo,2020-05-29,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/05/29/2020.05.26.20113373.source.xml,10.3324/haematol.2020.261784,medrxiv,10.1101__2020.05.26.20113373_doc.txt
10.1101/2020.05.29.20115915,Digital proximity tracing on empirical contact networks for pandemic control,"Cencetti, G.; Santin, G.; Longa, A.; Pigani, E.; Barrat, A.; Cattuto, C.; Lehmann, S.; Salathe, M.; Lepri, B.",Gabriele Santin,Fondazione Bruno Kessler,2021-02-18,3,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/02/18/2020.05.29.20115915.source.xml,/10.1038/s41467-021-21809-w,medrxiv,10.1101__2020.05.29.20115915_doc.txt
10.1101/2020.05.31.20118588,The Effect of Ultraviolet C Radiation Against SARS-CoV-2 Inoculated N95 Respirators,"Ozog, D. M.; Sexton, J. Z.; Narla, S.; Pretto-Kernahan, C. D.; Mirabelli, C.; Lim, H. W.; Hamzavi, I. H.; Tibbetts, R. J.; Mi, Q.-S.",David M. Ozog,Henry Ford Health System,2020-06-26,3,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/06/26/2020.05.31.20118588.source.xml,10.1016/j.ijid.2020.08.077,medrxiv,10.1101__2020.05.31.20118588_doc.txt
10.1101/2020.05.31.20118349,Covid-19 and Population Age Structure,"Haridas, A.; Pratap, G.",Ajit Haridas,individual,2020-06-03,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/06/03/2020.05.31.20118349.source.xml,,medrxiv,10.1101__2020.05.31.20118349_doc.txt
10.1101/2020.06.02.20120865,Decreased plasma levels of the survival factor renalase are associated with worse outcomes in COVID-19,"Wang, M.; Guo, X.; Chun, H. J.; Lee, A. I.; Cha, C.; Gorelick, F.; Desir, G. V.",Gary V Desir,Yale University School of Medicine,2020-06-09,2,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/06/09/2020.06.02.20120865.source.xml,,medrxiv,10.1101__2020.06.02.20120865_doc.txt
10.1101/2020.06.03.20121574,Predicting individual risk for COVID19 complications using EMR data,"Kinar, Y.; Lanyado, A.; Shoshan, A.; Yesharim, R.; Domany, T.; Shalev, V.; Chodcik, G.",Gabriel Chodcik,Maccabitech Maccabi Institute for Research & Innovation,2020-06-05,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/06/05/2020.06.03.20121574.source.xml,,medrxiv,10.1101__2020.06.03.20121574_doc.txt
10.1101/2020.06.03.20120576,A FRACTAL VIEWPOINT TO COVID-19 INFECTION,"Sotolongo-Costa, O.; Weberszpil, J.; Sotolongo-Grau, O.",José Weberszpil,Univ. Federal Rural do Rio de Janeiro-UFRRJ,2020-06-17,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/06/17/2020.06.03.20120576.source.xml,,medrxiv,10.1101__2020.06.03.20120576_doc.txt
10.1101/2020.05.28.20116012,Cremation based estimates suggest significant under- and delayed reporting of COVID-19 epidemic data in Wuhan and China,"He, M.; Li, L.; Dehner, L. P.; Dunn, L.",Mai He,Washington University in St. Louis School of Medicine,2020-06-16,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/06/16/2020.05.28.20116012.source.xml,,medrxiv,10.1101__2020.05.28.20116012_doc.txt
10.1101/2020.06.05.20122622,Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2,"Petrak, R.; Skorodin, N.; Van Hise, N.; Fliegelman, R.; Pinsky, J.; Didwania, V.; Anderson, M.; Diaz, M.; Shah, K.; Chundi, V.; Hines, D.; Harting, B.; Sidwha, K.; Yu, B.; Brune, P.; Owaisi, A.; Beezhold, D.; Kent, J.; Vais, D.; Han, A.; Gowda, N.; Sahgal, N.; Silverman, J.; Stake, J.; Nepomuceno, J.; Heddurshetti, R.",Russell Petrak,Metro Infectious Disease Consultants,2020-06-08,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/06/08/2020.06.05.20122622.source.xml,10.1111/cts.12894,medrxiv,10.1101__2020.06.05.20122622_doc.txt
10.1101/2020.06.07.20125047,Survival and predictors of deaths of patients hospitalized due to COVID-19 from a retrospective and multicenter cohort study in Brazil,"Santos, M.; Lucena, E. E.; Lima, K. C.; Brito, A. A.; Bay, M. B.; Bonfada, D.",Marquiony Santos,UERN,2020-06-09,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/06/09/2020.06.07.20125047.source.xml,10.1017/S0950268820002034,medrxiv,10.1101__2020.06.07.20125047_doc.txt
10.1101/2020.06.09.20126219,Whole genome sequencing of human enteroviruses from clinical samples by nanopore direct RNA sequencing,"Grädel, C.; Terrazos Miani, M. A.; Baumann, C.; Barbani, M. T.; Neuenschwander, S.; Leib, S. L.; Suter-Riniker, F.; Ramette, A.",Alban Ramette,University of Bern,2020-06-09,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/06/09/2020.06.09.20126219.source.xml,10.3390/v12080841,medrxiv,10.1101__2020.06.09.20126219_doc.txt
10.1101/2020.06.08.20125682,A community-based validation of the International Alliance for the Control of Scabies Consensus Criteria by expert and non-expert examiners in Liberia,"Walker, S.; Collinson, S.; Timothy, J.; Zayzay, S.; Kollie, K.; Lebas, E.; Halliday, K.; Pullan, R.; Fallah, M.; Marks, M.",Michael Marks,London School of Hygiene and Tropical Medicine,2020-06-09,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2020/06/09/2020.06.08.20125682.source.xml,10.1371/journal.pntd.0008717,medrxiv,10.1101__2020.06.08.20125682_doc.txt
10.1101/2020.06.09.20126334,Modeling the Transmission of Respiratory Infectious Diseases in Mass Transportation Systems,"Buhat, C. A. H.; Lutero, D. S.; Olave, Y. H.; Torres, M. C.; Rabajante, J. F.",Christian Alvin H Buhat,University of the Philippines Los Banos,2020-06-11,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/06/11/2020.06.09.20126334.source.xml,,medrxiv,10.1101__2020.06.09.20126334_doc.txt
10.1101/2020.06.10.20123281,Clinical outcomes of SARS-CoV-2 pandemic in long-term care facilities for people with epilepsy: observational study,"Balestrini, S.; Koepp, M. J.; Gandhi, S.; Rickman, H.; Shin, G. Y.; Houlihan, C.; Anders-Cannon, J.; Silvennoinen, K.; Xiao, F.; Zagaglia, S.; Hudgell, K.; Ziomek, M.; Haimes, P.; Sampson, A.; Parker, A.; Cross, J. H.; Pardington, R.; Nastouli, E.; Swanton, C.; Sander, J. W.; Sisodiya, S.",Matthias J Koepp,UCL Queen Square Institute of Neurology,2020-06-12,1,PUBLISHAHEADOFPRINT,cc_no,neurology,https://www.medrxiv.org/content/early/2020/06/12/2020.06.10.20123281.source.xml,,medrxiv,10.1101__2020.06.10.20123281_doc.txt
10.1101/2020.06.14.20130971,Inflammatory pathways amongst people living with HIV in Malawi differ according to socioeconomic status,"Kelly, C.; Tingao, W.; Alber, D.; Hunter, P.; Luckhurst, N.; Connolly, J.; Arrigoni, F.; Garcia Abner, A.; Kamn'gona, R.; Sheha, I.; Chammudzi, M.; Jambo, K.; Mallewa, J.; Rapala, A.; Mallon, P.; Mwandumba, H.; Klein, N.; Khoo, S.",Christine Kelly,UCD,2020-06-16,1,PUBLISHAHEADOFPRINT,cc_by,hiv aids,https://www.medrxiv.org/content/early/2020/06/16/2020.06.14.20130971.source.xml,10.1371/journal.pone.0256576,medrxiv,10.1101__2020.06.14.20130971_doc.txt
10.1101/2020.06.16.20126714,Comparative Survival Analysis of Immunomodulatory Therapy for COVID-19 'Cytokine Storm': A Retrospective Observational Cohort Study,"Narain, S.; Stefanov, D.; Chau, A. S.; Weber, A. G.; Marder, G. S.; Kaplan, B.; Malhotra, P.; Bloom, O.; Liu, A.; Lesser, M.; Hajizadeh, N.",Sonali Narain,Northwell Health,2020-06-19,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/06/19/2020.06.16.20126714.source.xml,,medrxiv,10.1101__2020.06.16.20126714_doc.txt
10.1101/2020.06.17.20133793,Development of a SARS-CoV-2 total antibody assay and the dynamics of antibody response over time in hospitalized and non-hospitalized patients with COVID-19,"Vogelzang, E. H.; Loeff, F. C.; Derksen, N. I.; Kruithof, S.; Ooijevaar-de Heer, P.; van Mierlo, G.; Linty, F.; Mok, J. Y.; van Esch, W.; de Bruin, S.; Vlaar, A. P.; Seppen, B.; Leeuw, M.; van Oudheusden, A. J.; Buiting, A. G.; Jim, K. K.; Vrielink, H.; Swaneveld, F.; Vidarsson, G.; van der Schoot, C. E.; Wever, P.; Li, W.; van Kuppeveld, F. J.; Murk, J.-L.; Bosch, B. J.; Wolbink, G. J.; Rispens, T.",Theo Rispens,Sanquin Research,2020-06-19,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/06/19/2020.06.17.20133793.source.xml,10.4049/jimmunol.2000767,medrxiv,10.1101__2020.06.17.20133793_doc.txt
10.1101/2020.06.19.20135483,Epidemiological Risk Factors Associated with Death and Severe Disease in Patients Suffering From COVID-19: A Comprehensive Systematic Review and Meta-analysis,"Dorjee, K.; Kim, H.",Kunchok Dorjee,Johns Hopkins University School of Medicine,2020-06-20,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/06/20/2020.06.19.20135483.source.xml,,medrxiv,10.1101__2020.06.19.20135483_doc.txt
10.1101/2020.06.21.20132944,Clinical predictors of donor antibody titer and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial,"Madariaga, M. L. L.; Guthmiller, J.; Schrantz, S.; Jansen, M.; Christenson, C.; Kumar, M.; Prochaska, M.; Wool, G.; Durkin, A.; Oh, W. H.; Trockman, L.; Vigneswaran, J.; Keskey, R.; Shaw, D. G.; Dugan, H.; Zheng, N.; Cobb, M.; Utset, H.; Wang, J.; Stovicek, O.; Bethel, C.; Matushek, S.; Giurcanu, M.; Beavis, K.; diSabato, D.; Meltzer, D.; Ferguson, M.; Kress, J. P.; Shanmugarajah, K.; Matthews, J.; Fung, J.; Wilson, P.; Alverdy, J. C.; Donington, J.",Maria Lucia L Madariaga,University of Chicago,2020-06-23,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/06/23/2020.06.21.20132944.source.xml,10.1111/joim.13185,medrxiv,10.1101__2020.06.21.20132944_doc.txt
10.1101/2020.06.22.20137448,Humidity and deposition solution play a critical role in virus inactivation by heat treatment on N95 respirators,"Rockey, N.; Arts, P. J.; Li, L.; Harrison, K. R.; Langenfeld, K.; Fitzsimmons, W. J.; Lauring, A. S.; Love, N. G.; Kaye, K. S.; Raskin, L.; Roberts, W. W.; Hegarty, B.; Wigginton, K. R.",Krista R. Wigginton,University of Michigan,2020-06-23,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/06/23/2020.06.22.20137448.source.xml,10.1128/mSphere.00588-20,medrxiv,10.1101__2020.06.22.20137448_doc.txt
10.1101/2020.06.22.20136309,Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance,"Larremore, D. B.; Wilder, B.; Lester, E.; Shehata, S.; Burke, J. M.; Hay, J. A.; Tambe, M.; Mina, M. J.; Parker, R.",Daniel B Larremore,University of Colorado Boulder,2020-09-08,3,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/09/08/2020.06.22.20136309.source.xml,10.1126/sciadv.abd5393,medrxiv,10.1101__2020.06.22.20136309_doc.txt
10.1101/2020.06.23.20134072,Treatment of ARDS and hyperinflammation in COVID-19 with IL-6 antagonist Tocilizumab: a tertiary care experience from Pakistan,"Nasir, N.; Mahmood, S. F.; Habib, K.; Khanum, I.; Jamil, B.",Nosheen Nasir,Aga Khan University,2020-06-26,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/06/26/2020.06.23.20134072.source.xml,,medrxiv,10.1101__2020.06.23.20134072_doc.txt
10.1101/2020.06.25.20139915,Neighborhood income and physical distancing during the COVID-19 pandemic in the U.S.,"Jay, J.; Bor, J.; Nsoesie, E.; Lipson, S. K.; Jones, D. K.; Galea, S.; Raifman, J.",Jonathan Jay,Boston University School of Public Health,2020-06-26,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/06/26/2020.06.25.20139915.source.xml,,medrxiv,10.1101__2020.06.25.20139915_doc.txt
10.1101/2020.06.27.20141440,A Modelling Study for Designing a Multi-layered Surveillance Approach to Detect the Potential Resurgence of SARS-CoV-2,"Liu, Y.; Gong, W.; Clifford, S.; Sundaram, M. E.; CMMID COVID19 Working Group,  ; Jit, M.; Flasche, S.; Klepac, P.",Yang Liu,London School of Hygiene and Tropical Medicine,2020-06-29,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2020/06/29/2020.06.27.20141440.source.xml,,medrxiv,10.1101__2020.06.27.20141440_doc.txt
10.1101/2020.06.28.20140475,Reliability of serological tests for COVID-19: Comparison of three immunochromatography test kits for SARS-CoV-2 antibodies.,"Fujigaki, H.; Takemura, M.; Osawa, M.; Sakurai, A.; Nakamoto, K.; Seto, K.; Fujita, T.; Hata, T.; Akiyama, H.; Doi, Y.; Saito, K.",Hidetsugu Fujigaki,Fujita Health University Graduate School of Health Sciences,2020-06-29,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/06/29/2020.06.28.20140475.source.xml,10.1016/j.heliyon.2020.e04929,medrxiv,10.1101__2020.06.28.20140475_doc.txt
10.1101/2020.06.29.20141978,"Pseudo-Likelihood Based Logistic Regression for Estimating COVID-19 Infection and Case Fatality Rates by Gender, Race, and Age in California","Xiong, D.; Zhang, L.; Watson, G. L.; Sundin, P.; Bufford, T.; Zoller, J. A.; Shamshoian, J.; Suchard, M. A.; Ramirez, C. M.",Christina M. Ramirez,"University of California, Los Angeles",2020-07-01,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/07/01/2020.06.29.20141978.source.xml,10.1016/j.epidem.2020.100418,medrxiv,10.1101__2020.06.29.20141978_doc.txt
10.1101/2020.07.01.20143966,A translational multiplex serology approach to profile the prevalence of anti-SARS-CoV-2 antibodies in home-sampled blood,"Roxhed, N.; Bendes, A.; Dale, M.; Mattsson, C.; Hanke, L.; Dodig-Crnkovic, T.; Christian, M.; Meineke, B.; Elsasser, S.; Andrell, J.; Haverall, S.; Thalin, C.; Eklund, C.; Dillner, J.; Beck, O.; Thomas, C. E.; McInerney, G.; Hong, M.-G.; Murrell, B.; Fredolini, C.; Schwenk, J. M.",Jochen M Schwenk,KTH - Royal Institute of Technology,2020-07-02,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/07/02/2020.07.01.20143966.source.xml,10.1038/s41467-021-23893-4,medrxiv,10.1101__2020.07.01.20143966_doc.txt
10.1101/2020.06.29.20136572,Routine measurement of serum procalcitonin allows antibiotics to be safely withheld in patients admitted to hospital with SARS-CoV-2 infection.,"Williams, E. J.; Mair, L.; de Silva, T. I.; Green, D. J.; House, P.; Cawthron, K.; Gillies, C.; Wigfull, J.; Parsons, H.; Partridge, D. G.",Emma Jane Williams,Sheffield Teaching Hospitals NHS Foundation Trust,2020-07-02,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/07/02/2020.06.29.20136572.source.xml,,medrxiv,10.1101__2020.06.29.20136572_doc.txt
10.1101/2020.07.02.20145425,How was the Mental Health of Colombian people on March during Pandemics Covid19?,"Chire Saire, J. E.",Josimar E. Chire Saire,University of Sao Paulo,2020-07-04,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,psychiatry and clinical psychology,https://www.medrxiv.org/content/early/2020/07/04/2020.07.02.20145425.source.xml,,medrxiv,10.1101__2020.07.02.20145425_doc.txt
10.1101/2020.07.02.20145003,Tissue-specific tolerance in fatal Covid-19,"Dorward, D. A.; Russell, C. D.; Um, I. H.; Elshani, M.; Armstrong, S. D.; Penrice-Randal, R.; Millar, T.; Lerpiniere, C. E.; Tagliavini, G.; Hartley, C. S.; Randall, N. P.; Gachanja, N. N.; Potey, P. M.; Anderson, A. M.; Campbell, V. L.; Duguid, A. J.; Al Qsous, W.; BouHaidar, R.; Baillie, J. K.; Dhaliwal, K.; Wallace, W. A.; Bellamy, C. O.; Prost, S.; Smith, C.; Hiscox, J. A.; Harrison, D. J.; Lucas, C. D.; ICECAP,  ",Christopher D Lucas,University of Edinburgh,2020-07-04,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/07/04/2020.07.02.20145003.source.xml,10.1164/rccm.202008-3265OC,medrxiv,10.1101__2020.07.02.20145003_doc.txt
10.1101/2020.06.29.20131367,Evaluation of Viasure SARS-CoV-2 RT-qPCR kit (CerTest Biotec) using CDC FDA EUA RT-qPCR kit as a gold standard.,"Freire-Paspuel, B.; Vega-Marino, P. A.; Velez, A.; Cruz, M.; Perez, F.; Garcia Bereguiain, M. A.",Miguel Angel Garcia Bereguiain,Universidad de Las Americas,2020-07-06,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/07/06/2020.06.29.20131367.source.xml,10.1016/j.virol.2020.10.010,medrxiv,10.1101__2020.06.29.20131367_doc.txt
10.1101/2020.07.02.20143271,Daily viral kinetics and innate and adaptive immune responses assessment in COVID-19: a case series,"Vetter, P.; Eberhardt, C.; Meyer, B.; Martinez, P.; Torriani, G.; Pigny, F.; Lemeille, S.; Cordey, S.; Laubscher, F.; Vu, D.-L.; Calame, A.; Schibler, M.; Jacquerioz, F.; Blanchard, G.; Siegrist, C.-A.; Kaiser, L.; Didierlaurent, A.; eckerle, i.",Pauline Vetter,Geneva University Hospitals,2020-07-06,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/07/06/2020.07.02.20143271.source.xml,10.1128/mSphere.00827-20,medrxiv,10.1101__2020.07.02.20143271_doc.txt
10.1101/2020.07.05.20146886,Characterization of prolonged COVID-19 symptoms and patient comorbidities in an outpatient telemedicine cohort,"O'Keefe, J. B.; Cellai, M.",James B O'Keefe,Emory University School of Medicine,2020-07-07,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/07/07/2020.07.05.20146886.source.xml,,medrxiv,10.1101__2020.07.05.20146886_doc.txt
10.1101/2020.07.06.20147348,Community prevalence of SARS-CoV-2 in England: Results from the ONS Coronavirus Infection Survey Pilot,"Pouwels, K. B.; House, T.; Robotham, J. V.; Birrell, P.; Gelman, A. B.; Bowers, N.; Boreham, I.; Thomas, H.; Lewis, J.; Bell, I.; Bell, J. I.; Newton, J.; Farrar, J.; Diamond, I.; Benton, P.; Walker, S.",Koen B Pouwels,University of Oxford,2020-07-07,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2020/07/07/2020.07.06.20147348.source.xml,,medrxiv,10.1101__2020.07.06.20147348_doc.txt
10.1101/2020.07.06.20146712,Risk of Transmission of infection to Healthcare Workers delivering Supportive Care for Coronavirus Pneumonia;A Rapid GRADE Review,"Luqman Arafath, T.; Jubbal, S. S.; Gireesh, E. D.; Margapuri, J.; Jogu, H. R.; Patni, H.; Thompson, T.; Patel, A.; Abdulla, A.; Menon, S.; Penupolu, S.",TK Luqman Arafath,Wake Forest School of Medicine,2020-07-08,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/07/08/2020.07.06.20146712.source.xml,,medrxiv,10.1101__2020.07.06.20146712_doc.txt
10.1101/2020.07.06.20143719,Performance characteristics of a high throughput automated transcription mediated amplification test for SARS-CoV-2 detection,"Pham, J.; Meyer, S.; Nguyen, C.; Williams, A.; Hunsicker, M.; McHardy, I.; Gendlina, I.; Goldstein, D. Y.; Fox, A. S.; Hudson, A.; Darby, P.; Hovey, P.; Morales, J.; Mitchell, J.; Harrington, K.; Majlessi, M.; Moberly, J.; Shah, A.; Worlock, A.; Walcher, M.; Eaton, B.; Getman, D.; Clark, C.",Damon Getman,Hologic Inc,2020-07-10,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/07/10/2020.07.06.20143719.source.xml,10.1128/JCM.01669-20,medrxiv,10.1101__2020.07.06.20143719_doc.txt
10.1101/2020.07.10.20150771,In-house modification and improvement of the CDC real-time PCR diagnostic assay for SARS-CoV-2 detection.,"Das, S.; Dowell-Martino, C.; Arrigo, L.; Fiedler, P. N.; Lobo, S.",Srirupa Das,Nuvance Health,2020-07-11,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2020/07/11/2020.07.10.20150771.source.xml,,medrxiv,10.1101__2020.07.10.20150771_doc.txt
10.1101/2020.07.11.20147157,Effects of environmental factors on severity and mortality of COVID-19,"Kifer, D.; Bugada, D.; Villar-Garcia, J.; Gudelj, I.; Menni, C.; Sudre, C. H.; Vuckovic, F.; Ugrina, I.; Lorini, L. F.; Bettinelli, S.; Ughi, N.; Maloberti, A.; Epis, O.; Giannattasio, C.; Rossetti, C.; Kalogjera, L.; Persec, J.; Ollivere, L.; Ollivere, B.; Yan, H.; Cai, T.; Aithal, G.; Steves, C.; Kantele, A.; Kajova, M.; Vapalahti, O.; Sajantila, A.; Wojtowicz, R.; Wierzba, W.; Krol, Z.; Zaczynski, A.; Zycinska, K.; Postula, M.; Luksic, I.; Civljak, R.; Markotic, A.; Mahnkopf, C.; Markl, A.; Brachmann, J.; Murray, B.; Ourselin, S.; Pascual, J.; Valdes, A. M.; Posso, M.; Horcajada, J.; Castel",Gordan Lauc,University of Zagreb,2020-12-14,3,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2020/12/14/2020.07.11.20147157.source.xml,10.3389/fmed.2020.607786,medrxiv,10.1101__2020.07.11.20147157_doc.txt
10.1101/2020.07.12.20148387,Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations,"Andrasfay, T.; Goldman, N.",Theresa Andrasfay,Princeton University,2020-10-15,3,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2020/10/15/2020.07.12.20148387.source.xml,10.1073/pnas.2014746118,medrxiv,10.1101__2020.07.12.20148387_doc.txt
10.1101/2020.07.12.20151191,COVID-19 scenarios for the United States,"IHME COVID-19 Forecasting Team,  ; Hay, S. I.",Simon I Hay,"Institute for Health Metrics and Evaluation, University of Washington",2020-07-14,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2020/07/14/2020.07.12.20151191.source.xml,10.1038/s41591-020-1132-9,medrxiv,10.1101__2020.07.12.20151191_doc.txt
10.1101/2020.07.13.20153114,Dynamics of B-cell repertoires and emergence of cross-reactive responses in COVID-19 patients with different disease severity,"Montague, Z.; Lv, H.; Otwinowski, J.; DeWitt, W. S.; Isacchini, G.; Yip, G. K.; Ng, W. W.; Tsang, O. T.-Y.; Yuan, M.; Liu, H.; Wilson, I. A.; Peiris, M.; Wu, N. C.; Nourmohammad, A.; Mok, C. K. P.",Armita Nourmohammad,"Department of Physics, University of Washington",2021-04-06,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/04/06/2020.07.13.20153114.source.xml,10.1016/j.celrep.2021.109173,medrxiv,10.1101__2020.07.13.20153114_doc.txt
10.1101/2020.07.18.20157008,Adjunctive Corticosteroids for COVID-19: A Retrospective Cohort Study,"Ooi, S. T.; Parthasarathy, P.; Lin, Y.; Nallakaruppan, V.; Ng, S.; Tan, T. C.; Low, S.; Tang, T.",Say Tat Ooi,"Khoo Teck Puat hospital, Singapore",2020-07-21,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/07/21/2020.07.18.20157008.source.xml,,medrxiv,10.1101__2020.07.18.20157008_doc.txt
10.1101/2020.07.21.20158758,Temporal dynamics of human respiratory and gut microbiomes during the course of COVID-19 in adults,"Xu, R.; Lu, R.; Zhang, T.; Wu, Q.; Cai, W.; Han, X.; Jin, X.; Zhang, Z.; Zhang, C.; Wan, Z.",Chiyu Zhang,Shanghai Public Health Clinical Center,2020-07-22,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/07/22/2020.07.21.20158758.source.xml,,medrxiv,10.1101__2020.07.21.20158758_doc.txt
10.1101/2020.07.21.20159327,COVID-19 Vulnerability of Transgender Women With and Without HIV Infection in the Eastern and Southern U.S.,"Poteat, T.; Reisner, S.; Miller, M.; Wirtz, A.",Tonia Poteat,"Department of Social Medicine, University of North Carolina at Chapel Hill",2020-07-24,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,hiv aids,https://www.medrxiv.org/content/early/2020/07/24/2020.07.21.20159327.source.xml,10.1097/qai.0000000000002490,medrxiv,10.1101__2020.07.21.20159327_doc.txt
10.1101/2020.07.17.20156463,SARS-CoV-2 Infection and Stroke: Coincident or Causal?,"Walker, M.; Young, C. C.; Sharma, M.; Levitt, M. R.; Tirschwell, D. L.; WWAMI Stroke Investigators,  ",Melanie Walker,University of Washington School of Medicine,2020-07-29,1,PUBLISHAHEADOFPRINT,cc_no,neurology,https://www.medrxiv.org/content/early/2020/07/29/2020.07.17.20156463.source.xml,,medrxiv,10.1101__2020.07.17.20156463_doc.txt
10.1101/2020.07.27.20162354,Non-communicable disease and the risk of infection death: a UK Biobank prospective cohort study,"Drozd, M.; Lillie, P.; Pujades-Rodriguez, M.; Straw, S.; Morgan, A. W.; Kearney, M. T.; Witte, K. K.; Cubbon, R. M.",Richard M Cubbon,University of Leeds,2020-07-29,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2020/07/29/2020.07.27.20162354.source.xml,,medrxiv,10.1101__2020.07.27.20162354_doc.txt
10.1101/2020.07.26.20159756,Efficacy and tolerability of bevacizumab in patients with severe Covid -19,"Pang, J.; Xu, F.; Aondio, G.; Li, Y.; Fumagalli, A.; Lu, M.; Valmadre, G.; Wei, J.; Bian, Y.; Canesi, M.; Damiani, G.; Zhang, Y.; Yu, D.; Chen, J.; Ji, X.; Sui, W.; Wang, B.; Wu, S.; Kovacs, A.; Revera, M.; Wang, H.; Zhang, Y.; Chen, Y.; Cao, Y.",Yihai Cao,Karolinska Institute,2020-07-29,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/07/29/2020.07.26.20159756.source.xml,10.1038/s41467-021-21085-8,medrxiv,10.1101__2020.07.26.20159756_doc.txt
10.1101/2020.07.27.20162693,Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors,"Uyoga, S.; Adetifa, I. M. O.; Karanja, H. K.; Nyagwange, J.; Tuju, J.; Wanjiku, P.; Aman, R.; Mwangangi, M.; Amoth, P.; Kasera, K.; Ng'ang'a, W.; Rombo, C.; Yegon, C. K.; Kithi, K.; Odhiambo, E.; Rotich, T.; Orgut, I.; Kihara, S.; Otiende, M.; Bottomley, C.; Mupe, Z. N.; Kagucia, E. W.; Gallagher, K.; Etyang, A.; Voller, S.; Gitonga, J.; Mugo, D.; Agoti, C. N.; Otieno, E.; Ndwiga, L.; Lambe, T.; Wright, D.; Barasa, E.; Tsofa, B.; Bejon, P.; Ochola-Oyier, L. I.; Agweyu, A.; Scott, J. A. G.; Warimwe, G. M.",Sophie Uyoga,"KEMRI Wellcome Trust Research Programme, Kenya",2020-07-29,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/07/29/2020.07.27.20162693.source.xml,10.1126/science.abe1916,medrxiv,10.1101__2020.07.27.20162693_doc.txt
10.1101/2020.07.28.20164004,SARS-CoV-2 detection with de novo designed synthetic riboregulators,"Koksaldi, I. C.; Ahan, R. E.; Kose, S.; Haciosmanoglu, N.; Kehribar, E. S.; Gungen, M. A.; Ozkul, A.; Seker, U. O. S.",Urartu Ozgur Safak Seker,Bilkent University,2020-07-30,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/07/30/2020.07.28.20164004.source.xml,,medrxiv,10.1101__2020.07.28.20164004_doc.txt
10.1101/2020.08.03.20167320,Retrospective SARS-CoV-2 Real-Time PCR Testing of Stored Bronchoalveolar Lavage Samples from February 2020,"Challener, D. W.; Shah, A.; Binnicker, M.; Badley, A.; O'Horo, J.",Douglas W Challener,Mayo Clinic,2020-08-04,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/08/04/2020.08.03.20167320.source.xml,,medrxiv,10.1101__2020.08.03.20167320_doc.txt
10.1101/2020.08.07.20170514,Comparison of the Safety and Immunogenicity of a Novel Matrix-M-adjuvanted Nanoparticle Influenza Vaccine with a Quadrivalent Seasonal Influenza Vaccine in Older Adults: A Randomized Controlled Trial,"Shinde, V.; Cho, I.; Plested, J. S.; Agrawal, S.; Fiske, J.; Cai, R.; Zhou, H.; Pham, X.; Zhu, M.; Cloney-Clark, S.; Wang, N.; Zhou, B.; Lewis, M.; Price-Abbott, P.; Patel, N.; Massare, M. J.; Smith, G.; Keech, C.; Fries, L.; Glenn, G. M.",Vivek Shinde,Novavax,2020-08-11,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/08/11/2020.08.07.20170514.source.xml,,medrxiv,10.1101__2020.08.07.20170514_doc.txt
10.1101/2020.08.07.20166389,The emergence of azithromycin-resistant Salmonella Typhi in Nepal,"Pham, D. T.; Dongol, S.; Giri, A.; Nguyen, T. N. T.; Ho, T. N. D.; Nguyen, Q. P. N.; Pham, T. D.; Thwaites, G. E.; Basnyat, B.; Baker, S.; Rabaa, M. A.; Karkey, A.",Duy Thanh Pham,Oxford University Clinical Research Unit-Vietnam,2020-08-12,1,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2020/08/12/2020.08.07.20166389.source.xml,10.1093/jacamr/dlaa109,medrxiv,10.1101__2020.08.07.20166389_doc.txt
10.1101/2020.08.12.20170282,"Observational Study on Clinical Features, Treatment and Outcome of COVID 19 in a tertiary care Centre in India- a retrospective case series","Bhattacharya, R.; Ghosh, R.; Kulshrestha, M.; Chowdhury, S.; Mukherjee, R.; Ray, I.",Indranil Ray,"Medical College, Kolkata",2020-08-14,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/08/14/2020.08.12.20170282.source.xml,10.36106/ijsr/7232245,medrxiv,10.1101__2020.08.12.20170282_doc.txt
10.1101/2020.08.18.20176693,Exhaled SARS-CoV-2 quantified by face-mask sampling in hospitalised patients with covid-19,"Williams, C.; Pan, D.; Decker, J.; Fletcher, E.; Wisniewska, A.; Sze, S.; Assadi, S.; Haigh, R.; Abdulwhhab, M.; Bird, P.; Holmes, C.; Al-Taie, A.; Saleem, B.; Pan, J.; Garton, N.; Pareek, M.; Barer, M.",Caroline Williams,University of Leicester,2021-02-21,2,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/02/21/2020.08.18.20176693.source.xml,10.1016/j.jinf.2021.03.018,medrxiv,10.1101__2020.08.18.20176693_doc.txt
10.1101/2020.08.18.20177402,Convalescent plasma for patients with severe COVID-19: a matched cohort study,"Rogers, R.; Shehadeh, F.; Mylona, E.; Rich, J.; Neill, M.; Touzard-Romo, F.; Geffert, S.; Larkin, J.; Bailey, J. A.; Lu, S.; Sweeney, J.; Mylonakis, E.",Ralph Rogers,Warren Alpert Medical School of Brown University,2020-08-21,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/08/21/2020.08.18.20177402.source.xml,10.1093/cid/ciaa1548,medrxiv,10.1101__2020.08.18.20177402_doc.txt
10.1101/2020.08.25.20181321,"Lymphocyte subset alterations with disease severity, imaging manifestation, and delayed hospitalization in COVID-19 patients","Wu, D. X.; Wu, X. P.; Huang, J. S.; Rao, Q. F.; Zhang, Q.; Zhang, W. F.",Wen Feng Zhang,"The First Affiliated Hospital, Nanchang University",2020-08-31,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/08/31/2020.08.25.20181321.source.xml,,medrxiv,10.1101__2020.08.25.20181321_doc.txt
10.1101/2020.08.25.20171595,Multiple introductions followed by ongoing community spread of SARS-CoV-2 at one of the largest metropolitan areas in the Northeast of Brazil,"Paiva, M. H. S.; Guedes, D. R. D.; Docena, C.; Bezerra, M. F.; Dezordi, F. Z.; Machado, L. C.; Krokovsky, L.; Helvecio, E.; da Silva, A. F.; Vasconcelos, L. R. S.; Rezende, A. M.; da Silva, S. J. R.; Sales, K. G. d. S.; de Sa, B. S. L. F.; da Cruz, D. L.; Cavalcanti, C. E.; Neto, A. d. M.; da Silva, C. T. A.; Mendes, R. P. G.; da Silva, M. A. L.; Barros, M. d. S.; do Nascimento, W. R. C.; Arcoverde, R. M. L.; Bezerra, L. C. A.; Filho, S. P. B.; Ayres, C. F. J.; Wallau, G. L.",Gabriel Luz Wallau,Oswaldo Cruz Foundation,2020-08-31,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/08/31/2020.08.25.20171595.source.xml,10.3390/v12121414,medrxiv,10.1101__2020.08.25.20171595_doc.txt
10.1101/2020.08.25.20154252,Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19.,"Bermejo-Martin, J. F.; Gonzalez-Rivera, M.; Almansa, R.; Micheloud, D.; Tedim, A. P.; Dominguez-Gil, M.; Resino, S.; Martin-Fernandez, M.; Ryan Murua, P.; Perez-Garcia, F.; Tamayo, L.; Lopez-Izquierdo, R.; Bustamante, E.; Aldecoa, C.; Gomez, J. M.; Rico-Feijoo, J.; Orduna, A.; Mendez, R.; Fernandez Natal, I.; Megias, G.; Gonzalez-Estecha, M.; Carriedo, D.; Doncel, C.; Jorge, N.; Ortega, A.; de la Fuente, A.; del Campo, F.; Fernandez-Ratero, J. A.; Trapiello, W.; Gonzalez-Jimenez, P.; Ruiz, G.; Kelvin, A. A.; Ostadgavahi, A. T.; Oneizat, R.; Ruiz, L. M.; Miguens, I.; Gargallo, E.; Munoz, I.; Pe",David J Kelvin,"Department of Microbiology and Immunology, Faculty of Medicine, Dalhousie University,Halifax, Nova Scotia, Canada / International Institute of Infection and Imm",2020-10-27,3,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/10/27/2020.08.25.20154252.source.xml,10.1186/s13054-020-03398-0,medrxiv,10.1101__2020.08.25.20154252_doc.txt
10.1101/2020.08.24.20181248,Preliminary report on the development of a colorimetric loop-mediated isothermal amplification diagnostic assay for deer tick virus,"Roy, B. G.; Ryndock, E. J.; Decker, M. A.; Vickery, L.",Brandon G. Roy,Cornell University,2021-01-11,4,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/01/11/2020.08.24.20181248.source.xml,,medrxiv,10.1101__2020.08.24.20181248_doc.txt
10.1101/2020.08.28.20183905,Participatory syndromic surveillance as a tool for tracking COVID-19 in Bangladesh,"Mahmud, A. S.; Chowdhury, S.; Sojib, K. H.; Chowdhury, A.; Quader, M. T.; Paul, S.; Saidy, M. S.; Uddin, R.; Engo-Monsen, K.; Buckee, C. O.",Ayesha S Mahmud,"University of California, Berkeley",2020-09-01,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/09/01/2020.08.28.20183905.source.xml,10.1016/j.epidem.2021.100462,medrxiv,10.1101__2020.08.28.20183905_doc.txt
10.1101/2020.08.30.20184309,Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers,"Figueiredo-Campos, P.; Blankenhaus, B.; Mota, C.; Gomes, A.; Serrano, M.; Ariotti, S.; Costa, C.; Nunes-Cabaco, H.; Mendes, A. M.; Gaspar, P.; Pereira-Santos, C. M.; Rodrigues, F.; Condeco, J.; Escoval, A. M.; Santos, M.; Ramirez, M.; Melo-Cristino, J.; Simas, P. J.; Vasconcelos, E.; Afonso, A.; Veldhoen, M.",Marc Veldhoen,"Instituto de Medicina Molecular | Joao Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa",2020-09-02,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/09/02/2020.08.30.20184309.source.xml,,medrxiv,10.1101__2020.08.30.20184309_doc.txt
10.1101/2020.09.01.20185447,Rapid evaluation of neutralizing antibodies in COVID-19 patients,"Zhang, P.; Li, B.; Min, W.; Wang, X.; Li, Z.; Zhao, Y.; Zhang, H.; Jiang, M.; Zheng, H.; Yang, C.; Zhang, W.; Zuo, L.; Gao, Q.; Yang, Z.; Li, Y.; Feng, T.; Lin, C.; Hu, Q.; Song, T.; Yang, R.",Ruifu Yang,Beijing Institute of Microbiology and Epidemiology,2020-09-02,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/09/02/2020.09.01.20185447.source.xml,,medrxiv,10.1101__2020.09.01.20185447_doc.txt
10.1101/2020.09.01.20186213,Performance of serum apolipoprotein-A1 as a sentinel of Covid-19,"Poynard, T.; Deckmyn, O.; Rudler, M.; Peta, V.; Ngo, Y.; Vautier, M.; Akhavan, S.; Calvez, V.; Franc, C.; Castille, J. M.; Drane, F.; Sakka, M.; Bonnefont-Rousselot, D.; Lacorte, J. M.; Saadoun, D.; Allenbach, Y.; Benveniste, O.; Gandjbakhch, F.; Mayaux, J.; Lucidarme, O.; Fautrel, B.; Ratziu, V.; Housset, C.; Thabut, D.; Cacoub, P.",Thierry Poynard,APHP Sorbonne University,2020-09-03,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/09/03/2020.09.01.20186213.source.xml,,medrxiv,10.1101__2020.09.01.20186213_doc.txt
10.1101/2020.09.02.20187021,Impact of universal masking in health care and community on SARS-CoV-2 spread,"Pletz, M. W.; Steiner, A.; Kesselmeier, M.; Loeffler, B.; Trommer, S.; Weis, S.; Maschmann, J.; Stallmach, A.",Mathias W. Pletz,"Institute for Infectious Disease and Infection Control, Jena University Hospital, Jena, Germany",2020-09-08,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/09/08/2020.09.02.20187021.source.xml,,medrxiv,10.1101__2020.09.02.20187021_doc.txt
10.1101/2020.09.01.20186254,Equivalent SARS-CoV-2 viral loads between nasopharyngeal swab and saliva in symptomatic patients,"Yokota, I.; Hattori, T.; Shane, P. Y.; Konno, S.; Nagasaka, A.; Takeyabu, K.; Fujisawa, S.; Nishida, M.; Teshima, T.",Takanori Teshima,Hokkaido University,2020-09-03,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/09/03/2020.09.01.20186254.source.xml,10.1038/s41598-021-84059-2,medrxiv,10.1101__2020.09.01.20186254_doc.txt
10.1101/2020.09.01.20186080,Early elevation of FIB-4 liver fibrosis score is associated with adverse outcomes among patients with COVID-19,"Xiang, F.; Sun, J.; Chen, P.-H.; Han, P.; Zheng, H.; Cai, S.; Kirk, G. D.",Jing Sun,Johns Hopkins University Bloomberg School of Public Health,2020-09-03,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/09/03/2020.09.01.20186080.source.xml,10.1093/cid/ciaa1710,medrxiv,10.1101__2020.09.01.20186080_doc.txt
10.1101/2020.08.25.20181354,Causes of false-negative rapid diagnostic tests for symptomatic malaria in the DRC,"Parr, J. B.; Kieto, E.; Phanzu, F.; Masiangi, P.; Mwandagalirwa, K.; Mvuama, N.; Landela, A.; Atibu, J.; Efundu, S. U.; Olenga, J. W.; Thwai, K.; Morgan, C.; Denton, M.; Poffley, A.; Juliano, J. J.; Mungala, P.; Likwela, J.; Sompwe, E.; Tshefu, A. K.; N'Siala, A.; Kalonji, A.",Jonathan B Parr,University of North Carolina at Chapel Hill,2020-08-31,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/08/31/2020.08.25.20181354.source.xml,,medrxiv,10.1101__2020.08.25.20181354_doc.txt
10.1101/2020.08.10.20171728,Decontamination of SARS-CoV-2 and other RNA viruses from N95 level meltblown polypropylene fabric using heat under different humidities,"Campos, R. K.; Jin, J.; Rafael, G. H.; Zhao, M.; Liao, L.; Simmons, G.; Chu, S.; Weaver, S.; Chiu, W.; Cui, Y.",Yi Cui,"Department of Materials Science and Engineering, Stanford University, Stanford, California, United States and Stanford Institute for Materials and Energy Scienc",2020-08-14,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/08/14/2020.08.10.20171728.source.xml,10.1021/acsnano.0c06565,medrxiv,10.1101__2020.08.10.20171728_doc.txt
10.1101/2020.09.07.20189357,"COMBINATION OF TOCILIZUMAB AND STEROIDS TO IMPROVE MORTALITY IN PATIENTS WITH SEVERE COVID-19 INFECTION: A SPANISH, MULTICENTER, COHORT STUDY","Ruiz-Antoran, B.; Sancho-Lopez, A.; Torres, F.; Moreno-Torres, V.; de Pablo Lopez de Abechuco, I.; Garcia Lopez, P.; Abad-Santos, F.; Rosso Fernandez, C. M.; Aldea-Perona, A.; Montane, E.; Aparicio-Hernandez, R. M.; LLop Rius, R.; Pedros, C.; Gijon, P.; Hernandez Carballo, C.; Pedrosa Martinez, M. J.; Prada-Ramallal, G.; Cabrera Garcia, L.; Aguilar Garcia, J. A.; Sanjuan-Jimenez, R.; Ortiz Barraza, E. I.; Sanchez Chica, E.; Fernandez-Cruz, A.; TOCICOV-study group.,  ",Ana Fernandez-Cruz,Hospital Universitario Puerta de Hierro Majadahonda,2020-09-10,2,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/09/10/2020.09.07.20189357.source.xml,10.1007/s40121-020-00373-8,medrxiv,10.1101__2020.09.07.20189357_doc.txt
10.1101/2020.09.07.20190165,Insufficient hyperfibrinolysis in COVID-19: a systematic review of thrombolysis based on meta-analysis and meta-regression,"Ji, H.-L. J.; Su, Z.; Zhao, R.; Komissarov, A. A.; Yi, G.; Liu, S.-L.; Idell, S.; Matthay, M. A.",Hong-Long J Ji,University of Texas Health Science Center at Tyler,2020-09-11,2,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/09/11/2020.09.07.20190165.source.xml,,medrxiv,10.1101__2020.09.07.20190165_doc.txt
10.1101/2020.09.08.20190686,"Mortality and risk factors among US Black, Hispanic, and White patients with COVID-19","Jun, T.; Nirenberg, S.; Kovatch, P.; Huang, K.-l.",Kuan-lin Huang,Icahn School of Medicine at Mount Sinai,2020-09-11,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/09/11/2020.09.08.20190686.source.xml,,medrxiv,10.1101__2020.09.08.20190686_doc.txt
10.1101/2020.09.10.20191619,"Safety and Efficacy of the combined use of ivermectin, dexamethasone, enoxaparin and aspirin against COVID-19","Carvallo, H. E.; Hirsch, R. R.; Farinella, M. E.",Hector Eduardo Carvallo,"Universidad Abierta Interamericana, Eurnekian Public Hospital, Argentina",2020-09-15,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/09/15/2020.09.10.20191619.source.xml,,medrxiv,10.1101__2020.09.10.20191619_doc.txt
10.1101/2020.09.15.20192765,Novel ELISA protocol links pre-existing SARS-CoV-2 reactive antibodies with endemic coronavirus immunity and age and reveals improved serologic identification of acute COVID-19 via multi-parameter detection,"Yuen, R.; Steiner, D.; Pihl, R.; Chavez, E.; Olson, A.; Baird, L.; Korkmaz, F.; Urick, P.; Sagar, M.; Berrigan, J.; Gummuluru, R.; Corley, R.; Quillen, K.; Belkina, A.; Mostoslavsky, G.; Rifkin, I.; Kataria, Y.; Cappione, A.; Lin, N.; Bhadelia, N.; Snyder-Cappione, J.; Smith, E. L.; Gao, W.",Jennifer Snyder-Cappione,Boston University School of Medicine,2020-12-23,4,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/12/23/2020.09.15.20192765.source.xml,,medrxiv,10.1101__2020.09.15.20192765_doc.txt
10.1101/2020.09.18.20195669,How do the general population behave with facemasks to prevent COVID-19 in the community?,"DESCHANVRES, C.; HAUDEBOURG, T.; PEIFFER-SMADJA, N.; BLANCKAERT, K.; BOUTOILLE, D.; LUCET, J.-C.; BIRGAND, G.",Gabriel BIRGAND,CHU de Nantes,2020-09-18,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/09/18/2020.09.18.20195669.source.xml,,medrxiv,10.1101__2020.09.18.20195669_doc.txt
10.1101/2020.09.16.20195750,Association between corticosteroids and intubation or death among patients with COVID-19 pneumonia in non-ICU settings: an observational study using of real-world data from 51 hospitals in France and Luxembourg,"Tran, V.-T.; Mahevas, M.; Bani Sadr, F.; Robineau, O.; Perpoint, T.; Perrodeau, E.; Gallay, L.; Ravaud, P.; Goehringer, F.; Lescure, X.; COCORICO,  ",Xavier Lescure,APHP,2020-09-18,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/09/18/2020.09.16.20195750.source.xml,,medrxiv,10.1101__2020.09.16.20195750_doc.txt
10.1101/2020.09.17.20196469,Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care,"Haroon, S.; Subramanian, A.; Cooper, J.; Anand, A.; Gokhale, K.; Byne, N.; Dhalla, S.; Acosta-Mena, D.; Taverner, T.; Okoth, K.; Wang, J.; Chandan, J. S.; Sainsbury, C.; Zemedikun, D. T.; Thomas, G. N.; Parekh, D.; Marshall, T.; Sapey, E.; Adderley, N. J.; Nirantharakumar, K.",Nicola J Adderley,University of Birmingham,2020-09-18,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/09/18/2020.09.17.20196469.source.xml,10.1186/s12879-021-05951-w,medrxiv,10.1101__2020.09.17.20196469_doc.txt
10.1101/2020.09.22.20199497,"An analysis of clinical and geographical metadata of over 75,000 records in the GISAID COVID-19 database","Velazquez, A.; Bustria, M.; Ouyang, Y.; Moshiri, N.",Niema Moshiri,"University of California, San Diego",2020-09-23,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/09/23/2020.09.22.20199497.source.xml,,medrxiv,10.1101__2020.09.22.20199497_doc.txt
10.1101/2020.09.20.20198515,Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 infection: An Open Label Feasibility Study,"Kumar, A.; Prasad, G.; Srivastav, S.; Gautam, V. K.; Sharma, N.",Neha Sharma,"Aarogyam (UK) CIC, United Kingdom",2020-09-23,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/09/23/2020.09.20.20198515.source.xml,,medrxiv,10.1101__2020.09.20.20198515_doc.txt
10.1101/2020.09.20.20198093,Effect of daily human movement on some characteristics of dengue dynamics,"Tocto-Erazo, M. R.; Olmos-Liceaga, D.; Montoya-Laos, J. A.",Mayra R. Tocto-Erazo,Universidad de Sonora,2020-09-23,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/09/23/2020.09.20.20198093.source.xml,10.1016/j.mbs.2020.108531,medrxiv,10.1101__2020.09.20.20198093_doc.txt
10.1101/2020.09.21.20191288,Validation and clinical evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT),"Meyer, B.; Reimerink, J.; Torriani, G.; Brouwer, F.; Godeke, G.-J.; Yerly, S.; Hoogerwerf, M.; Vuilleumier, N.; Kaiser, L.; Eckerle, I.; Reusken, C.",Chantal Reusken,RIVM,2020-09-23,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/09/23/2020.09.21.20191288.source.xml,,medrxiv,10.1101__2020.09.21.20191288_doc.txt
10.1101/2020.09.25.20201996,The quantitative landscape of the neutralizing antibody response to SARS-CoV-2,"Padmanabhan, P.; Desikan, R.; Dixit, N. M.",Narendra M Dixit,Indian Institute of Science,2020-09-28,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/09/28/2020.09.25.20201996.source.xml,,medrxiv,10.1101__2020.09.25.20201996_doc.txt
10.1101/2020.09.30.20204636,Impact of reproduction number on multiwave spreading dynamics of COVID-19 with temporary immunity : a mathematical model,"Shayak, B.; Sharma, M. M.; Gaur, M.; Mishra, A. K.",B Shayak,Cornell University,2021-01-07,2,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2021/01/07/2020.09.30.20204636.source.xml,10.1016/j.ijid.2021.01.018,medrxiv,10.1101__2020.09.30.20204636_doc.txt
10.1101/2020.10.01.20205229,Cardiovascular risk factors are independently associated with COVID-19 mortality: a prospective cohort study,"Collard, D.; Nurmohamed, N. S.; Kaiser, Y.; Reeskamp, L. F.; Dormans, T.; Moeniralam, H.; Simsek, S.; Douma, R. A.; Eerens, A.; Reidinga, A. C.; Elbers, P. W. G.; Beudel, M.; Vogt, L.; Stroes, E. S. G.; van den Born, B.-J. H.",Bert-Jan H. van den Born,Amsterdam UMC,2020-10-02,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/10/02/2020.10.01.20205229.source.xml,,medrxiv,10.1101__2020.10.01.20205229_doc.txt
10.1101/2020.10.02.20205641,Seroprevalence of SARS-COV-2 Antibodies in Scottish Healthcare Workers,"Abo-Leyah, H.; Gallant, S.; Cassidy, D.; Giam, Y. H.; Killick, J.; Marshall, B.; Hay, G.; Pembridge, T.; Strachan, R.; Gallant, N.; Parcell, B.; George, J.; Furrie, E.; Chalmers, J. D.",James Duncan Chalmers,University of Dundee,2020-10-02,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/10/02/2020.10.02.20205641.source.xml,,medrxiv,10.1101__2020.10.02.20205641_doc.txt
10.1101/2020.10.01.20205427,A broad-based probe-free qPCR assay for detection and discrimination of three human herpes viruses,"Gupta, A.; Lawrence, S. M.; Fraley, S. I.",Stephanie I Fraley,"University of California, San Diego",2020-10-04,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/10/04/2020.10.01.20205427.source.xml,,medrxiv,10.1101__2020.10.01.20205427_doc.txt
10.1101/2020.09.25.20199562,Pathogenesis-based pre-exposure prophylaxis associated with low risk of SARS-CoV-2 infection in healthcare workers at a designated Covid-19 hospital,"Dubina, M. V.; Gomonova, V. V.; Taraskina, A. E.; Vasilyeva, N. V.; Sayganov, S. A.",Michael V. Dubina,State Research Institute of Highly Pure Bioprepartions,2020-10-06,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/10/06/2020.09.25.20199562.source.xml,10.1186/s12879-021-06241-1,medrxiv,10.1101__2020.09.25.20199562_doc.txt
10.1101/2020.10.07.20208264,Detecting and isolating false negatives of SARS-CoV-2 primers and probe sets among the Japanese Population: A laboratory testing methodology and study,"Tsutae, W.; Chaochaisit, W.; Aoshima, H.; Ida, C.; Miyakawa, S.; Sekine, H.; Sheikh, A.; Baran, I. S.; Furukawa, T.; Sekine, A.",Iri Baran Sato,"Genesis Institute of Genetic Research, Genesis Healthcare Corporation, Tokyo, Japan",2021-01-08,3,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/01/08/2020.10.07.20208264.source.xml,,medrxiv,10.1101__2020.10.07.20208264_doc.txt
10.1101/2020.10.06.20207902,Evaluation of saliva sampling procedures for SARS-CoV-2 diagnostics reveals differential sensitivity and association with viral load,"Mestdagh, P.; Gillard, M.; Arbyn, M.; Pirnay, J.-P.; Poels, J.; Hellemans, J.; Peeters, E.; Hutse, V.; Vermeiren, C.; Boutier, M.; De Wever, V.; Soentjens, P.; Djebara, S.; Malonne, H.; Andre, E.; Smeraglia, J.; Vandesompele, J.",Pieter Mestdagh,Ghent University,2020-10-13,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/10/13/2020.10.06.20207902.source.xml,,medrxiv,10.1101__2020.10.06.20207902_doc.txt
10.1101/2020.10.08.20209114,Antibody-dependent enhancement (ADE) of SARS-CoV-2 infection in recovered COVID-19 patients: studies based on cellular and structural biology analysis,"Wu, F.; Yan, R.; Liu, M.; Liu, Z.; Wang, Y.; Luan, D.; Wu, K.; Song, Z.; Sun, T.; Ma, Y.; Zhang, Y.; Wang, Q.; Li, X.; Ji, P.; Li, Y.; Li, C.; Wu, Y.; Ying, T.; Wen, Y.; Jiang, S.; Zhu, T.; Lu, L.; Zhang, Y.; Zhou, Q.; Huang, J.",Jinghe Huang,"Shanghai Public Health Clinical Center and Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan University, Shan",2020-10-13,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/10/13/2020.10.08.20209114.source.xml,,medrxiv,10.1101__2020.10.08.20209114_doc.txt
10.1101/2020.10.12.20211243,Antimicrobial resistance surveillance: can we estimate resistance in bloodstream infections from other types of specimen?,"Vihta, K.-D.; Gordon, N. C.; Stoesser, N.; Quan, P.; Tyrrell, C. S.; Vongsouvath, M.; Ashley, E. A.; Chansamouth, V.; Turner, P.; Ling, C. L.; Eyre, D. W.; White, N. J.; Crook, D. W.; Peto, T. E.; Walker, A. S.",Karina-Doris Vihta,University of Oxford,2020-10-14,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2020/10/14/2020.10.12.20211243.source.xml,,medrxiv,10.1101__2020.10.12.20211243_doc.txt
10.1101/2020.10.12.20211540,The HIV/STI Epidemic Potential of Dynamic Sexual Networks of Men Who Have Sex With Men in Atlanta and San Francisco,"Anderson, E. J.; Weiss, K. M.; Morris, M. M.; Sanchez, T. H.; Prasad, P.; Jenness, S. M.",Emeli J Anderson,Emory University,2020-10-14,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,hiv aids,https://www.medrxiv.org/content/early/2020/10/14/2020.10.12.20211540.source.xml,,medrxiv,10.1101__2020.10.12.20211540_doc.txt
10.1101/2020.10.13.20212043,"Is there a resistance-threshold for macrolide consumption? Positive evidence from an ecological analysis of resistance data from Streptococcus pneumoniae, Treponema pallidum and Mycoplasma genitalium","Kenyon, C.; Van Dijck, C.; Basil, S.",Chris Kenyon,"Institute of Tropical Medicine, Antwerp",2020-10-14,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/10/14/2020.10.13.20212043.source.xml,10.1089/mdr.2020.0490,medrxiv,10.1101__2020.10.13.20212043_doc.txt
10.1101/2020.10.19.20214494,Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App,"Sudre, C. H.; Murray, B.; Varsavsky, T.; Graham, M. S.; Penfold, R. S.; Bowyer, R. C. E.; Capdevila Pujol, J.; Klaser, K.; Antonelli, M.; Canas, L. S.; Molteni, E.; Modat, M.; Cardoso, M. J.; May, A.; Ganesh, S.; Davies, R.; Nguyen, L. H.; Drew, D. A.; Astley, C. M.; Joshi, A. D.; Merino, J.; Tsereteli, N.; Fall, T.; Gomez, M. F.; Duncan, E.; Menni, C.; Williams, F. M.; Franks, P. W.; Chan, A. T.; Wolf, J.; Ourselin, S.; Spector, T.; Steves, C. J.",Claire J Steves,King\'s College London,2020-12-19,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/12/19/2020.10.19.20214494.source.xml,,medrxiv,10.1101__2020.10.19.20214494_doc.txt
10.1101/2020.10.21.20217083,"Epidemiological, clinical, and laboratory findings for patients of different age groups with confirmed coronavirus disease 2019 (COVID-19) in a hospital in Saudi Arabia","Ibrahim, M. E.; AL-Aklobi, O. S.; Abomughaid, M. M.; Al-Ghamdi, M. A.",Mutasim E Ibrahim,"Department of Basic Medical Sciences (Microbiology Unit), College of Medicine, University of Bisha, Bisha, Saudi Arabia",2020-10-25,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/10/25/2020.10.21.20217083.source.xml,10.1371/journal.pone.0250955,medrxiv,10.1101__2020.10.21.20217083_doc.txt
10.1101/2020.10.26.20219428,Community prevalence of SARS-CoV-2 in England during April to September 2020: Results from the ONS Coronavirus Infection Survey,"Pouwels, K. B.; House, T.; Pritchard, E.; Robotham, J. V.; Birrell, P.; Gelman, A.; Vihta, K.-D.; Bowers, N.; Boreham, I.; Thomas, H.; Lewis, J.; Bell, I.; Bell, J. I.; Newton, J. N.; Farrar, J.; Diamond, I.; Benton, P.; Walker, A. S.",Koen B Pouwels,University of Oxford,2020-10-27,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2020/10/27/2020.10.26.20219428.source.xml,,medrxiv,10.1101__2020.10.26.20219428_doc.txt
10.1101/2020.10.28.20221267,Predicting the Effect of Malaria Control Strategies Using Mathematical Modeling Approach,"Eguda, F. Y.; Abah, S. E.; Andrawus, J.; Atuba, S.; Abba, A.",Samuel Eneojo Abah,"EBIHAS Virtual Research and Training, British Hospital and Outpatients Clinics, Ipaja, Lagos; Coventry University, UK",2020-11-03,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/11/03/2020.10.28.20221267.source.xml,,medrxiv,10.1101__2020.10.28.20221267_doc.txt
10.1101/2020.10.30.20215335,Innate immunity plays a key role in controlling viral load in COVID-19: mechanistic insights from a whole-body infection dynamics model,"Dogra, P.; Ruiz-Ramirez, J.; Sinha, K.; Butner, J. D.; Pelaez, M. J.; Rawat, M.; Yellepeddi, V. K.; Pasqualini, R.; Arap, W.; Sostman, H. D.; Cristini, V.; Wang, Z.",Prashant Dogra,Houston Methodist Research Institute,2020-11-05,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/11/05/2020.10.30.20215335.source.xml,10.1021/acsptsci.0c00183,medrxiv,10.1101__2020.10.30.20215335_doc.txt
10.1101/2020.11.03.20225235,Successive waves in pandemic infections: physical diffusion theory and data comparisons,"Duffey, R. B.",Romney B Duffey,,2020-11-04,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/11/04/2020.11.03.20225235.source.xml,10.2991/jracr.k.210609.001,medrxiv,10.1101__2020.11.03.20225235_doc.txt
10.1101/2020.11.06.20227165,ConceptWAS: a high-throughput method for early identification of COVID-19 presenting symptoms,"Zhao, J.; Grabowska, M. E.; Kerchberger, V. E.; Smith, J. C.; Eken, H. N.; Feng, Q.; Peterson, J. F.; Rosenbloom, S. T.; Johnson, K. B.; Wei, W.-Q.",Wei-Qi Wei,Vanderbilt University Medical Center,2020-11-10,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/11/10/2020.11.06.20227165.source.xml,10.1016/j.jbi.2021.103748,medrxiv,10.1101__2020.11.06.20227165_doc.txt
10.1101/2020.11.10.20228890,Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patients,"Lei, Q.; Yu, C.; Li, Y.; Hou, H.; Xu, Z.; He, M.; Sun, Z.; Wang, F.; Tao, S.-c.; Fan, X.",Xionglin Fan,Huazhong University of Science and Technology,2021-05-08,3,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/05/08/2020.11.10.20228890.source.xml,10.1016/j.jare.2021.11.014,medrxiv,10.1101__2020.11.10.20228890_doc.txt
10.1101/2020.11.10.20229005,Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among Hospital Workers - a multicentre cross-sectional study,"Kahlert, C. R.; Persi, R.; Guesewell, S.; Egger, T.; Leal-Neto, O. B.; Sumer, J.; Flury, D.; Brucher, A.; Lemmenmeier, E.; Moeller, C.; Rieder, P.; Stocker, R.; Vuichard-Gysin, D.; Wiggli, B.; Albrich, W. C.; Babouee Flury, B.; Besold, U.; Fehr, J.; Kuster, S. P.; McGeer, A.; Risch, L.; Schlegel, M.; Vernazza, P.; Friedl, A.; Kohler, P.",Philipp Kohler,"Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, Switzerland",2020-12-13,3,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/12/13/2020.11.10.20229005.source.xml,10.1016/j.cmi.2021.05.014,medrxiv,10.1101__2020.11.10.20229005_doc.txt
10.1101/2020.11.10.20228528,"Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020","Bal, A.; Destras, G.; Gaymard, A.; Marlet, J.; Stefic, K.; Regue, H.; Semanas, Q.; d'Aubarde, C.; Billaud, G.; Laurent, F.; Gonzales, C.; Valette, M.; Bouscambert, M.; Gaudy-graffin, C.; Lina, B.; Morfin, F.; Josset, L.",Laurence Josset,HCL,2021-01-11,3,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/01/11/2020.11.10.20228528.source.xml,10.2807/1560-7917.ES.2021.26.3.2100008,medrxiv,10.1101__2020.11.10.20228528_doc.txt
10.1101/2020.11.10.20227371,Correlation of SARS-CoV-2 nucleocapsid antigen and RNA concentrations in nasopharyngeal samples from children and adults using an ultrasensitive and quantitative antigen assay,"Pollock, N. R.; Savage, T. J.; Wardell, H.; Lee, R.; Mathew, A.; Stengelin, M.; Sigal, G. B.",Nira R. Pollock,Boston Children\'s Hospital,2020-11-13,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/11/13/2020.11.10.20227371.source.xml,10.1128/JCM.03077-20,medrxiv,10.1101__2020.11.10.20227371_doc.txt
10.1101/2020.11.11.20229500,Association of social distancing and masking with risk of COVID-19,"Kwon, S.; Joshi, A. D.; Lo, C.-H.; Drew, D. A.; Nguyen, L.; Guo, C.-G.; Ma, W.; Mehta, R. S.; Warner, E. T.; Astley, C. M.; Merino, J.; Murray, B.; Wolf, J.; Ourselin, S.; Steves, C.; Spector, T.; Hart, J. E.; Song, M.; VoPham, T.; Chan, A. T.",Andrew T. Chan,Massachusetts General Hospital,2020-11-13,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/11/13/2020.11.11.20229500.source.xml,,medrxiv,10.1101__2020.11.11.20229500_doc.txt
10.1101/2020.11.13.20231076,SARS-CoV-2 serological tests can generate false positive results for samples from patients with chronic inflammatory diseases,"Kharlamova, N.; Dunn, N.; Bedri, S. K.; Jerling, S.; Almgren, M.; Faustini, F.; Gunnarsson, I.; Ronnelid, J.; Pullerits, R.; Gjertsson, I.; Lundberg, K.; Manberg, A.; Pin, E.; Nilsson, P.; Hober, S.; Fink, K.; Fogdell-Hahn, A.",Anna Fogdell-Hahn,Karolinska Institutet,2020-11-13,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/11/13/2020.11.13.20231076.source.xml,10.3389/fimmu.2021.666114,medrxiv,10.1101__2020.11.13.20231076_doc.txt
10.1101/2020.11.12.20230656,Development and validation of a highly sensitive and specific electrochemical assay to quantify anti-SARS-CoV-2 IgG antibodies to facilitate pandemic surveillance and monitoring of vaccine response,"Chiang, S. H.; Tu, M.; Cheng, J.; Wei, F.; Li, F.; Chia, D.; Garner, O. B.; Chandrasekaran, S.; Bender, R.; Strom, C.; Wong, D. T. W.",Charles Strom,UCLA,2020-11-16,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2020/11/16/2020.11.12.20230656.source.xml,,medrxiv,10.1101__2020.11.12.20230656_doc.txt
10.1101/2020.11.15.20232033,"Breadth of humoral immune responses to the C-terminus of the circumsporozoite protein is associated with protective efficacy inducedby the RTS,S malaria vaccine","Chaudhury, S.; MacGill, R. S.; Early, A. M.; Bolton, J. S.; King, C. R.; Locke, E.; Pierson, T.; Wirth, D. F.; Neafsey, D. E.; Bergmann-Leitner, E. S.",Elke S Bergmann-Leitner,WRAIR,2020-11-16,1,PUBLISHAHEADOFPRINT,cc0,infectious diseases,https://www.medrxiv.org/content/early/2020/11/16/2020.11.15.20232033.source.xml,10.1016/j.vaccine.2020.12.055,medrxiv,10.1101__2020.11.15.20232033_doc.txt
10.1101/2020.11.16.20232512,5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men,"Cadegiani, F. A.; McCoy, J.; Wambier, C. G.; Goren, A.",John McCoy,"Applied Biology, Inc. Irvine, CA, USA",2020-11-18,1,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2020/11/18/2020.11.16.20232512.source.xml,,medrxiv,10.1101__2020.11.16.20232512_doc.txt
10.1101/2020.11.17.20233296,Accuracy of Rapid Point-of-Care Antibody Test in patients with suspected or confirmed COVID-19,"Vancheeswaran, R.; Willcox, M. L.; Stuart, B.; Knight, M.; Kandil, H.; Barlow, A.; Patel, M. H.; Stockham, J.; O'Neill, A.; Clark, T. L.; Wilkinson, T.; Little, P.; Francis, N. A.; Griffiths, G.; Moore, M.",Merlin L Willcox,"School of Primary Care, Population Sciences and Medical Education, University of Southampton Aldermoor Health Centre, Aldermoor Close, Southampton SO16 5ST",2020-11-18,1,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2020/11/18/2020.11.17.20233296.source.xml,10.1016/j.jinf.2021.07.006,medrxiv,10.1101__2020.11.17.20233296_doc.txt
10.1101/2020.11.17.20233171,Interaction of intestinal bacteria with human rotavirus during infection in children,"Gozalbo-Robira, R.; Rubio del Campo, A.; Santiso-Bellon, C.; Vila-Vicent, S.; Buesa, J.; Delgado, S.; Molinero, N.; Margolles, A.; Yebra, M. J.; Collado, M. C.; Monedero, V.; Rodriguez-Diaz, J.",Jesus Rodriguez-Diaz,Universitat de Valencia,2020-11-18,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/11/18/2020.11.17.20233171.source.xml,10.3390/ijms22031010,medrxiv,10.1101__2020.11.17.20233171_doc.txt
10.1101/2020.11.19.20234922,Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice,"Healy, S. A.; Anderson, C.; Swihart, B. J.; Mwakingwe, A.; Gabriel, E. E.; Decederfelt, H.; Hobbs, C. V.; Rausch, K. M.; Zhu, D.; Muratova, O.; Herrera, R.; Scaria, P. V.; MacDonald, N. J.; Lambert, L. E.; Zaidi, I.; Coelho, C. H.; Renn, J. P.; Wu, Y.; Narum, D. L.; Duffy, P. E.",Patrick E. Duffy,"Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health",2020-11-22,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/11/22/2020.11.19.20234922.source.xml,10.1172/jci146221,medrxiv,10.1101__2020.11.19.20234922_doc.txt
10.1101/2020.11.19.20235077,Comparing COVID-19 and influenza presentation and trajectory,"Reiner Benaim, A.; Sobel, J. A.; Almog, R.; Lugassy, S.; Ben Shabbat, T.; Johnson, A.; Eytan, D.; Behar, J. A.",Joachim A. Behar,"Faculty of Biomedical Engineering, Technion, Israel Institute of Technology, Haifa, Israel",2021-04-14,2,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/04/14/2020.11.19.20235077.source.xml,,medrxiv,10.1101__2020.11.19.20235077_doc.txt
10.1101/2020.11.20.20234500,ANTIBODY RESPONSE TO COVID-19 INFECTION- CLINICAL VARIABLES AT PLAY,"PARKASH, A.; SINGLA, P.; BHATIA, M.",ANUJ PARKASH,RAJIV GANDHI CANCER INSTITUTE AND RESEARCH CENTRE,2020-11-23,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/11/23/2020.11.20.20234500.source.xml,,medrxiv,10.1101__2020.11.20.20234500_doc.txt
10.1101/2020.11.18.20234161,Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial,"Jagannathan, P.; Andrews, J.; Bonilla, H.; Hedlin, H.; Jacobson, K.; Balasubramanian, V.; Purington, N.; Kamble, S.; de Vries, C.; Quintero, O.; Feng, K.; Ley, C.; Winslow, D.; Newberry, J.; Edwards, K.; Hislop, C.; Choong, I.; Maldonado, Y.; Glenn, J.; Bhatt, A.; Blish, C.; Wang, T.; Khosla, C.; Pinsky, B.; Desai, M.; Parsonnet, J.; Singh, U.",Prasanna Jagannathan,Stanford University,2020-11-23,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/11/23/2020.11.18.20234161.source.xml,10.1038/s41467-021-22177-1,medrxiv,10.1101__2020.11.18.20234161_doc.txt
10.1101/2020.11.22.20236448,Interventions for treatment of COVID-19: second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project),"Juul, S.; Nielsen, E. E.; Feinberg, J.; Siddiqui, F.; Joergensen, C. K.; Barot, E.; Holgersson, J.; Nielsen, N.; Bentzer, P.; Veroniki, A. A.; Thabane, L.; Bu, F.; Klingenberg, S.; Gluud, C.; Jakobsen, J. C.",Sophie Juul,"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark",2020-11-24,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/11/24/2020.11.22.20236448.source.xml,10.1371/journal.pone.0248132,medrxiv,10.1101__2020.11.22.20236448_doc.txt
10.1101/2020.11.24.20237560,"Demography, social contact patterns and the COVID-19 burden in different settings of Ethiopia: a modeling study","Trentini, F.; Guzzetta, G.; Galli, M.; Zardini, A.; Manenti, F.; Putoto, G.; Marziano, V.; Nigussa, W. G.; Tsegaye, A.; Greblo, A.; Melegaro, A.; Ajelli, M.; Merler, S.; Poletti, P.",Piero Poletti,Bruno Kessler Foundation,2020-11-24,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/11/24/2020.11.24.20237560.source.xml,,medrxiv,10.1101__2020.11.24.20237560_doc.txt
10.1101/2020.11.25.20236646,Systematic evaluation of transcriptomic disease risk and diagnostic biomarker overlap between COVID-19 and tuberculosis: a patient-level meta-analysis,"Sheerin, D.; Abhimanyu, A.; Wang, X.; Johnson, W. E.; Coussens, A.",Dylan Sheerin,"Infectious Diseases and Immune Defence Division, WEHI (formerly The Walter & Eliza Hall Institute of Medical Research), Parkville 3279, VIC, Australia.",2020-11-26,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/11/26/2020.11.25.20236646.source.xml,,medrxiv,10.1101__2020.11.25.20236646_doc.txt
10.1101/2020.11.24.20238055,How Timing of Stay-home Orders and Mobility Reductions Impacted First-Wave COVID-19 Deaths in US Counties,"Audirac, M.; Tec, M.; Fox, S. J.; Meyers, L. A.; Zigler, C. M.",Corwin Matthew Zigler,The University of Texas at Austin,2021-09-26,2,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/09/26/2020.11.24.20238055.source.xml,,medrxiv,10.1101__2020.11.24.20238055_doc.txt
10.1101/2020.11.30.20241265,"Detection of the Novel SARS-CoV-2 European Lineage B.1.177 in Ontario, Canada","Guthrie, J. L.; Teatero, S.; Zittermann, S.; Chen, Y.; Sullivan, A.; Rilkoff, H.; Joshi, E.; Sivaraman, K.; de Borja, R.; Sundaravadanam, Y.; Laszloffy, M.; Heisler, L.; Allen, V. G.; Simpson, J. T.; Fittipaldi, N.",Jennifer L. Guthrie,Public Health Ontario,2020-12-02,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/12/02/2020.11.30.20241265.source.xml,10.1016/j.jcvp.2021.100010,medrxiv,10.1101__2020.11.30.20241265_doc.txt
10.1101/2020.12.01.20237784,Validation testing to determine the effectiveness of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings,"Ferguson, J.; Dunn, S.; Best, A.; Mirza, J.; Percival, B.; Mayhew, M.; Megram, O.; Ashford, F.; White, T.; Moles-Garcia, E.; Plant, T.; Bosworth, A.; Kidd, M.; Richter, A.; Deeks, J. J.; McNally, A.",Alan McNally,University of Birmingham,2020-12-24,2,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2020/12/24/2020.12.01.20237784.source.xml,,medrxiv,10.1101__2020.12.01.20237784_doc.txt
10.1101/2020.12.01.20242263,"A Novel Model for Simulating COVID-19 Dynamics Through Layered Infection States that Integrate Concepts from Epidemiology, Biophysics and Medicine: SEI3R2S-Nrec","Winters, J. M.",Jack M Winters,Marquette University,2020-12-08,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/12/08/2020.12.01.20242263.source.xml,,medrxiv,10.1101__2020.12.01.20242263_doc.txt
10.1101/2020.12.02.20242909,"Treatment of Severe COVID-19 with Convalescent Plasma in the Bronx, NYC","Yoon, H. a.; Bartash, R.; Gendlina, I.; Rivera, J.; Nakouzi, A.; Bortz, R. H.; Wirchnianski, A. S.; Paroder, M.; Fehn, K.; Serrano-Rahman, L.; Babb, R.; Sarwar, U. N.; Haslwanter, D.; Laudermilch, E.; Florez, C.; Dieterle, M. E.; Jangra, R. K.; Fels, J. M.; Tong, K.; Mariano, M. C.; Vergnolle, O.; Georgiev, G. I.; Herrera, N. G.; Malonis, R. J.; Quiroz, J. A.; Morano, N. C.; Krause, G. J.; Sweeney, J. M.; Cowman, K.; Allen, S.; Annam, J.; Applebaum, A.; Barboto, D.; Khokhar, A.; Lally, B. J.; Lee, A.; Lee, M.; Malaviya, A.; Sample, R.; Yang, X. A.; Li, Y.; Ruiz, R.; Thota, R.; Barnhill, J.; Go",Liise-anne Pirofski,Albert Einstein College of Medicine and Montefiore Medical Center,2020-12-04,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/12/04/2020.12.02.20242909.source.xml,,medrxiv,10.1101__2020.12.02.20242909_doc.txt
10.1101/2020.12.04.20241059,Sensitive detection and quantification of SARS-CoV-2 in saliva,"Abasiyanik, M. F.; Flood, B.; Lin, J.; Ozcan, S.; Rouhani, S.; Pyzer, A.; Trujillo, J.; Zhen, C.; Wu, P.; Jumic, S.; Wang, A.; Gajewski, T.; Wang, P.; Hartley, M.; Ameti, B.; Niemiec, R.; Fernando, M.; Aydogan, B.; Bethel, C.; Matushek, S.; Beavis, K.; Agrawal, N.; Segal, J.; Tay, S.; Izumchenko, E.",Savas Tay,UNIVERSITY OF CHICAGO,2020-12-07,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/12/07/2020.12.04.20241059.source.xml,,medrxiv,10.1101__2020.12.04.20241059_doc.txt
10.1101/2020.12.07.20245480,Evolution during primary HIV infection does not require adaptive immune selection,"Swan, D. A.; Rolland, M.; Herbeck, J.; Schiffer, J. T.; Reeves, D. B.",Daniel B Reeves,Fred Hutchinson Cancer Research Center,2020-12-08,2,PUBLISHAHEADOFPRINT,cc_by_nd,hiv aids,https://www.medrxiv.org/content/early/2020/12/08/2020.12.07.20245480.source.xml,,medrxiv,10.1101__2020.12.07.20245480_doc.txt
10.1101/2020.12.05.20241927,Neutralising antibodies drive Spike mediated SARS-CoV-2 evasion,"Kemp, S. A.; Collier, D. A.; Datir, R.; Ferreira, I. A.; Gayed, S.; Jahun, A.; Hosmillo, M.; Rees-Spear, C.; Mlcochova, P.; Lumb, I. U.; Roberts, D.; Chandra, A.; Temperton, N.; The COVID-19 Genomics UK (COG-UK) Consortium,  ; Sharrocks, K.; Blane, E.; The CITIID-NIHR BioResource COVID-19 Collaboration,  ; Briggs, J. A.; van Gils, M.; Smith, K. G.; Bradley, J. R.; Smith, C.; Doffinger, R.; Ceron-Gutierrez, L.; Barcenas-Morales, G.; Pollock, D.; Goldstein, R.; Smielewska, A.; Skittrall, J. P.; Gouliouris, T.; Goodfellow, I. G.; Gkrania-Klotsas, E.; Illingworth, C. J.; McCoy, L. E.; Gupta, R. K.",Ravindra K Gupta,"Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.",2020-12-29,3,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/12/29/2020.12.05.20241927.source.xml,10.1038/s41586-021-03291-y,medrxiv,10.1101__2020.12.05.20241927_doc.txt
10.1101/2020.12.10.20246975,QT Interval Prolongation in Patients Treated for COVID-19,"Habibzadeh, P.; Sarami, A.; Yadollahie, M.; Hashemiasl, K.; Salahi, A.; Habibzadeh, F.",Farrokh Habibzadeh,"R&D Headquarters, Petroleum Industry Health Organization, Shiraz, Iran",2020-12-11,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/12/11/2020.12.10.20246975.source.xml,,medrxiv,10.1101__2020.12.10.20246975_doc.txt
10.1101/2020.12.11.20247437,Clinical and Demographic Characteristics of COVID-19 Patients Admitted in a Tertiary Care Hospital in the Dominican Republic,"De Luna, D.; Roque, Y.; Batlle, N.; Cabrera, B.; Cruz, L. M.; Gomez, K.; Jaquez, M.; Belliard, R.; Tavarez, O.; Sanchez, J. J.",Yori Roque,Hospital Metropolitano De Santiago (HOMS),2020-12-14,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/12/14/2020.12.11.20247437.source.xml,,medrxiv,10.1101__2020.12.11.20247437_doc.txt
10.1101/2020.12.12.20247726,Clinical and Virological Characteristics of Hospitalized COVID-19 Patients in a German Tertiary Care Center during the First Wave of the SARS-CoV-2 Pandemic,"Thibeault, C.; Muehlemann, B.; Helbig, E. T.; Mittermaier, M.; Lingscheid, T.; Tober-Lau, P.; Meyer-Arndt, L. A.; Meiners, L.; Stubbemann, P.; Haenel, S. S.; Bosquillon de Jarcy, L.; Lippert, L.; Pfeiffer, M.; Stegemann, M. S.; Roehle, R.; Wiebach, J.; Hippenstiel, S.; Zoller, T.; Mueller-Redetzky, H.; Uhrig, A.; Balzer, F.; von Kalle, C.; Suttorp, N.; Jones, T. C.; Drosten, C.; Witzenrath, M.; Sander, L. E.; Pa-COVID Study Group,  ; Corman, V. M.; Kurth, F.",Florian Kurth,Charite Universistaetsmedizin Berlin,2020-12-14,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/12/14/2020.12.12.20247726.source.xml,,medrxiv,10.1101__2020.12.12.20247726_doc.txt
10.1101/2020.12.14.20242768,Distinct kinetics in antibody responses to 111 Plasmodium falciparum antigens identifies novel serological markers of recent malaria exposure,"Yman, V.; Tuju, J.; White, M. T.; Kamuyu, G.; Mwai, K.; Kibinge, N.; Asghar, M.; Sundling, C.; Sonden, K.; Murungi, L.; Kiboi, D.; Kimathi, R.; Chege, T.; Chepsat, E.; Kiyuka, P.; Nyamako, L.; Osier, F. H. A.; Farnert, A.",Victor Yman,"Karolinska Institutet, Department of Medicine Solna and Center for Molecular Medicine, Division of Infectious Diseases",2020-12-16,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/12/16/2020.12.14.20242768.source.xml,,medrxiv,10.1101__2020.12.14.20242768_doc.txt
10.1101/2020.12.15.20248254,"Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study","Hayward, A.; Fragaszy, E.; Kovar, J.; Nguyen, V.; Beale, S.; Byrne, T. E.; Aryee, A.; Hardelid, P.; Wijlaars, L.; Fong, W. L. E.; Geismar, C.; Patel, P.; Shrotri, M.; Navaratnam, A. M. D.; Nastouli, E.; Spyer, M.; Killingley, B.; Cox, I.; Lampos, V.; McKendry, R. A.; Cheng, T.; Johnson, A. M.; Michie, S.; Gibbs, J.; Gilson, R.; Rodger, A.; Aldridge, R. W.",Andrew Hayward,"Institute of Epidemiology and Health Care, University College London, London, UK",2021-05-13,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/05/13/2020.12.15.20248254.source.xml,10.1136/bmjopen-2020-048042,medrxiv,10.1101__2020.12.15.20248254_doc.txt
10.1101/2020.12.08.20233056,"Minimizing exposure to respiratory droplets, 'jet riders' and aerosols in air-conditioned hospital rooms by a 'Shield-and-Sink' strategy","Hunziker, P.",Patrick Hunziker,University Hospital Basel,2020-12-16,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/12/16/2020.12.08.20233056.source.xml,,medrxiv,10.1101__2020.12.08.20233056_doc.txt
10.1101/2020.12.16.20248297,Etiological Group Analysis of Cytokine Response To Influenza-Like Illnesses,"Plotnikova, M. A.; Klotchenko, S. A.; Lozhkov, A. A.; Lebedev, K. I.; Taraskin, A. S.; Baranovskaya, I. L.; Egorova, M. A.; Ramsay, E. S.; Vasin, A. V.",Marina A Plotnikova,Smorodintsev Research Institute of Influenza,2020-12-18,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/12/18/2020.12.16.20248297.source.xml,,medrxiv,10.1101__2020.12.16.20248297_doc.txt
10.1101/2020.12.19.20248567,"SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants","Tea, F.; Ospina Stella, A.; Aggarwal, A.; Darley, D. R.; Pilli, D.; Vitale, D.; Merheb, V.; Lee, F. X. Z.; Cunningham, P.; Walker, G. J.; Brown, D. A.; Rawlinson, W. D.; Isaacs, S. R.; Mathivanan, V.; Hoffman, M.; Poehlmann, S.; Dwyer, D. E.; Rockett, R.; Sintchenko, V.; Hoad, V. C.; Irving, D. O.; Dore, G. J.; Gosbell, I. B.; Kelleher, A. D.; Matthews, G. V.; Brilot, F.; Turville, S. G.",Fabienne Brilot,The University of Sydney,2021-01-23,2,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/01/23/2020.12.19.20248567.source.xml,10.1371/journal.pmed.1003656,medrxiv,10.1101__2020.12.19.20248567_doc.txt
10.1101/2020.12.22.20248386,Social disparities in the first wave of COVID-19 infections in Germany: A county-scale explainable machine learning approach,"Doblhammer, G.; Reinke, C.; Kreft, D.",Gabriele Doblhammer,University of Rostock,2020-12-22,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2020/12/22/2020.12.22.20248386.source.xml,,medrxiv,10.1101__2020.12.22.20248386_doc.txt
10.1101/2020.12.23.20248757,The spatial spread of HIV in Malawi: An individual-based mathematical model,"Estill, J.; Ng'ambi, W.; Rozanova, L.; Keiser, O.",Janne Estill,University of Geneva,2021-06-01,3,PUBLISHAHEADOFPRINT,cc_by_nc_nd,hiv aids,https://www.medrxiv.org/content/early/2021/06/01/2020.12.23.20248757.source.xml,,medrxiv,10.1101__2020.12.23.20248757_doc.txt
10.1101/2020.12.22.20239392,Clinical characteristics of COVID-19 patients in Latvia under low incidence in Spring 2020,"Viksna, L.; Kolesova, O.; Kolesovs, A.; Vanaga, I.; Arutjunana, S.; Laivacuma, S.; Storozenko, J.; Tolmane, I.; Berzina, I.; Rozentale, B.",Oksana Kolesova,Riga Stradins University,2020-12-24,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/12/24/2020.12.22.20239392.source.xml,,medrxiv,10.1101__2020.12.22.20239392_doc.txt
10.1101/2020.12.23.20248725,Engineered CRISPR/Cas12a Enables Rapid SARS-CoV-2 Detection,"Nguyen, L. T.; Rananaware, S. R.; Pizzano, B. L. M.; Stone, B. T.; Jain, P. K.",Piyush K. Jain,University of Florida,2020-12-24,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/12/24/2020.12.23.20248725.source.xml,,medrxiv,10.1101__2020.12.23.20248725_doc.txt
10.1101/2020.12.23.20231589,Characteristics of SARS-CoV-2 Testing for Rapid Diagnosis of COVID-19 during the Initial Stages of a Global Pandemic,"Guthrie, J. L.; Chen, A. J.; Budhram, D. R.; Cronin, K.; Peci, A.; Nelson, P.; Mallo, G. V.; Broukhanski, G.; Murti, M.; Majury, A.; Mazzulli, T.; Allen, V. G.; Patel, S. N.; Kus, J. V.; Tran, V.; Gubbay, J. B.",Jennifer L Guthrie,Public Health Ontario,2020-12-26,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/12/26/2020.12.23.20231589.source.xml,10.1371/journal.pone.0253941,medrxiv,10.1101__2020.12.23.20231589_doc.txt
10.1101/2020.12.24.20248834,S-variant SARS-CoV-2 is associated with significantly higher viral loads in samples tested by ThermoFisher TaqPath RT-PCR,"Kidd, M.; Richter, A.; Best, A.; Mirza, J.; Percival, B.; Mayhew, M.; Megram, O.; Ashford, F.; White, T.; Moles-Garcia, E.; Crawford, L.; Bosworth, A.; Plant, T.; McNally, A.",Mike Kidd,Public Health England and University Hospitals Birmingham NHS Foundation Trust,2020-12-27,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/12/27/2020.12.24.20248834.source.xml,10.1093/infdis/jiab082,medrxiv,10.1101__2020.12.24.20248834_doc.txt
10.1101/2020.12.25.20248427,Maori and Pacific People in New Zealand have higher risk of hospitalisation for COVID-19,"Steyn, N.; Binny, R. N.; Hannah, K.; Hendy, S.; James, A.; Lustig, A.; Ridings, K.; Plank, M. J.; Sporle, A.",Michael J Plank,University of Canterbury,2021-05-27,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/05/27/2020.12.25.20248427.source.xml,,medrxiv,10.1101__2020.12.25.20248427_doc.txt
10.1101/2020.12.24.20248842,Simulating Retarded SEIRS model for COVID-19: will the second epidemic happen?,"Pour Mohammad, H.",Hamid Pour Mohammad,Sharif University of Technology,2020-12-30,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2020/12/30/2020.12.24.20248842.source.xml,,medrxiv,10.1101__2020.12.24.20248842_doc.txt
10.1101/2021.01.03.21249180,"The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in children","Hachim, A.; Gu, H.; Kavian, O.; Kwan, M. Y.; Chan, W.-h.; Yau, Y. S.; Chiu, S. S.; Tsang, O. T.; Hui, D. S.; Ma, F.; Lau, E. H.; Cheng, S. M.; Poon, L. L.; Peiris, M. J.; Valkenburg, S. A.; Kavian, N.",Sophie A Valkenburg,"HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.",2021-01-04,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/01/04/2021.01.03.21249180.source.xml,,medrxiv,10.1101__2021.01.03.21249180_doc.txt
10.1101/2020.12.29.20248976,Laboratory Biomarkers of COVID-19 Disease Severity and Outcome: Findings from a Developing Country,"Leulseged, T. W.; Hassen, I. S.; Ayele, B. T.; Tsegay, Y. G.; Abebe, D. S.; Edo, M. G.; Maru, E. H.; Zewde, W. C.; Naylor, L. K.; Semane, D. F.; Deresse, M. T.; Tezera, B. B.",Tigist W. Leulseged,"Millennium COVID-19 Care Center, St Paul\'s Hospital Millennium Medical College, Addis Ababa, Ethiopia",2021-01-04,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/01/04/2020.12.29.20248976.source.xml,10.1371/journal.pone.0246087,medrxiv,10.1101__2020.12.29.20248976_doc.txt
10.1101/2021.01.05.21249154,Use of the FebriDx point-of-care assay as part of a triage algorithm for medical admissions with possible COVID-19,"Houston, H.; Gupta-Wright, A.; Deas, G.; Naik, S.; Shah, K.; Patel, S.; Dottori, M. G.; Tay, M.; Filson, S.; Biggin-Lamming, J.; Ross, J.; Vaughan, N.; Vaid, N.; Gopal Rao, G.; Amin, A.; John, L.",Ankur Gupta-Wright,"Institute for Global Health, University College London, Mortimer Market off Caper Street, London, UK WC1E 6JB",2021-01-25,2,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/01/25/2021.01.05.21249154.source.xml,,medrxiv,10.1101__2021.01.05.21249154_doc.txt
10.1101/2021.01.08.21249426,Engineered RNA biosensors enable ultrasensitive SARS-CoV-2 detection in a simple color and luminescence assay,"Chakravarthy, A.; N, A. K.; George, G.; Ranganathan, S.; Shettigar, N.; U, S.; Palakodeti, D.; Gulyani, A.; Ramesh, A.",Arati Ramesh,"National Centre for Biological Sciences, GKVK Campus, Bellary Road, Bangalore, India 560065",2021-04-16,3,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/04/16/2021.01.08.21249426.source.xml,10.26508/lsa.202101213,medrxiv,10.1101__2021.01.08.21249426_doc.txt
10.1101/2021.01.05.21249237,Enisamium is an inhibitor of the SARS-CoV-2 RNA polymerase and shows improvement of recovery in COVID-19 patients in an interim analysis of a clinical trial,"Holubovska, O.; Bojkova, D.; Elli, S.; bechtel, M.; Boltz, D.; Muzzio, M.; Peng, X.; Sala, F.; Cosentino, C.; Mironenko, A.; Milde, J.; Lebed, Y.; Stammer, H.; Goy, A.; Guerrini, M.; Mueller, L.; Cinatl, J.; Margitich, V.; te Velthuis, A.",Aartjan te Velthuis,University of Cambridge,2021-01-21,2,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2021/01/21/2021.01.05.21249237.source.xml,,medrxiv,10.1101__2021.01.05.21249237_doc.txt
10.1101/2021.01.04.21249249,"Role of pollution and weather indicators in the COVID-19 outbreak: A brief study on Delhi, India","Singh, K.; Agarwal, A.",Kuldeep Singh,Malaviya National Institute of Technology,2021-01-12,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/01/12/2021.01.04.21249249.source.xml,,medrxiv,10.1101__2021.01.04.21249249_doc.txt
10.1101/2021.01.08.20248771,Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infection,"Ahava, M. J.; Kurkela, S.; Kuivanen, S.; Lappalainen, M.; Jarva, H.; Jaaskelainen, A. J.",Maarit J Ahava,University of Helsinki and Helsinki University Hospital,2021-01-13,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/01/13/2021.01.08.20248771.source.xml,,medrxiv,10.1101__2021.01.08.20248771_doc.txt
10.1101/2021.01.11.20248765,"Delayed bystander CD8 T cell activation, early immune pathology and persistent dysregulation characterise severe COVID-19","Bergamaschi, L.; Mescia, F.; Turner, L.; Hanson, A.; Kotagiri, P.; Dunmore, B. J.; Ruffieux, H.; DeSa, A.; Huhn, O.; Morgan, M. D.; Pereyra Gerber, P.; Wills, M. R.; Baker, S.; Calero Nieto, F. J.; Doffinger, R.; Dougan, G.; Elmer, A.; Goodfellow, I. G.; Gupta, R. K.; Hosmillo, M.; Hunter, K.; Kingston, N.; Lehner, P. J.; Matheson, N. J.; Nicholson, J. K.; Petrunkina, A. M.; Richardson, S.; Saunders, C.; Thaventhiran, J. E. D.; Toonen, E. J. M.; Weekes, M. P.; CambridgeInstituteofTherapeuticImmunologyandInfectiousDisease-NationalInstituteofHealthResearch(CITI,  ; Gottgens, B.; Toshner, M.; Hes",Laura Bergamaschi,"Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK",2021-03-26,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/03/26/2021.01.11.20248765.source.xml,,medrxiv,10.1101__2021.01.11.20248765_doc.txt
10.1101/2021.01.15.21249810,SARS-CoV-2 seropositivity and seroconversion in patients undergoing active cancer-directed therapy,"Sun, L.; Surya, S.; G., N.; Le, A. N.; Kelly, G.; Owoyemi, O.; Desai, H.; Zheng, C.; DeLuca, S.; Good, M. L.; Hussain, J.; Jeffries, S. D.; Kry, Y. R.; Kugler, E. M.; Mansour, M.; Ndicu, J.; Osei-Akoto, A.; Prior, T.; Pundock, S. L.; Varughese, L. A.; Weaver, J.; Doucette, A.; Dudek, S.; Verma, S. S.; Gouma, S.; Weirick, M. E.; McAllister, C. M.; Bange, E.; Gabriel, P.; Ritchie, M.; Rader, D. J.; Vonderheide, R. H.; Schuchter, L. M.; Verma, A.; Maillard, I.; Mamtani, R.; Hensley, S. E.; Gross, R.; Wileyto, E. P.; Huang, A. C.; Maxwell, K. N.; DeMichele, A.",Angela DeMichele,"Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104",2021-01-16,1,PUBLISHAHEADOFPRINT,cc_no,oncology,https://www.medrxiv.org/content/early/2021/01/16/2021.01.15.21249810.source.xml,10.1200/OP.21.00113,medrxiv,10.1101__2021.01.15.21249810_doc.txt
10.1101/2021.01.15.21249891,Inactivation of SARS-CoV-2 virus in saliva using a guanidium based transport medium suitable for RT-PCR diagnostic assays,"Banik, S.; Saibire, K.; Suryavanshi, S.; Johns, G.; Chakravorty, S.; Kwiatkawoski, R.; Alland, D.; Banada, P. P.",David Alland,Rutgers New Jersey Medical School,2021-01-20,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/01/20/2021.01.15.21249891.source.xml,10.1371/journal.pone.0252687,medrxiv,10.1101__2021.01.15.21249891_doc.txt
10.1101/2021.01.18.21249414,Temporal Trends in COVID-19 associated AKI from March to December 2020 in New York City,"Dellepiane, S.; Vaid, A.; Jaladanki, S. K.; Paranjpe, I.; Coca, S.; Fayad, Z.; Charney, A.; Bottinger, E. P.; He, J. C.; Glicksberg, B. S.; Chan, L.; Nadkarni, G.",Girish Nadkarni,Mount Sinai Hospital,2021-01-20,1,PUBLISHAHEADOFPRINT,cc_no,nephrology,https://www.medrxiv.org/content/early/2021/01/20/2021.01.18.21249414.source.xml,,medrxiv,10.1101__2021.01.18.21249414_doc.txt
10.1101/2021.01.13.20202200,"Extending influenza surveillance to detect non-influenza respiratory viruses of public health relevance: analysis of surveillance data, 2015-2019, Belgium","Subissi, L.; Bossuyt, N.; Reynders, M.; Gerard, M.; Dauby, N.; Lacor, P.; Daelemans, S.; Lissoir, B.; Holemans, X.; Magerman, K.; Jouck, D.; Bourgeois, M.; Delaere, B.; Quoilin, S.; Van Gucht, S.; Thomas, I.; Barbezange, C.",Cyril Barbezange,Sciensano,2021-01-22,1,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2021/01/22/2021.01.13.20202200.source.xml,10.2807/1560-7917.es.2021.26.38.2001104,medrxiv,10.1101__2021.01.13.20202200_doc.txt
10.1101/2021.01.22.21249945,Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients,"Bliddal, S.; Banasik, K.; Pedersen, O. B.; Nissen, I.; Cantwell, L.; Schwinn, M.; Tulstrup, M.; Westergaard, D.; Ullum, H.; Brunak, S.; Tommerup, N.; Feenstra, B.; Geller, F.; Ostrowski, S. R.; Groenbaek, K.; Nielsen, C. H.; Nielsen, S. D.; Feldt-Rasmussen, U.",Ulla Feldt-Rasmussen,Copenhagen University Hospital (Rigshospitalet),2021-01-25,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/01/25/2021.01.22.21249945.source.xml,10.1038/s41598-021-92045-x,medrxiv,10.1101__2021.01.22.21249945_doc.txt
10.1101/2021.01.25.21250082,SARS-CoV-2 RNA screening in routine pathology specimens,"von Stillfried, S. E.; Villwock, S.; Buelow, R. D.; Djudjaj, S.; Buhl, E. M.; Maurer, A.; Ortiz-Bruechle, N.; Celec, P.; Klinkhammer, B. M.; Wong, D. W.; Cacchi, C.; Braunschweig, T.; Knuechel, R.; Dahl, E.; Boor, P.",Peter Boor,"Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany and Departments of Nephrology and Immunology, RWTH Aachen University Hospital, Aachen, ",2021-01-26,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/01/26/2021.01.25.21250082.source.xml,10.1111/1751-7915.13828,medrxiv,10.1101__2021.01.25.21250082_doc.txt
10.1101/2021.01.21.21250235,Force of infection: A determinant of vaccine efficacy?,"Kaslow, D. C.",David C. Kaslow,PATH,2021-01-26,1,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2021/01/26/2021.01.21.21250235.source.xml,10.1038/s41541-021-00316-5,medrxiv,10.1101__2021.01.21.21250235_doc.txt
10.1101/2021.01.28.21250675,Age significantly influences the sensitivity of SARS-CoV-2 rapid antibody assays,"Irwin, N.; Murray, L.; Ozynski, B.; Richards, G. A.; Paget, G.; Venturas, J.; Kalla, I.; Diana, N.; Mahomed, A.; Zamparini, J.",Jarrod Zamparini,"Department of Internal Medicine, University of the Witwatersrand",2021-02-01,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/02/01/2021.01.28.21250675.source.xml,10.1016/j.ijid.2021.07.027,medrxiv,10.1101__2021.01.28.21250675_doc.txt
10.1101/2021.01.29.21250804,A mathematical model to estimate percentage secondary infections from margin of error of diagnostic sensitivity: Useful tool for regulatory agencies to assess the risk of propagation due to false negative outcome of diagnostics,"Palavesam, A.; Kumaragurubaran, K.; R Parthiban, A. B.; TMA, S.; Chidambaram, B.; Gopal, D. R.",Azhahianambi Palavesam,Tamil Nadu Veterinary and Animal Sciences University,2021-02-01,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/02/01/2021.01.29.21250804.source.xml,,medrxiv,10.1101__2021.01.29.21250804_doc.txt
10.1101/2021.02.02.21250940,IgA autoantibodies target pulmonary surfactant in patients with severe COVID-19,"Sinnberg, T.; Lichtensteiger, C.; Hasan Ali, O.; Pop, O. T.; Gilardi, M.; Risch, L.; Bomze, D.; Kohler, P.; Vernazza, P.; Albrich, W. C.; Kahlert, C. R.; Brugger, S. D.; Abdou, M.-T.; Zinner, C.; Tzankov, A.; Roecken, M.; Kern, L.; Brutsche, M. H.; Kalbacher, H.; Velic, A.; Macek, B.; Penninger, J. M.; Matter, M. S.; Flatz, L.",Lukas Flatz,"Department of Dermatology, University Hospital Tuebingen, Liebermeisterstrasse 25, 72076 Tuebingen",2021-02-07,2,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/02/07/2021.02.02.21250940.source.xml,,medrxiv,10.1101__2021.02.02.21250940_doc.txt
10.1101/2021.02.02.21250799,Infection and mRNA-1273 vaccine antibodies neutralize SARS-CoV-2 UK variant,"Edara, V. V.; Floyd, K.; Lai, L.; Gardner, M.; Hudson, W.; Piantadosi, A.; Waggoner, J.; Babiker, A.; Ahmed, R.; Xie, X.; Lokugamage, K.; Menachery, V.; Shi, P.-Y.; COVID-19 Neutralization Study Group,  ; Suthar, M. S.",Mehul S Suthar,Emory University,2021-02-05,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/02/05/2021.02.02.21250799.source.xml,,medrxiv,10.1101__2021.02.02.21250799_doc.txt
10.1101/2021.02.02.21250362,Bronchoscopy in COVID19 ARDS patients on mechanical ventilation: a prospective study,"Mehta, R. M.; Bansal, S.; Kumar, A.; Thorbole, A.; L, C.; Kalpakam, H.",Ravindra M Mehta,Apollo Super Specialty Hospital,2021-02-05,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/02/05/2021.02.02.21250362.source.xml,,medrxiv,10.1101__2021.02.02.21250362_doc.txt
10.1101/2021.02.04.21249959,"Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome: A single center experience from Pune, Western India","Dravid, A.; Kashiva, R.; Khan, Z.; Memon, D.; Kodre, A.; Potdar, P.; Mane, M.; Borse, R.; Pawar, V.; Patil, D.; Banerjee, D.; Bhoite, K.; Pharande, R.; Kalyani, S.; Raut, P.; Bapte, M.; Mehta, A.; Reddy, M. S.; Bhayani, K.; Laxmi, S. S.; Vishnu, P. D.; Srivastava, S.; Khandelwal, S.; More, S.; Shinde, R.; Pawar, M.; Harshe, A.; Kadam, S.; Mahajan, U.; Joshi, G.; Mane, D.",Ameet Dravid,"Noble Hospital and Research Center, Pune, State - Maharashtra, India",2021-02-06,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2021/02/06/2021.02.04.21249959.source.xml,,medrxiv,10.1101__2021.02.04.21249959_doc.txt
10.1101/2021.02.06.21251159,Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States,"Washington, N. L.; Gangavarapu, K.; Zeller, M.; Bolze, A.; Cirulli, E. T.; Schiabor Barrett, K. M.; Larsen, B. B.; Anderson, C.; White, S.; Cassens, T.; Jacobs, S.; Levan, G.; Nguyen, J.; Ramirez, J. M.; Rivera-Garcia, C.; Sandoval, E.; Wang, X.; Wong, D.; Spencer, E.; Robles-Sikisaka, R.; Kurzban, E.; Hughes, L. D.; Deng, X.; Wang, C.; Servellita, V.; Valentine, H.; De Hoff, P.; Seaver, P.; Sathe, S.; Gietzen, K.; Sickler, B.; Antico, J.; Hoon, K.; Liu, J.; Harding, A.; Bakhtar, O.; Basler, T.; Austin, B.; Isaksson, M.; Febbo, P.; Becker, D.; Laurent, M.; McDonald, E.; Yeo, G. W.; Knight, R.;",Nicole L. Washington,Helix,2021-02-07,1,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2021/02/07/2021.02.06.21251159.source.xml,,medrxiv,10.1101__2021.02.06.21251159_doc.txt
10.1101/2021.02.10.21251484,An analysis of school absences in England during the Covid-19 pandemic,"Southall, E. R.; Holmes, A.; Hill, E. M.; Atkins, B. D.; Leng, T.; Thompson, R. N.; Dyson, L. J.; Keeling, M. J.; Tildesley, M.",Michael Tildesley,University of Warwick,2021-02-17,2,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2021/02/17/2021.02.10.21251484.source.xml,10.1186/s12916-021-01990-x,medrxiv,10.1101__2021.02.10.21251484_doc.txt
10.1101/2021.02.15.21251727,Artificial Intelligence Applications for COVID-19 in Intensive Care and Emergency Settings: A Systematic Review,"Chee, M. L.; Ong, M. E. H.; Siddiqui, F. J.; Zhang, Z.; Lim, S. L.; Ho, A. F. W.; Liu, N.",Nan Liu,Duke-NUS Medical School,2021-02-18,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2021/02/18/2021.02.15.21251727.source.xml,10.3390/ijerph18094749,medrxiv,10.1101__2021.02.15.21251727_doc.txt
10.1101/2021.02.17.21251863,Ultrasensitive assay for saliva-based SARS-CoV-2 antigen detection.,"Ren, A.; Sohaei, D.; Zacharioudakis, I.; Sigal, G. B.; Stengelin, M.; Matthew, A.; Campbell, C.; Padmanabhan, N.; Romero, D.; Joe, J.; Soosaipillai, A.; Kulasingam, V.; Mazzulli, T.; Li, X. A.; McGeer, A.; Diamandis, E. P.; Prassas, I.",Ioannis Prassas,"Mount Sinai Hospital, Lunenfeld Tanenbaum Research Institute",2021-02-19,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/02/19/2021.02.17.21251863.source.xml,,medrxiv,10.1101__2021.02.17.21251863_doc.txt
10.1101/2021.02.18.21252032,The COVID-19 Incarceration Model: a tool for corrections staff to analyze outbreaks of COVID-19,"Kwon, J. A.; Bretana, N. A.; Grant, L.; Galouzis, J.; Hoey, W.; Blogg, J.; Lloyd, A. R.; Gray, R. T.",Jisoo Amy Kwon,"The Kirby Institute, University of New South Wales",2021-03-08,3,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/03/08/2021.02.18.21252032.source.xml,,medrxiv,10.1101__2021.02.18.21252032_doc.txt
10.1101/2021.02.20.20248421,Nosocomial outbreak of SARS-CoV-2 in a 'non-COVID-19' hospital ward: virus genome sequencing as a key tool to understand cryptic transmission,"Borges, V.; Isidro, J.; Macedo, F.; Neves, J.; Silva, L.; Paiva, M.; Barata, J.; Catarino, J.; Ciobanu, L.; Duarte, S.; Vieira, L.; Guiomar, R.; Gomes, J. P.",Vitor Borges,"Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal.",2021-02-23,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/02/23/2021.02.20.20248421.source.xml,10.3390/v13040604,medrxiv,10.1101__2021.02.20.20248421_doc.txt
10.1101/2021.02.22.21252207,Critical COVID-19 represents an endothelial disease with high similarity to kidney disease on the molecular level,"Siwy, J.; Wendt, R.; Albalat, A.; He, T.; Mischak, H.; Mullen, W.; Latosinska, A.; Luebbert, C.; Kalbitz, S.; Mebazaa, A.; Peters, B.; Stegmayr, B.; Spasovski, G.; Wiech, T.; Staessen, J.; Wolf, J.; Beige, J.",Justyna Siwy,Mosaiques-Diagnostics GmbH,2021-02-23,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/02/23/2021.02.22.21252207.source.xml,,medrxiv,10.1101__2021.02.22.21252207_doc.txt
10.1101/2021.02.24.21252047,Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2,"Marien, j.; Michiels, J.; Heyndrickx, L.; Nkuba-Ndaye, A.; Ceulemans, A.; Koen Bartholomeeusen, K.; Madinga, J.; Mbala-Kingebeni, P.; Vanlerberghe, V.; Ahuka-Mundeke, S.; Wang, L.; Arien, K. K.",joachim Marien,Institute of Tropical medicine Antwerp,2021-02-25,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/02/25/2021.02.24.21252047.source.xml,10.1016/j.jviromet.2021.114228,medrxiv,10.1101__2021.02.24.21252047_doc.txt
10.1101/2021.02.24.21252337,A prospective evaluation of the analytical performance of GENECUBE(R) HQ SARS-CoV-2 and GENECUBE(R) FLU A/B,"Kiyasu, Y.; Akashi, Y.; Sugiyama, A.; Takeuchi, Y.; Notake, S.; Naito, A.; Nakamura, K.; Ishikawa, H.; Suzuki, H.",Yusaku Akashi Dr.,"Division of Infectious Diseases, Department of Medicine, Tsukuba Medical Center Hospital",2021-02-25,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/02/25/2021.02.24.21252337.source.xml,10.1007/s40291-021-00535-5,medrxiv,10.1101__2021.02.24.21252337_doc.txt
10.1101/2021.03.05.21252960,SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19,"Grobbelaar, L. M.; Venter, C.; Vlok, M.; Ngoepe, M.; Laubscher, G. J.; Lourens, P. J.; Steenkamp, J.; Kell, D. B.; Pretorius, E.; Kell, D. B.",Etheresia Pretorius,Stellenbosch University,2021-03-08,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2021/03/08/2021.03.05.21252960.source.xml,10.1042/bsr20210611,medrxiv,10.1101__2021.03.05.21252960_doc.txt
10.1101/2021.03.10.21253079,Antimicrobial susceptibility patterns of respiratory Gram-negative bacterial isolates from COVID-19 patients in Switzerland,"Gysin, M.; Acevedo, C. T.; Haldimann, K.; Bodendoerfer, E.; Imkamp, F.; Bulut, K.; Buehler, P. K.; Brugger, S. D.; Becker, K.; Hobbie, S. N.",Sven N. Hobbie,University of Zurich,2021-07-17,3,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/07/17/2021.03.10.21253079.source.xml,10.1186/s12941-021-00468-1,medrxiv,10.1101__2021.03.10.21253079_doc.txt
10.1101/2021.03.11.21252969,Reducing the Cost of Rapid Antigen Tests through Swab Pooling and Extraction in a Device,"Berking, T.; Lorenz, S. G.; Ulrich, A.; Greiner, J.; Richert, C.",Clemens Richert,University of Stuttgart,2021-03-12,1,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2021/03/12/2021.03.11.21252969.source.xml,10.3390/diagnostics11071290,medrxiv,10.1101__2021.03.11.21252969_doc.txt
10.1101/2021.03.12.21253493,Seroprevalence of Antibodies to SARS-CoV-2 among Health Care Workers in Kenya,"Etyang, A. O.; Lucinde, R.; Karanja, H.; Kalu, C.; Mugo, D.; Nyagwange, J.; Gitonga, J.; Tuju, J.; Wanjiku, P.; Karani, A.; Mutua, S.; Maroko, H.; Nzomo, E.; Maitha, E.; Kamuri, E.; Kaugiria, T.; Weru, J.; Ochola, L. B.; Kilimo, N.; Charo, S.; Emukule, N.; Moracha, W.; Mukabi, D.; Okuku, R.; Ogutu, M.; Angujo, B.; Otiende, M.; Bottomley, C.; Otieno, E.; Ndwiga, L.; Nyaguara, A.; Voller, S.; Agoti, C.; Nokes, D. J.; Ochola-Oyier, L. I.; Aman, R.; Amoth, P.; Mwangangi, M.; Kasera, K.; Nganga, W.; Adetifa, I.; Kagucia, W.; Gallagher, K.; Uyoga, S.; Tsofa, B.; Barasa, E.; Bejon, P.; Scott, J. A. G",Anthony O. Etyang,"KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya",2021-03-13,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2021/03/13/2021.03.12.21253493.source.xml,,medrxiv,10.1101__2021.03.12.21253493_doc.txt
10.1101/2021.03.18.21253228,SARS-CoV-2 show no infectivity at later stages in a prolonged COVID-19 patient despite positivity in RNA testing,"Wan, X.-F.; Tang, C. Y.; Ritter, D.; Wang, Y.; Li, T.; Segovia, K.; Kosikova, M.; Johnson, M.; Kwon, H. J.; Xie, H.; Hammer, R. D.; McElroy, J. A.; Hamid, A.; Collins, N. D.; Hang, J.; Camp, S.",Xiu-Feng Wan,University of Missouri,2021-03-20,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/03/20/2021.03.18.21253228.source.xml,10.1002/jmv.27001,medrxiv,10.1101__2021.03.18.21253228_doc.txt
10.1101/2021.03.17.21253800,Investigation of the ventilation situation in a lecture room of building 033 at the Universität der Bundeswehr München,"Kähler, C. J.; Fuchs, T.; Hain, R.",Christian J. Kähler,"Universität der Bundeswehr München, Institute of Fluid Mechanics and Aerodynamics",2021-03-20,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/03/20/2021.03.17.21253800.source.xml,,medrxiv,10.1101__2021.03.17.21253800_doc.txt
10.1101/2021.03.19.21253975,Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors,"Kunze, K. L.; Johnson, P. W.; van Helmond, N.; Senefeld, J. W.; Petersen, M. M.; Klassen, S. A.; Wiggins, C. C.; Klompas, A. M.; Bruno, K. A.; Mills, J. R.; Theel, E. S.; Buras, M. R.; Golafshar, M. A.; Sexton, M. A.; Diaz Soto, J. C.; Baker, S. E.; Shepherd, J. R. A.; Verdun, N. C.; Marks, P.; Paneth, N. S.; Fairweather, D.; Wright, R. S.; van Buskirk, C. M.; Winters, J. L.; Stubbs, J. R.; Senese, K. A.; Pletsch, M. C.; Buchholtz, Z. A.; Rea, R. F.; Herasevich, V.; Whelan, E. R.; Clayburn, A. J.; Larson, K. F.; Ripoll, J. G.; Andersen, K. J.; Lesser, E. R.; Vogt, M. N. P.; Dennis, J. J.; Regi",Jonathon W Senefeld,Mayo Clinic,2021-04-02,2,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/04/02/2021.03.19.21253975.source.xml,,medrxiv,10.1101__2021.03.19.21253975_doc.txt
10.1101/2021.03.20.21254010,Older biological age is associated with adverse COVID-19 outcomes: A cohort study in UK Biobank,"Wang, Q.; Codd, V.; Raisi-Estabragh, Z.; Musicha, C.; Vasiliki, B.; Kaptoge, S.; Allara, E.; Di Angelantonio, E.; Butterworth, A. S.; Wood, A. M.; Thompson, J. R.; Petersen, S. E.; Harvey, N. C.; Danesh, J. N.; Samani, N. J.; Nelson, C. P.",Christopher P Nelson,University of Leicester,2021-03-22,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/03/22/2021.03.20.21254010.source.xml,,medrxiv,10.1101__2021.03.20.21254010_doc.txt
10.1101/2021.03.19.21253005,Corticosteroids and mortality in patients with severe Covid-19 who have autoantibodies,"Cui, Z.; Roth, M.; Averbukh, Y.; Assa, A.; Al-ani, A.; Southern, W.; Reyes Gill, M.; Arora, S.",Shitij Arora,Montefiore Medical Center,2021-03-23,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/03/23/2021.03.19.21253005.source.xml,,medrxiv,10.1101__2021.03.19.21253005_doc.txt
10.1101/2021.03.17.21253849,Some Clinical and Immunological Features of Imported COVID-19 Cases in Mongolia,"Sandag, T.; Lkhagvasuren, E.; Batmunkh, M.; Ravjir, O.",Tsogtsaikhan Sandag,"School of Biomedicine, Mongolian National University of Medical Sciences",2021-03-24,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/03/24/2021.03.17.21253849.source.xml,,medrxiv,10.1101__2021.03.17.21253849_doc.txt
10.1101/2021.03.26.21254435,Prevalence and associated factors with mental health outcomes among interns and residents physicians during COVID-19 epidemic in Panama: a cross-sectional study,"Espinosa-Guerra, E. A.; Rodriguez-Barria, E. R.; Donnelly, C. A.; Carrera, J. P.",Jean Paul Carrera,University of Oxford,2021-03-28,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,psychiatry and clinical psychology,https://www.medrxiv.org/content/early/2021/03/28/2021.03.26.21254435.source.xml,,medrxiv,10.1101__2021.03.26.21254435_doc.txt
10.1101/2021.03.27.21253966,Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR,"Wagenhaeuser, I.; Knies, K.; Rauschenberger, V.; Eisenmann, M.; McDonogh, M.; Petri, N.; Andres, O.; Flemming, S.; Gawlik, M.; Papsdorf, M.; Taurines, R.; Boehm, H.; Forster, J.; Weismann, D.; Weissbrich, B.; Doelken, L.; Liese, J.; Kurzai, O.; Vogel, U.; Krone, M.",Manuel Krone,"Institute for Hygiene and Microbiology, University of Wuerzburg, Wuerzburg, Germany",2021-03-29,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2021/03/29/2021.03.27.21253966.source.xml,10.1016/j.ebiom.2021.103455,medrxiv,10.1101__2021.03.27.21253966_doc.txt
10.1101/2021.03.31.21254699,Tryptophan and arginine metabolism is significantly altered at the time of admission in hospital for severe COVID-19 patients: findings from longitudinal targeted metabolomics analysis,"Ansone, L.; Ustinova, M.; Terentjeva, A.; Perkons, I.; Birzniece, L.; Rovite, V.; Rozentale, B.; Viksna, L.; Kolesova, O.; Klavins, K.; Klovins, J.",Janis Klovins,Latvian Biomedical Research and Study Centre,2021-04-06,1,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2021/04/06/2021.03.31.21254699.source.xml,,medrxiv,10.1101__2021.03.31.21254699_doc.txt
10.1101/2021.04.05.21254712,"Evaluation of the performance of SARS-CoV-2 antibody assays for the longitudinal population-based study of COVID-19 spread in St. Petersburg, Russia","Barchuk, A.; Shirokov, D.; Sergeeva, M.; Tursun-zade, R.; Dudkina, O.; Tychkova, V.; Barabanova, L.; Skougarevskiy, D.; Danilenko, D.",Anton Barchuk,European University at St. Petersburg,2021-04-07,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/04/07/2021.04.05.21254712.source.xml,10.1002/jmv.27126,medrxiv,10.1101__2021.04.05.21254712_doc.txt
10.1101/2021.04.01.21254813,Prospective analytical performance evaluation of the QuickNavi™-COVID19 Ag for asymptomatic individuals,"Kiyasu, Y.; Takeuchi, Y.; Akashi, Y.; Kato, D.; Kuwahara, M.; Muramatsu, S.; Notake, S.; Ueda, A.; Nakamura, K.; Ishikawa, H.; Suzuki, H.",Yoshihiko Kiyasu,University of Tsukuba Hospital,2021-04-07,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/04/07/2021.04.01.21254813.source.xml,10.1016/j.jiac.2021.07.005,medrxiv,10.1101__2021.04.01.21254813_doc.txt
10.1101/2021.04.08.21254791,Emergence of multiple SARS-CoV-2 antibody escape variants in an immunocompromised host undergoing convalescent plasma treatment,"Chen, L.; Zody, M. C.; Mediavilla, J. R.; Cunningham, M. H.; Composto, K.; Chow, K. F.; Kordalewska, M.; Corvelo, A.; Oschwald, D. M.; Fennessey, S.; Zetkulic, M.; Dar, S.; Kramer, Y.; Mathema, B.; Maniatis, T.; Perlin, D. S.; Kreiswirth, B. N.",Barry N Kreiswirth,Hackensack Meridian Health Center for Discovery and Innovation,2021-04-11,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/04/11/2021.04.08.21254791.source.xml,10.1128/msphere.00480-21,medrxiv,10.1101__2021.04.08.21254791_doc.txt
10.1101/2021.04.09.21255220,Metabolic Preference Assay for Rapid Diagnosis of Bloodstream Infections,"Rydzak, T.; Groves, R. A.; Zhang, R.; Pushpker, R.; Mapar, M.; Lewis, I. A.",Ian A Lewis,University of Calgary,2021-04-13,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/04/13/2021.04.09.21255220.source.xml,,medrxiv,10.1101__2021.04.09.21255220_doc.txt
10.1101/2021.04.12.21253817,"Spread of the SARS-CoV-2 UK-variant in the South East of France: impact on COVID-19 patients age, comorbidity profiles and clinical presentation, week 50 2020 to week 8 2021","Courjon, J.-V.; Contenti, J.; Demonchy, E.; Levraut, J.; Barbry, P.; Rios, G.; Dellamonica, J.; Chirio, D.; Bonnefoy, C.; Giordanengo, V.; Carles, M.",Johan-Victor Courjon,"UCA, Inserm, U1065, C3M, Nice, France",2021-04-15,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/04/15/2021.04.12.21253817.source.xml,10.1038/s41598-021-95067-7,medrxiv,10.1101__2021.04.12.21253817_doc.txt
10.1101/2021.04.09.21255190,IL-1 Mediates Tissue Specific Inflammation and Severe Respiratory Failure In Covid-19: Clinical And Experimental Evidence,"Renieris, G.; Karakike, E.; Gkavogianni, T.; Droggiti, D.- E.; Kafousopoulos, D.; Netea, M. G.; Eugen-Olsen, J.; Simard, J.; Giamarellos-Bourboulis, E. J.",Evangelos J Giamarellos-Bourboulis,"4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, 124 62 Athens, Greece",2021-04-16,2,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/04/16/2021.04.09.21255190.source.xml,,medrxiv,10.1101__2021.04.09.21255190_doc.txt
10.1101/2021.04.13.21255117,A distinct metabolic profile associated with a fatal outcome in COVID-19 patients during early epidemic in Italy,"Saccon, E.; Bandera, A.; Sciume, M.; Mikaeloff, F.; Lashari, A. A.; Aliberti, S.; Sachs, M.; Billi, F.; Blasi, F.; Gabriel, E.; Costantino, G.; Deroberto, P.; Krishnan, S.; Gori, A.; Peyvandi, F.; Scudeller, L.; Lorson, C. L.; Valenti, L.; Singh, K.; Baldini, L.; Fracchiolla, N. S.; Neogi, U.",Ujjwal Neogi,Karolinska Institutet,2021-04-15,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/04/15/2021.04.13.21255117.source.xml,10.1128/spectrum.00549-21,medrxiv,10.1101__2021.04.13.21255117_doc.txt
10.1101/2021.04.16.21255647,Prospective predictive performance comparison between Clinical Gestalt and validated COVID-19 mortality scores.,"Soto-Mota, A.; Marfil-Garza, B. A.; Castiello, S.; Martinez-Rodriguez, E.; Carrillo-Vazquez, D.; Tadeo Espinoza, H.; Guerrero-Cabrera, J. P.; Dardon-Fierro, F. E.; Escobar Valderrama, J. M.; Alanis-Mendizabal, J.; Gutierrez-Mejia, J.",Adrian Soto-Mota,National Institute of Medical Sciences and Nutrition Salvador Zubiran,2021-04-18,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/04/18/2021.04.16.21255647.source.xml,,medrxiv,10.1101__2021.04.16.21255647_doc.txt
10.1101/2021.04.14.21255479,Unlocking low- and middle-income countries to detect SARS-CoV-2,"Alcantara, R.; Penaranda, K.; Mendoza, G.; Nakamoto, J. A.; Martins-Luna, J.; Del Valle, J.; Adaui, V.; Milon, P.",Pohl Milon,Universidad Peruana de Ciencias Aplicadas (UPC),2021-04-20,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2021/04/20/2021.04.14.21255479.source.xml,,medrxiv,10.1101__2021.04.14.21255479_doc.txt
10.1101/2021.04.17.21255540,Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19,"Stefania, C. L.; Ramirez, G. A.; Scavini, M.; Da Prat, V.; Di Lucca, G.; Laurenzi, A.; Gallina, G.; Cavallo, L.; Borio, G.; Farolfi, F.; Pascali, M.; Castellani, J.; Lampasona, V.; D'Angelo, A.; Landoni, G.; Ciceri, F.; Rovere Querini, P.; Tresoldi, M.; Piemonti, L.",Lorenzo Piemonti,IRCCS Ospedale San Raffaele,2021-05-17,2,PUBLISHAHEADOFPRINT,cc_no,endocrinology,https://www.medrxiv.org/content/early/2021/05/17/2021.04.17.21255540.source.xml,10.1016/j.metabol.2021.154845,medrxiv,10.1101__2021.04.17.21255540_doc.txt
10.1101/2021.04.20.21255596,Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland,"McDonald, L.; Wise, H.; Muecksch, F.; Poston, D.; Mavin, S.; Templeton, K.; Furrie, E.; Richardson, C.; McGuire, J.; Jarvis, L.; Malloy, K.; McAuley, A.; Palmateer, N.; Dickson, E.; Hatziioannou, T.; Bieniasz, P.; Jenks, S.",Sara Jenks,"Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, Scotland",2021-04-22,1,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2021/04/22/2021.04.20.21255596.source.xml,10.1016/j.jcvp.2021.100028,medrxiv,10.1101__2021.04.20.21255596_doc.txt
10.1101/2021.04.23.21255964,Detection of SARS-CoV-2 infection by saliva and nasopharyngeal sampling in frontline healthcare workers: an observational cohort study.,"Walker, N. F.; Byrne, R. L.; Howard, A.; Nikolaou, E.; Farrar, M.; Glynn, S.; Cheliotis, K. S.; Cubas Atienzar, A. I.; Davies, K.; Reine, J.; Rashid-Gardner, Z.; German, E. L.; Solorzano, C.; Blandamer, T.; Hitchins, L.; Myerscough, C.; Grassner, B.; Biegner, E.; Collins, A. M.; Beadsworth, M.; Todd, S.; Hill, H.; Houlihan, C. F.; Nastouli, E.; Adams, E. R.; Mitsi, E.; Ferreira, D. M.",Naomi F Walker,Liverpool School of Tropical Medicine,2021-04-26,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/04/26/2021.04.23.21255964.source.xml,,medrxiv,10.1101__2021.04.23.21255964_doc.txt
10.1101/2021.04.23.21255846,Transmission of SARS-CoV-2 within households: a prospective cohort study in the Netherlands and Belgium - Interim results,"de Hoog, M. L.; Verberk, J. D.; Westerhof, I.; van Goethem, S.; Lammens, C.; Ieven, G.; de Bruin, E.; Bielicki, J.; Coenen, S.; van Beek, J.; Bonten, M. J.; Goossens, H.; Bruijning-Verhagen, P. C.",Marieke MLA de Hoog,UMC Utrecht,2021-05-10,2,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/05/10/2021.04.23.21255846.source.xml,,medrxiv,10.1101__2021.04.23.21255846_doc.txt
10.1101/2021.04.23.21255998,"Knowledge and Impact of COVID-19 on Middle-Aged and Older People living with HIV in Lima, Peru","Diaz, M. M.; Cabrera, D. M.; Gil-Zacarias, M.; Ramirez, V.; Saavedra, M.; Carcamo, C.; Hsieh, E.; Garcia, P. J.",Monica Maria Diaz,University of North Carolina at Chapel Hill,2021-04-26,1,PUBLISHAHEADOFPRINT,cc_no,hiv aids,https://www.medrxiv.org/content/early/2021/04/26/2021.04.23.21255998.source.xml,,medrxiv,10.1101__2021.04.23.21255998_doc.txt
10.1101/2021.04.28.21255760,SARS-CoV-2 infections in airway epithelial cells from smokers versus non-smokers,"Essaidi-Laziosi, M.; Torriani, G.; Alvarez, C.; Kaiser, L.; Eckerle, I.",Isabella Eckerle,University Hospitals of Geneva,2021-09-22,2,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/09/22/2021.04.28.21255760.source.xml,,medrxiv,10.1101__2021.04.28.21255760_doc.txt
10.1101/2021.04.29.21256291,Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19,"Hoeter, K.; Neuberger, E.; Fischer, S.; Herbst, M.; Juskeviciute, E.; Rossmann, H.; Sprinzl, M. F.; Simon, P.; Bodenstein, M.; Schäfer, M. K. E.",Michael K.E. Schäfer,"Department of Anesthesiology, University Medical Center of the Johannes Gutenberg-University of Mainz, Germany",2021-05-02,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/05/02/2021.04.29.21256291.source.xml,,medrxiv,10.1101__2021.04.29.21256291_doc.txt
10.1101/2021.05.12.21257125,COVID-19 Serology in New York State Using a Multiplex Microsphere Immunoassay,"Hunt, D. T.; Yates, J. L.; Kulas, K. E.; Carson, K.; Lamson, T.; Demarest, V.; Furuya, A.; Howard, K.; Marchewka, M.; Stone, R.; Tucker, H.; Warszycki, C.; Yee, J.; Yang, H. S.; Racine-Brzostek, S.; Zhao, Z.; Ejemel, M.; Li, Q.; Wang, Y.; Fernando, S.; La Carpia, F.; Hod, E. A.; McDonough, K. A.; Lee, W. T.",William T. Lee,Wadsworth Center/New York State Department of Health,2021-05-15,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/05/15/2021.05.12.21257125.source.xml,,medrxiv,10.1101__2021.05.12.21257125_doc.txt
10.1101/2021.05.14.21257059,Hydroxychloroquine For Prophylaxis Of COVID-19 In Health Workers: A Randomized Clinical Trial.,"Rojas-Serrano, J.; Portillo-Vasquez, A. M.; Thirion-Romero, I.; Vazquez-Perez, J.; Mejia-Nepomuceno, F.; Ramirez-Venegas, A.; Perez-Kawabe, K. M.; Perez-Padilla, R.; RESEARCH GROUP ON HYDROXYCHLOROQUINE FOR COVID-19,  ",Jorge Rojas-Serrano,Instituto Nacional de Enfermedades Respiratorias,2021-05-16,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/05/16/2021.05.14.21257059.source.xml,,medrxiv,10.1101__2021.05.14.21257059_doc.txt
10.1101/2021.05.13.21257019,Viral metagenomic sequencing in a cohort of international travellers returning with febrile illness,"Reyes, A.; Carbo, E. C.; van Harinxma thoe Slooten, J.; Kraakman, M. E. M.; Sidorov, I. A.; Claas, E. C. J.; Kroes, A. C. M.; Visser, L. G.; de Vries, J. J. C.",Ellen C. Carbo,"Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands",2021-05-17,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/05/17/2021.05.13.21257019.source.xml,10.1016/j.jcv.2021.104940,medrxiv,10.1101__2021.05.13.21257019_doc.txt
10.1101/2021.05.13.21257065,HLA-B*15:01 is associated with asymptomatic SARS-CoV-2 infection,"Augusto, D. G.; Yusufali, T.; Peyser, N. D.; Butcher, X.; Marcus, G. M.; Olgin, J. E.; Pletcher, M. J.; Maiers, M.; Hollenbach, J. A.",Jill A Hollenbach,"Department of Neurology and Department of Epidemiology and Biostatistics, University of California, San Francisco",2021-09-10,2,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2021/09/10/2021.05.13.21257065.source.xml,,medrxiv,10.1101__2021.05.13.21257065_doc.txt
10.1101/2021.05.08.21256896,Epidemiological characteristics and incubation period of SARS-CoV-2 during the 2020-2021 winter pandemic wave in north China: an observational study,"Liu, T.; Chen, Z.; Xu, J.",Jin Xu,East China Normal University,2021-05-18,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/05/18/2021.05.08.21256896.source.xml,10.1002/jmv.27226,medrxiv,10.1101__2021.05.08.21256896_doc.txt
10.1101/2021.05.21.21257547,Environmental surveillance for Salmonella Typhi as a tool to estimate the incidence of typhoid fever in low-income populations,"Uzzell, C. B.; Troman, C. M.; Rigby, J.; Mohan, V. R.; John, J.; Abraham, D.; Srinivasan, R.; Nair, S.; Meschke, J. S.; Elviss, N.; Kang, G.; Feasey, N.; Grassly, N. C.",Christopher B Uzzell,Imperial College London,2021-05-22,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2021/05/22/2021.05.21.21257547.source.xml,,medrxiv,10.1101__2021.05.21.21257547_doc.txt
10.1101/2021.05.19.21257439,Rapid And high throughput RT-qPCR assay for identification and differentiation between SARS-CoV-2 variants B.1.1.7 and B.1.351,"Erster, O.; Mendelson, E.; Levy, V.; Kabat, A.; Mannasse, B.; Asraf, H.; Azar, R.; Ali, Y.; Shirazi, R.; Bucris, E.; Bar-Ilan, D.; Mor, O.; Mandelboim, M.; Sofer, D.; Fleishon, S.; Zukerman, N. S.",Oran Erster,"Central Virology Laboratory, Public Health Services, Ministry of Health, Chaim Sheba Medical Center, Ramat Gan, Israel",2021-05-22,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/05/22/2021.05.19.21257439.source.xml,,medrxiv,10.1101__2021.05.19.21257439_doc.txt
10.1101/2021.05.22.21257660,Emergence of SARS-CoV-2 variants of concern in the pediatric population of the United States,"Dien Bard, J.; Bootwalla, M.; Leber, A.; Planet, P.; Moustafa, A.; Harris, R.; Chen, P. Y.; Shen, L.; Ostrow, D.; Maglinte, D.; Flores, J.; Somak, R.; Ranganathan, S.; Perlman, E.; Zheng, X.; Selvarangan, R.; Banerjee, D.; Delaney, M.; Campos, J.; Michael, D. G.; Vilain, E.; LoTempio, J.; Dunn, J.; Jung, S.; Dominguez, S.; Judkins, A.; Gai, X.",Jennifer Dien Bard,Children\'s Hospital Los Angeles,2021-05-30,2,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/05/30/2021.05.22.21257660.source.xml,,medrxiv,10.1101__2021.05.22.21257660_doc.txt
10.1101/2021.05.26.21257854,"Corowa-kun: Impact of a COVID-19 vaccine information chatbot on vaccine hesitancy, Japan 2021","Kobayashi, T.; Nishina, Y.; Tomoi, H.; Harada, K.; Tanaka, K.; Matsumoto, E.; Horimukai, K.; Ishihara, J.; Sasaki, S.; Inaba, K.; Seguchi, K.; Takahashi, H.; Salinas, J.; Yamada, Y.",Takaaki Kobayashi,University of Iowa Hospitals and Clinics,2021-05-30,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2021/05/30/2021.05.26.21257854.source.xml,,medrxiv,10.1101__2021.05.26.21257854_doc.txt
10.1101/2021.05.30.21258068,COVID-19 Associated Mucormycosis: Scoping Review Protocol,"Hussain, S.; Baxi, H.; Riad, A.; Kulgarova, J.; Licenik, R.; Klugar, M.",Miloslav Klugar,Masaryk University,2021-06-01,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/06/01/2021.05.30.21258068.source.xml,,medrxiv,10.1101__2021.05.30.21258068_doc.txt
10.1101/2021.05.31.21255594,Signatures of mast cell activation are associated with severe COVID-19,"Tan, J.; Anderson, D.; Rathore, A. P. S.; O'Neill, A.; Mantri, C. K.; Saron, W. A. A.; Lee, C.; Chu, W. C.; Kang, A.; Foo, R.; Kalimuddin, S.; Low, J.; Ho, L.; Tambyah, P.; Burke, T. W.; Woods, C. W.; Chan, K. R.; Karhausen, J.; St John, A. L.",Ashley L. St John,Duke-NUS Medical School,2021-06-01,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/06/01/2021.05.31.21255594.source.xml,,medrxiv,10.1101__2021.05.31.21255594_doc.txt
10.1101/2021.06.02.21257975,Function is more reliable than quantity to follow up the humoral response to the Receptor Binding Domain of SARS- CoV-2 Spike Protein after Natural Infection or COVID-19 vaccination,"Sariol, C. A.; Pantoja, P.; Serrano-Collazo, C.; Rosa-Arocho, T.; Armina, A.; Cruz, L.; Stone, E. T.; Arana, T.; Climent, C.; Latoni, G.; Atheortua, D.; Pabon-Carrero, C.; Pinto, A. K.; Brien, J. D.; Espino, A. M.",Carlos A Sariol,"Unit of Comparative Medicine,  Department of Medicine, Department of Microbiology and Medical Zoology,  of Puerto Rico, Medical Sciences Campus, PR USA",2021-08-10,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/08/10/2021.06.02.21257975.source.xml,,medrxiv,10.1101__2021.06.02.21257975_doc.txt
10.1101/2021.06.01.21258117,Plasmodium falciparum hrp2 and hrp3 gene deletion status in Africa and South America by highly sensitive and specific digital PCR,"Vera-Arias, C. A.; Holzschuh, A.; Oduma, C. O.; Badu, K.; Abdul-Hakim, M.; Yukich, J.; Hetzel, M. W.; Fakih, B. S.; Ali, A.; Ferreira, M. U.; Ladeia-Andrade, S.; Saenz, F. E.; Afrane, Y.; Zemene, E.; Yewhalaw, D.; Kazura, J. W.; Yan, G.; Koepfli, C.",Cristian Koepfli,"University of Notre Dame, Notre Dame, IN, United States",2021-06-04,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2021/06/04/2021.06.01.21258117.source.xml,,medrxiv,10.1101__2021.06.01.21258117_doc.txt
10.1101/2021.06.03.21258274,Transmission of SARS-CoV-2 associated with aircraft travel: a systematic review (Version 1),"Rosca, E. C.; Heneghan, C.; Spencer, E. A.; Brassey, J.; Pluddemann, A.; Onakpoya, I.; Evans, D. H.; Conly, J. M.; Jefferson, T.",Elena Cecilia Rosca,Victor Babes University of Medicine and Pharmacy of Timisoara,2021-06-05,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/06/05/2021.06.03.21258274.source.xml,10.1093/jtm/taab133,medrxiv,10.1101__2021.06.03.21258274_doc.txt
10.1101/2021.06.07.21258351,Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections,"Dupont, L.; Snell, L. B.; Graham, C.; Seow, J.; Merrick, B.; Lechmere, T.; Hallett, S. R.; Charalampous, T.; Alcolea-Medina, A.; Huettner, I.; Maguire, T. J. A.; Acors, S.; Almeida, N.; Cox, D.; Dickenson, R. E.; Galao, R. P.; Jimenez-Guardeno, J. M.; Kouphou, N.; Lista, M. J.; Pickering, S.; Ortega-Prieto, A. M.; Wilson, H.; Winstone, H.; Fairhead, C.; Su, J.; Nebbia, G.; Batra, R.; Neil, S.; Shankar-Hari, M.; Edgeworth, J. D.; Malim, M. H.; Doores, K.",Katie Doores,King\'s College London,2021-06-08,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/06/08/2021.06.07.21258351.source.xml,,medrxiv,10.1101__2021.06.07.21258351_doc.txt
10.1101/2021.06.10.21258721,"Early Prediction of In-Hospital Death of COVID-19 Patients: A Machine-Learning Model Based on Age, Blood Analyses, and Chest X-Ray Score","Garrafa, E.; Vezzoli, M.; Ravanelli, M.; Farina, D.; Borghesi, A.; Calza, S.; Maroldi, R.",Emirena Garrafa,University of Brescia,2021-06-13,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2021/06/13/2021.06.10.21258721.source.xml,10.7554/eLife.70640,medrxiv,10.1101__2021.06.10.21258721_doc.txt
10.1101/2021.06.15.21258940,Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms,"Uhlen, M.; Zhong, W.; Altay, O.; Arif, M.; Edfors, F.; Mardinoglu, A.; Fagerberg, L.",Mathias Uhlen,KTH - Royal Institute of Technology,2021-06-21,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/06/21/2021.06.15.21258940.source.xml,10.1016/j.ebiom.2021.103723,medrxiv,10.1101__2021.06.15.21258940_doc.txt
10.1101/2021.06.22.21259318,"Efficacy of Proxalutamide in Hospitalized COVID-19 Patients: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Clinical Trial","Cadegiani, F. A.; Fonseca, D. N.; McCoy, J.; Zimerman, R. A.; Mirza, F. N.; Correia, M. N.; Barros, R. N.; Onety, D. C.; Israel, K. C. P.; Almeida, B. G.; Guerreiro, E. O.; Medeiros, J. E. M.; Nicolau, R. N.; Nicolau, L. F.; Cunha, R. X.; Barroco, M. F. R.; da Silva, P. S.; Ferreira, G. S.; Alcantara, F. R. P.; Ribeiro, A. M.; de Almeida, F. O.; de Souza, A. A.; do Rosario, S. S.; Paulain, R. W.; Reis, A.; Li, M.; Thompson, C. E.; Nau, G. J.; Wambier, C. G.; Goren, A.",Flavio A Cadegiani,"Applied Biology Inc. Irvine, CA, USA, and Corpometria Institute, Brasilia, Brazil",2021-06-22,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/06/22/2021.06.22.21259318.source.xml,,medrxiv,10.1101__2021.06.22.21259318_doc.txt
10.1101/2021.06.19.21259186,Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial -- BCPP/ Ya Tsie trial,"Magosi, L. E.; Zhang, Y.; Golubchik, T.; De Gruttola, V.; Tchetgen Tchetgen, E. J.; Novitsky, V.; Moore, J.; Bachanas, P.; Segolodi, T.; Lebelonyane, R.; Pretorius Holme, M.; Moyo, S.; Makhema, J.; Lockman, S.; Fraser, C.; Essex, M.; Lipsitch, M.",Lerato E Magosi,"Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, USA",2021-07-03,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,hiv aids,https://www.medrxiv.org/content/early/2021/07/03/2021.06.19.21259186.source.xml,,medrxiv,10.1101__2021.06.19.21259186_doc.txt
10.1101/2021.06.21.21258990,SARS-CoV-2 Breakthrough Infections in Fully Vaccinated Individuals,"Ramirez, E.; Wilkes, R. P.; Carpi, G.; Dorman, J.; Bowen, C.; Smith, L.",Esteban Ramirez,"Indiana University School of Medicine, One To One Health",2021-06-25,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/06/25/2021.06.21.21258990.source.xml,,medrxiv,10.1101__2021.06.21.21258990_doc.txt
10.1101/2021.06.29.21259511,Subgenomic and negative sense RNAs are not markers of active replication of SARS-CoV-2 in nasopharyngeal swabs,"Chamings, A.; Bhatta, T. R.; Alexandersen, S.",Soren Alexandersen,Deakin University,2021-09-17,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/09/17/2021.06.29.21259511.source.xml,,medrxiv,10.1101__2021.06.29.21259511_doc.txt
10.1101/2021.06.23.21259391,Extensive validation and prospective observation of the impact of an AI-based rapid antibiotics susceptibility prediction platform in multiple medical centers,"Wang, H.-Y.; Chung, C.-R.; Tseng, Y.-J.; Yu, J.-R.; Chen, C.-J.; Wu, M.-H.; Lin, T.-W.; Huang, W.-T.; Liu, T.-P.; Lee, T.-Y.; Horng, J.-T.; Lu, J.-J.",Hsin-Yao Wang,"Department of Laboratory Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan City, Taiwan",2021-07-05,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/07/05/2021.06.23.21259391.source.xml,,medrxiv,10.1101__2021.06.23.21259391_doc.txt
10.1101/2021.07.05.21259999,Sustaining effective COVID-19 control in Malaysia through large-scale vaccination,"Jayasundara, P.; Peariasamy, K. M.; Law, K. B.; Rahim, K. N. K. A.; Lee, S. W.; Ghazali, I. M. M.; Abayawardana, M.; Le, L.-V.; Khalaf, R. K. S.; Razali, K.; Le, X.; Chong, Z. L.; McBryde, E. S.; Meehan, M. T.; Caldwell, J. M.; Ragonnet, R.; Trauer, J. M.",Pavithra Jayasundara,"School of Public Health and Preventive Medicine, Monash University, Australia",2021-07-07,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/07/07/2021.07.05.21259999.source.xml,10.1016/j.epidem.2021.100517,medrxiv,10.1101__2021.07.05.21259999_doc.txt
10.1101/2021.07.08.21260169,Endothelial dysfunction determines severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks,"Ruhl, L.; Pink, I.; Kuehne, J. F.; Beushausen, K.; Keil, J.; Christoph, S.; Sauer, A.; Boblitz, L.; Schmidt, J.; David, S.; Jaeck, H.-M.; Roth, E.; Cornberg, M.; Schulz, T. F.; Welte, T.; Hoeper, M.; Falk, C. S.",Christine S. Falk,Hannover Medical School,2021-07-10,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/07/10/2021.07.08.21260169.source.xml,,medrxiv,10.1101__2021.07.08.21260169_doc.txt
10.1101/2021.07.08.21260194,Humoral immune response in inactivated SARS-CoV-2 vaccine: When should a booster dose be administered?,"Kara, E.; Tanir, F.; Demirhindi, H.; Mete, B.; Kibar, F.; Cetiner, S.; Candevir, A.; Inaltekin, A.",Hakan Demirhindi,"Cukurova University, Faculty of Medicine, Department of Public Health, Adana, 01330 Turkey",2021-07-13,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/07/13/2021.07.08.21260194.source.xml,,medrxiv,10.1101__2021.07.08.21260194_doc.txt
10.1101/2021.07.12.21260227,Convergent epitope-specific T cell responses after SARS-CoV-2 infection and vaccination,"Minervina, A. A.; Pogorelyy, M. V.; Kirk, A. M.; Allen, E. K.; Allison, K. J.; Lin, C.-Y.; Brice, D. C.; Zhu, X.; Vegesana, K.; Wu, G.; Crawford, J. C.; Schultz-Cherry, S.; Estepp, J. H.; McGargill, M.; the SJTRC Study Team,  ; Wolf, J.; Thomas, P. G.",Paul G Thomas,St. Jude Children\'s Research Hospital,2021-07-27,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/07/27/2021.07.12.21260227.source.xml,,medrxiv,10.1101__2021.07.12.21260227_doc.txt
10.1101/2021.07.12.21260388,Significant Structural Breaks in the International Incidence of Hepatitis Delta Virus,"Fallon, B. S.; Cooke, E. M.; Hesterman, M. C.; Norseth, J. S.; Akhundjanov, S. B.; Weller, M. L.",Melodie L. Weller,UNIVERSITY OF UTAH,2021-09-23,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/09/23/2021.07.12.21260388.source.xml,,medrxiv,10.1101__2021.07.12.21260388_doc.txt
10.1101/2021.07.14.21260539,Trans Cohorts Metabolomic Modulation Following Long-Term Successful Therapy in HIV-Infection,"Mikaeloff, F.; Svensson-Akusjarvi, S.; Ikomey, G. M.; Krishnan, S.; Sperk, M.; Gupta, S.; Vega Magdaleno, G. D.; Escos, A.; Lyonga, E.; Okomo, M. C.; Tagne, C. T.; Babu, H.; Lorson, C. L.; Vegvari, A.; Banerjea, A. C.; Kele, J.; Hanna, L. E.; Singh, K.; de Magalhaes, J. P.; Benfeitas, R.; Neogi, U.",Ujjwal Neogi,Karolinska Institute,2021-07-18,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,hiv aids,https://www.medrxiv.org/content/early/2021/07/18/2021.07.14.21260539.source.xml,,medrxiv,10.1101__2021.07.14.21260539_doc.txt
10.1101/2021.07.15.21260285,Upper airway gene expression reveals a more robust innate and adaptive immune response to SARS-CoV-2 in children compared with older adults,"Mick, E.; Tsitsiklis, A.; Spottiswoode, N.; Caldera, S.; Serpa, P. H.; Detweiler, A. M.; Neff, N.; Pisco, A. O.; Li, L. M.; Retallack, H.; Ratnasiri, K.; Williamson, K. M.; Soesanto, V.; Simoes, E. A.; Kistler, A.; Wagner, B. D.; DeRisi, J. L.; Ambroggio, L.; Mourani, P. M.; Langelier, C.",Charles Langelier,"Division of Infectious Diseases, University of California, San Francisco, CA, USA; Chan Zuckerberg Biohub, San Francisco, CA, USA",2021-07-19,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/07/19/2021.07.15.21260285.source.xml,,medrxiv,10.1101__2021.07.15.21260285_doc.txt
10.1101/2021.07.15.21260600,Remdesivir for the treatment of COVID-19 disease: A retrospective comparative study of patients treated with and without Remdesivir,"Madan, S.; Patel, A.; Sharan, K.; Ghosh, S.; Venugopal, V.; Shah, N.; Shah, B.; Thakkar, V.; Chovatiya, R.; Shah, H.; Dhabhi, P.; Patel, M.; Meghnathi, B.; Sankhla, V.; Kapoor, V.; Patel, T.; Soni, M.; Bapat, N.; Shah, K.; Chandarana, R.; Bhatt, P.; Rana, M.",Surabhi Madan,Care Institute of Medical Sciences,2021-07-19,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/07/19/2021.07.15.21260600.source.xml,,medrxiv,10.1101__2021.07.15.21260600_doc.txt
10.1101/2021.07.18.21260706,Salivary molecular testing for SARS-CoV-2: simplifying the diagnosis without losing accuracy,"Saluzzo, F.; Mantegani, P.; Poletti de Chaurand, V.; Cugnata, F.; Rovere-Querini, P.; Cilla, M.; Erba, P.; Racca, S.; Tresoldi, C.; Uberti-Foppa, C.; Di Serio, C.; Cirillo, D. M.",Daniela Maria Cirillo,"Division of Immunology, Transplantation and Infectious Disease, IRCCS Ospedale San Raffaele - Milano (Italy)",2021-07-22,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/07/22/2021.07.18.21260706.source.xml,10.1183/13993003.02099-2021,medrxiv,10.1101__2021.07.18.21260706_doc.txt
10.1101/2021.07.23.21260992,A cluster randomised trial of the impact of a policy of daily testing for contacts of COVID-19 cases on attendance and COVID-19 transmission in English secondary schools and colleges,"Young, B. C.; Eyre, D. W.; Kendrick, S.; White, C.; Smith, S.; Beveridge, G.; Nonnenmacher, T.; Ichofu, F.; Hillier, J.; Diamond, I.; Rourke, E.; Dawe, F.; Day, I.; Davies, L.; Staite, P.; Lacey, A.; McCrae, J.; Jones, F.; Kelly, J.; Bankiewicz, U.; Tunkel, S.; Ovens, R.; Chapman, D.; Marks, P.; Hicks, N.; Fowler, T.; Hopkins, S.; Yardley, L.; Peto, T. E.",Tim EA Peto,University of Oxford,2021-07-25,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2021/07/25/2021.07.23.21260992.source.xml,,medrxiv,10.1101__2021.07.23.21260992_doc.txt
10.1101/2021.07.22.21260942,"Safety and Immunogenicity of Nanocovax, a SARS-CoV-2 Recombinant Spike Protein Vaccine","Nguyen, T. P.; Do, Q.; Lan, L. T.; Dinh, D. V.; Khong, H.; Do, S. M.",Si Minh Do,Nanogen Biopharmaceuticals JSC,2021-07-25,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/07/25/2021.07.22.21260942.source.xml,,medrxiv,10.1101__2021.07.22.21260942_doc.txt
10.1101/2021.07.27.21261116,"Tolerability, safety and immunogenicity of intradermal delivery of a fractional dose mRNA -1273 SARS-CoV-2 vaccine in healthy adults as a dose sparing strategy","Roozen, G. V. T.; Prins, M.; van Binnendijk, R.; den, G.; Kuiper, V.; Prins, C.; Janse, J. J.; Kruithof, A. C.; Feltkamp, M. C. W.; Kuijer, M.; Roosendaal, F. R.; Roestenberg, M.; Visser, L. G.; Roukens, A. H. E.",Anna H.E. Roukens,Leiden University Medical Center,2021-07-28,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/07/28/2021.07.27.21261116.source.xml,,medrxiv,10.1101__2021.07.27.21261116_doc.txt
10.1101/2021.07.25.21261105,Development of a federated learning approach to predict acute kidney injury in adult hospitalized patients with COVID-19 in New York City,"Jaladanki, S. K.; Vaid, A.; Sawant, A. S.; Xu, J.; Shah, K.; Dellepiane, S.; Paranjpe, I.; Chan, L.; Kovatch, P.; Charney, A.; Wang, F.; Glicksberg, B. S.; Singh, K.; Nadkarni, G. N.",Girish N Nadkarni,Icahn School of Medicine at Mount Sinai (ISMMS),2021-07-28,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,nephrology,https://www.medrxiv.org/content/early/2021/07/28/2021.07.25.21261105.source.xml,,medrxiv,10.1101__2021.07.25.21261105_doc.txt
10.1101/2021.07.28.21261285,Impact of B.1.351 (beta) SARS-CoV-2 variant on BNT162b2 mRNA vaccine effectiveness in long-term care facilities of eastern France: a retrospective cohort study,"Lefevre, B.; Tondeur, L.; Madec, Y.; Grant, R.; Lina, B.; van der Werf, S.; Rabaud, C.; Fontanet, A.",Benjamin Lefevre,"Universite de Lorraine, CHRU-Nancy, Infectious and tropical diseases; and Universite de Lorraine, APEMAC,  France",2021-07-31,1,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2021/07/31/2021.07.28.21261285.source.xml,10.1016/S2666-7568(21)00230-0,medrxiv,10.1101__2021.07.28.21261285_doc.txt
10.1101/2021.07.30.21261329,The association between statin and COVID-19 adverse outcomes: National COVID-19 cohort in South Korea,"Chow, R.; Lee, J.; Noh, H.; Lee, J.; Shin, H. J.; Choi, Y.-G.",Hyun Joon Shin,"Division of Cardiology, Department of Medicine, Lemuel Shattuck Hospital, Massachusetts Department of Public Health, Jamaica Plains, MA, USA",2021-08-04,2,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/08/04/2021.07.30.21261329.source.xml,,medrxiv,10.1101__2021.07.30.21261329_doc.txt
10.1101/2021.07.30.21261389,Vibrio cholerae multifaceted adaptive strategies in response to bacteriophage predation in an endemic region of the Democratic Republic of the Congo,"Alam, M. T.; Mavian, C.; Salemi, M.; Tagliamonte, M. S.; Paisie, T. K.; Cash, M. N.; Angermeyer, A.; Seed, K. D.; Camilli, A.; Maisha, F. M.; Senga, R. K. K.; Morris, J. G.; Ali, A.",Afsar Ali,University of Florida,2021-08-03,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/08/03/2021.07.30.21261389.source.xml,,medrxiv,10.1101__2021.07.30.21261389_doc.txt
10.1101/2021.08.02.21260750,Hydroxychloroquine Prophylaxis against Coronavirus Disease-19: Practice Outcomes among Health-Care Workers,"Bhatt, P.; Patel, V.; Shah, P.; Parikh, K.",Parloop Bhatt,Care Institute of Medical Sciences,2021-08-04,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/08/04/2021.08.02.21260750.source.xml,,medrxiv,10.1101__2021.08.02.21260750_doc.txt
10.1101/2021.08.03.21261441,A single intramuscular injection of monoclonal antibody MAD0004J08 induces in healthy adults SARS-CoV-2 neutralising antibody titres exceeding those induced by infection and vaccination,"Lanini, S.; Milleri, S.; Andreano, E.; Nosari, S.; Paciello, I.; Piccini, G.; Gentili, A.; Phogat, A.; Hyseni, I.; Leonardi, M.; Torelli, A.; Montomoli, E.; Paolini, A.; Frosini, A.; Antinori, A.; Nicastri, E.; Girardi, E.; Plazzi, M. M.; Ippolito, G.; Vaia, F.; Della Cioppa, G.; Rappuoli, R.",Rino Rappuoli,"Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy; Department of Biotechnology, Chemistry and Pharmacy, University of Sien",2021-08-04,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/08/04/2021.08.03.21261441.source.xml,,medrxiv,10.1101__2021.08.03.21261441_doc.txt
10.1101/2021.08.04.21261613,Strategies to Estimate Prevalence of SARS-CoV-2 Antibodies in a Texas Vulnerable Population: Results from Phase I of the Texas Coronavirus Antibody REsponse Survey (TX CARES),"Valerio-Shewmaker, M. A.; Desantis, S. M.; Swartz, M. D.; Yaseen, A.; Gonzalez, M. O.; Kohl, H. W.; Kelder, S. H.; Messiah, S. M.; Aguillard, K. A.; Breaux, C. J.; Wu, L.; Lakey, D.; Shuford, J.; Pont, S.; Boerwinkle, E.","Melissa A Valerio-Shewmaker PhD, MPH","University of Texas Health Science Center Houston, School of Public Health, Brownsville Campus, Brownsville, TX, USA",2021-08-05,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/08/05/2021.08.04.21261613.source.xml,10.3389/fpubh.2021.753487,medrxiv,10.1101__2021.08.04.21261613_doc.txt
10.1101/2021.08.04.21261561,"More rapid, robust and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals","Racine-Brzostek, S. E.; Yee, J.; Sukhu, A.; Qiu, Y.; Rand, S.; Barron, P.; Hao, Y.; Yang, H. S.; Meng, Q. H.; Apple, F. S.; Shi, Y.; Chadburn, A.; Golden, E.; Formenti, S. C.; Cushing, M.; Zhao, Z.",Zhen Zhao,Weill Cornell Medicine,2021-08-05,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/08/05/2021.08.04.21261561.source.xml,,medrxiv,10.1101__2021.08.04.21261561_doc.txt
10.1101/2021.08.02.21260667,Low SARS-CoV-2 infection rate and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic,"Brehm, T. T.; Thompson, M.; Ullrich, F.; Schwinge, D.; Addo, M. M.; Spier, A.; Knobloch, J. K.; Aepfelbacher, M.; Lohse, A. W.; Lütgehetmann, M.; Schulze zur Wiesch, J.",Thomas Theo Brehm,University Medical Center Hamburg-Eppendorf,2021-08-07,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/08/07/2021.08.02.21260667.source.xml,,medrxiv,10.1101__2021.08.02.21260667_doc.txt
10.1101/2021.08.06.21261695,Prevalence and effect of bacterial co-infections on clinical outcomes in hospitalized COVID-19 patients at a tertiary care centre of India,"Pathak, A.; Singh, S.; Singh, S.; Patel, S. S.; Fatima, N.; Garg, A.; Ghoshal, U.; Sahu, C.",Chinmoy Sahu,Sanjay Gandhi Post Graduate Institute of Medical Sciences,2021-08-07,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/08/07/2021.08.06.21261695.source.xml,,medrxiv,10.1101__2021.08.06.21261695_doc.txt
10.1101/2021.08.08.21261510,COVID-19 in Brazilian children and adolescents: findings from 21 hospitals,"Liu, P. M. F.; de Melo, M. d. C. B.; Diniz, L. M. O.; Dias, C. d. S.; Costa, A. S. d. M.; Farace, B. L.; da Silva, C. T. C. A.; Anschau, F.; Aranha, F. G.; Nascimento, G. F.; Duani, H.; Costa, J. H. S. M.; Ruschel, K. B.; Nogueira, M. C. A.; de Oliveira, N. R.; Pozza, R.; Francisco, S. C.; Lage, T. M.; Ramires, Y. C.; Pereira, D. N.; Reis, Z. S. N.; Chatkin, J. M.; Marcolino, M. S.",Milena Soriano Marcolino,"Departamento de Clinica Medica, Faculdade de Medicina, Universidade Federal de Minas Gerais",2021-08-09,1,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2021/08/09/2021.08.08.21261510.source.xml,,medrxiv,10.1101__2021.08.08.21261510_doc.txt
10.1101/2021.08.13.21262006,Altered increase in STAT1 expression and phosphorylation in severe COVID-19,"Rincon-Arevalo, H.; Aue, A.; Ritter, J.; Szelinski, F.; Khadzhynov, D.; Zickler, D.; Stefanski, A.-L.; Lino, A. C.; Koerper, S.; Eckardt, K.-U.; Schrezenmeier, H.; Doerner, T.; Schrezenmeier, E.",Eva Schrezenmeier,Charite Berlin,2021-08-13,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/08/13/2021.08.13.21262006.source.xml,10.1002/eji.202149575,medrxiv,10.1101__2021.08.13.21262006_doc.txt
10.1101/2021.08.13.21261889,Robust SARS-CoV-2-specific and heterologous immune responses after natural infection in elderly residents of Long-Term Care Facilities,"Tut, G.; Lancaster, T.; Butler, M. S.; Sylla, P.; Spalkova, E.; Bone, D.; Kaur, N.; Bentley, C.; Amin, U.; Jadir, A. T.; Hulme, S.; Ayodele, M.; Dowell, A. C.; Pearce, H.; Margielewska-Davies, S.; Verma, K.; Nicol, S.; Begum, J.; Jinks, E.; Tut, E.; Bruton, R.; Krutikov, M.; Shrotri, M.; Giddings, R.; Azmi, B.; Fuller, C.; Irwin-Singer, A.; Hayward, A.; Copas, A.; Shallcross, L.; Moss, P.",Gokhan Tut,"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK",2021-08-18,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/08/18/2021.08.13.21261889.source.xml,,medrxiv,10.1101__2021.08.13.21261889_doc.txt
10.1101/2021.08.19.21262249,"Intention to receive a COVID-19 vaccine by HIV status among a population-based sample of women and gender diverse individuals in British Columbia, Canada","Kaida, A.; Brotto, L. A.; Murray, M. C. M.; Cote, H. C. F.; Albert, A. Y.; Nicholson, V.; Gormley, R.; Gordon, S.; Booth, A.; Smith, L. W.; Baaske, A.; Galea, L. A. M.; Sadarangani, M.; Ogilvie, G. S.",Angela Kaida,"Simon Fraser University (SFU), Faculty of Health Sciences, Burnaby, British Columbia, Canada ; Women\'s Health Research Institute (WHRI), Vancouver, British Col",2021-08-22,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,hiv aids,https://www.medrxiv.org/content/early/2021/08/22/2021.08.19.21262249.source.xml,,medrxiv,10.1101__2021.08.19.21262249_doc.txt
10.1101/2021.08.16.21262069,Reduced T cell and antibody responses to inactivated coronavirus vaccine among males and individuals above 55 years old,"medeiros, G. x.; sasahara, G. l.; Magawa, J. Y.; Nunes, J. P. S.; Bruno, F. R.; Kuramoto, A.; Almeida, R. R.; Ferreira, M. A.; Scagion, G. P.; Candido, E. D.; Leal, F. B.; Oliveira, D. B.; Durigon, E. L.; Silva, R. C. V.; Rosa, D. S.; Boscardin, S. B.; Coelho, V.; Kalil, J.; Santos, K. S.; Cunha-Neto, E.",Jorge Kalil,"Faculdade de Medicina da Universidade de Sao Paulo, Departamento de Clinica Medica, Disciplina de Alergia e Imunologia Clinica, Sao Paulo, SP, Brasil. Laborator",2021-08-23,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/08/23/2021.08.16.21262069.source.xml,,medrxiv,10.1101__2021.08.16.21262069_doc.txt
10.1101/2021.08.16.21262053,Physician Reimbursement and Retention in HIV Care: Racial Disparities in the US South,"Pan, Z.; Dahman, B.; Bono, R. S.; Sabik, L. M.; Belgrave, F. Z.; Nixon, D. E.; Kimmel, A.",April Kimmel,Virginia Commonwealth University / VCU Health,2021-08-24,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,hiv aids,https://www.medrxiv.org/content/early/2021/08/24/2021.08.16.21262053.source.xml,,medrxiv,10.1101__2021.08.16.21262053_doc.txt
10.1101/2021.08.23.21262283,HLA Class I and Plasma Viral Load of HIV-1 in Sexually Transmitted and Reproductive Tract Infections among Heterosexual Serodiscordant couples in Nigeria,"Otuonye, N. M.; Luo, M.; Chris, C.; Aniedobe, M.; Okoye, R.; Enya, V.; Ogbonna, F.; Audu, R.; Uwandu, M.; Adedeji, A.; Ponmak, J.; Nduaga, S.; Akindele, S.; Liboro, G.; Odewale, E.; Adesesan, A.; Musa, A.; Ezechi, O.; Ojetunde, M.; Odunukwe, N.",Ngozi Mirabel Otuonye,Nigerian Institute of Medical research (NIMR),2021-08-25,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,hiv aids,https://www.medrxiv.org/content/early/2021/08/25/2021.08.23.21262283.source.xml,,medrxiv,10.1101__2021.08.23.21262283_doc.txt
10.1101/2021.08.18.21262046,Reduction in initiations of HIV treatment in South Africa during the COVID pandemic,"Benade, M.; Long, L.; Rosen, S.; Meyer-Rath, G.; Tucker, J.-M.; Miot, J.",Sydney Rosen,Boston University School of Public Health,2021-08-25,1,PUBLISHAHEADOFPRINT,cc_by,hiv aids,https://www.medrxiv.org/content/early/2021/08/25/2021.08.18.21262046.source.xml,,medrxiv,10.1101__2021.08.18.21262046_doc.txt
10.1101/2021.08.19.21262275,"Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial (HERO-HCQ)","Naggie, S.; Milstone, A.; Castro, M.; Collins, S. P.; Seetha, L.; Anderson, D. J.; Cahuayme-Zuniga, L.; Batey-Turner, K.; Cohen, L. W.; Fraulo, E.; Friedland, A.; Garg, J.; George, A.; Mulder, H.; Olson, R. E.; O'Brien, E. C.; Rothman, R. L.; Shenkman, E.; Shostak, J.; Woods, C. W.; Anstrom, K. J.; Hernandez, A. F.; HERO Research Program,  ",Susanna Naggie,Duke Clinical Research Institute,2021-08-25,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/08/25/2021.08.19.21262275.source.xml,,medrxiv,10.1101__2021.08.19.21262275_doc.txt
10.1101/2021.09.08.21263268,Combined Impact of Prior SARS-CoV-2 Infection and Vaccination on Antibody Presence,"Boerwinkle, E.; Shuford, J. A.; Swartz, M. D.; Lakey, D. L.; Aguillard, K. A.; Pont, S. J.; Valerio-Shewmaker, M. A.",Eric Boerwinkle,"The University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, TX, USA",2021-09-12,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/09/12/2021.09.08.21263268.source.xml,,medrxiv,10.1101__2021.09.08.21263268_doc.txt
10.1101/2021.09.09.21262951,Investigating the biological and technical origins of unknown bases in the S region of the SARS-CoV-2 Delta variant genome sequences,"Borcard, L.; Gempeler, S.; Terrazos Miani, M. A.; Baumann, C.; Grädel, C.; Dijkman, R.; Suter-Riniker, F.; Leib, S. L.; Bittel, P.; Neuenschwander, S.; Ramette, A.",Alban Ramette,University of Bern,2021-09-13,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/09/13/2021.09.09.21262951.source.xml,,medrxiv,10.1101__2021.09.09.21262951_doc.txt
10.1101/2021.09.09.21263315,Professional practice for COVID-19 risk reduction among health care workers : a Cross-Sectional Study with Matched Case-Control Comparison,"WILSON, S.; MOUET, A.; JEANNE-LEROYER, C.; BORGEY, F.; ODINET-RAULIN, E.; HUMBERT, X.; LE HELLO, S.; THIBON, P.",Pascal THIBON,"Centre appui pour la Prevention des Infections Associees aux Soins, CPias Normandie, Centre Hospitalo-Universitaire, Caen F-14033, France",2021-10-21,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/10/21/2021.09.09.21263315.source.xml,,medrxiv,10.1101__2021.09.09.21263315_doc.txt
10.1101/2021.09.08.21263311,Determinants of hospital outcomes for COVID-19 infections in a large Pennsylvania Health System,"Shaw, P. A.; Yang, J. B.; Mowery, D. L.; Schriver, E. R.; Mahoney, K. B.; Bar, K. J.; Ellenberg, S. S.",Pamela A Shaw,Kaiser Permanente Washington Health Research Institute,2021-09-13,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2021/09/13/2021.09.08.21263311.source.xml,,medrxiv,10.1101__2021.09.08.21263311_doc.txt
10.1101/2021.09.04.21262414,Evaluation of commercially available high-throughput SARS-CoV-2 serological assays for serosurveillance and related applications,"Stone, M.; Grebe, E.; Sulaeman, H.; Di Germanio, C.; Dave, H.; Kelly, K.; Biggerstaff, B.; Crews, B. O.; Tran, N.; Jerome, K.; Denny, T. N.; Hogema, B.; Destree, M.; Jones, J. M.; Thornburg, N.; Simmons, G.; Krajden, M.; Kleinman, S.; Dumont, L. J.; Busch, M. P.",Mars Stone,Vitalant Research Institiute,2021-09-15,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/09/15/2021.09.04.21262414.source.xml,,medrxiv,10.1101__2021.09.04.21262414_doc.txt
10.1101/2021.09.17.21263758,"Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial","Pitisuttithum, P.; Mercer, L. D.; White, J. A.; Scharf, R.; Hjorth, R.; Lamola, S.; Raghunandan, R.; Lal, M.; McLellan, J. S.; Hsieh, C.-L.; Luvira, V.; Muangnoicharoen, S.; Lawpoolsri, S.; Sivakorn, C.; Phumratanaprapin, W.; Kamolratanakul, S.; Phonrat, B.; Sabmee, Y.; Thantamnu, N.; Wirachwong, P.; Poopipatpol, K.; Surichan, S.; Prangpratanporn, S.; Kaweepornpoj, R.; Theerasurakarn, S.; Narakorn, P.; Singchareon, R.; Suthepakul, N.; Puksuriwong, S.; Vilasmongkolchai, T.; Gagnon, L.; Tran, S.; Khan, S.; Krammer, F.; Mena, I.; Garcia-Sastre, A.; Sun, W.; Liu, Y.; McCroskery, S.; Slamanig, S.; ",Bruce L Innis,PATH,2021-09-22,2,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/09/22/2021.09.17.21263758.source.xml,,medrxiv,10.1101__2021.09.17.21263758_doc.txt
10.1101/2021.09.17.21263726,Single-Dose SARS-CoV-2 Vaccination With BNT162b2 and AZD1222 Induce Disparate Th1 Responses and IgA Production,"Müller, M.; Volzke, J.; Subin, B.; Müller, S.; Sombetzki, M.; Reisinger, E. C.; Müller-Hilke, B.",Brigitte Müller-Hilke,University Medical Center,2021-09-21,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/09/21/2021.09.17.21263726.source.xml,,medrxiv,10.1101__2021.09.17.21263726_doc.txt
10.1101/2021.09.17.21263729,Rapid semi-quantitative point of care diagnostic test for post vaccination antibody monitoring,"Engel Moeller, M.; Benfield, T. L.; Bang, D.; Donolato, M.; Fock, J.; Bade, M.; Pah, P.; Soerensen, A. L.; Engsig, F. N.",Maria Engel Moeller,Hvidovre Hospital,2021-09-22,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/09/22/2021.09.17.21263729.source.xml,,medrxiv,10.1101__2021.09.17.21263729_doc.txt
10.1101/2021.09.22.21263963,"Feasibility, Acceptability, and Barriers to Implementing Select Non-Pharmaceutical Interventions to Reduce the Transmission of Pandemic Influenza - United States, 2019","Ahmed, F.; Qualls, N.; Kowalczyk, S.; Randolph Cunningham, S. M.; Zviedrite, N.; Uzicanin, A.",Faruque Ahmed,Centers for Disease Control and Prevention,2021-09-23,1,PUBLISHAHEADOFPRINT,cc0,infectious diseases,https://www.medrxiv.org/content/early/2021/09/23/2021.09.22.21263963.source.xml,,medrxiv,10.1101__2021.09.22.21263963_doc.txt
10.1101/2021.09.21.21263902,Quantification and prognostic significance of interferon-γ secreting SARS-CoV-2 responsive T cells in hospitalised patients with acute COVID-19,"Pan, D.; Kim, J. W.; Nazareth, J.; Assadi, S.; Bellass, A.; Leach, J.; Brosnan, J. G.; Ahmed, A.; Starcevic, F.; Sze, S.; Martin, C. A.; Williams, C. M.; Barer, M. R.; Sahota, A.; Patel, P.; Tattersall, A.; Cooper, A.; Pareek, M.; Haldar, P.",Daniel Pan,University of Leicester,2021-09-26,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/09/26/2021.09.21.21263902.source.xml,,medrxiv,10.1101__2021.09.21.21263902_doc.txt
10.1101/2021.09.24.21263978,Lower probability and shorter duration of infections after Covid-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs,"Ronchini, C.; Gandini, S.; Pasqualato, S.; Mazzarella, L.; Facciotti, F.; Mapelli, M.; IEO Covid Team,  ; Frige', G.; Passerini, R.; Pase, L.; Capizzi, S.; Mastrilli, F.; Orecchia, R.; Natoli, G.; Pelicci, P. G.",Chiara Ronchini,European Institute of Oncology,2021-09-30,2,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2021/09/30/2021.09.24.21263978.source.xml,,medrxiv,10.1101__2021.09.24.21263978_doc.txt
10.1101/2021.09.27.21264013,Persistence of robust humoral immune response in COVID-19 convalescent individuals over 12 months after infection,"Miyakawa, K.; Kubo, S.; Jeremiah, S. S.; Go, H.; Yamaoka, Y.; Ohtake, N.; Kato, H.; Ikeda, S.; Mihara, T.; Matsuba, I.; Sanno, N.; Miyakawa, M.; Shinkai, M.; Miyazaki, T.; Ogura, T.; Ito, S.; Kaneko, T.; Yamamoto, K.; Goto, A.; Ryo, A.",Akihide Ryo,Yokohama City University Graduate School of Medicine,2021-09-29,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2021/09/29/2021.09.27.21264013.source.xml,,medrxiv,10.1101__2021.09.27.21264013_doc.txt
10.1101/2021.09.28.21264250,Reduced antibody activity against SARS-CoV-2 B.1.617.2 Delta virus in serum of mRNA-vaccinated patients receiving TNF-alpha inhibitors,"Chen, R. E.; Gorman, M. J.; Zhu, D. Y.; Carreno, J. M.; Yuan, D.; VanBlargan, L. A.; Burdess, S.; Lauffenburger, D. A.; Kim, W.; Turner, J. S.; Droit, L.; Handley, S. A.; Chahin, S.; Deepak, P.; O'Halloran, J.; Paley, M.; Presti, R.; Wu, G. F.; Krammer, F.; Alter, G.; Ellebedy, A.; Kim, A. H.; Diamond, M. S.",Michael S Diamond,Washington University School of Medicine,2021-09-29,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/09/29/2021.09.28.21264250.source.xml,,medrxiv,10.1101__2021.09.28.21264250_doc.txt
10.1101/2021.10.01.21264400,Recombinant adjuvanted zoster vaccine and reduced risk of COVID-19 diagnosis and hospitalization in older adults,"Bruxvoort, K. J.; Ackerson, B.; Sy, L. S.; Bhavsar, A.; Tseng, H. F.; Florea, A.; Luo, Y.; Tian, Y.; Solano, Z.; Widenmaier, R.; Shi, M.; Van Der Most, R.; Schmidt, J. E.; Danier, J.; Breuer, T.; Qian, L.",Katia J Bruxvoort,"Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S Los Robles, Pasadena, CA 91101, USA",2021-10-03,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/10/03/2021.10.01.21264400.source.xml,,medrxiv,10.1101__2021.10.01.21264400_doc.txt
10.1101/2021.10.01.21264333,Exhaled particles from nanometre to millimetre and their origin in the human respiratory tract,"Bagheri, G.; Schlenczek, O.; Turco, L.; Thiede, B.; Stieger, K.; Kosub, J.-M.; Poehlker, M.; Poehlker, C.; Molacek, J.; Scheithauer, S.; Bodenschatz, E.",Gholamhossein Bagheri,MPIDS,2021-10-03,1,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2021/10/03/2021.10.01.21264333.source.xml,,medrxiv,10.1101__2021.10.01.21264333_doc.txt
10.1101/2021.10.02.21264210,SARS-CoV-2 multi-variant graphene biosensor based on engineered dimeric ACE2 receptor,"D'Agostino, M.; Pavoni, E.; Romagnoli, A.; Ardiccioni, C.; Motta, S.; Crippa, P.; Biagetti, G.; Notarstefano, V.; Barocci, S.; Costabile, B. K.; Colasurdo, G.; Caucci, S.; Mencarelli, D.; Turchetti, C.; Farina, M.; Pierantoni, L.; La Teana, A.; Al Hadi, R.; Chinappi, M.; Trucchi, E.; Mancia, F.; Morozzo della Rocca, B.; D'Annessa, I.; Di Marino, D.",Daniele Di Marino,"Department of Life and Environmental Sciences, Polytechnic University of Marche, Via Brecce Bianche, 60131, Ancona, Italy. New York-Marche Structural Biology Ce",2021-10-04,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/10/04/2021.10.02.21264210.source.xml,,medrxiv,10.1101__2021.10.02.21264210_doc.txt
10.1101/2021.10.03.21264320,Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy,"Brumme, Z. L.; Mwimanzi, F. M.; Lapointe, H. R.; Cheung, P.; Sang, Y.; Duncan, M. C.; Yaseen, F.; Agafitei, O.; Ennis, S.; Ng, K.; Basra, S.; Lim, L. Y.; Kalikawe, R.; Speckmaier, S.; Moran-Garcia, N.; Young, L.; Ali, H.; Ganase, B.; Umviligihozo, G.; Omondi, F. H.; Atkinson, K.; Sudderuddin, H.; Toy, J.; Sereda, P.; Burns, L.; Costiniuk, C. T.; Cooper, C.; Anis, A. H.; Leung, V.; Holmes, D.; DeMarco, M. L.; Simons, J.; Hedgcock, M.; Romney, M. G.; Barrios, R.; Guillemi, S.; Brumme, C. J.; Pantophlet, R.; Montaner, J. S. G.; Niikura, M.; Harris, M.; Hull, M.; Brockman, M. A.",Zabrina L. Brumme,"Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada",2021-10-15,2,PUBLISHAHEADOFPRINT,cc_by_nd,hiv aids,https://www.medrxiv.org/content/early/2021/10/15/2021.10.03.21264320.source.xml,,medrxiv,10.1101__2021.10.03.21264320_doc.txt
10.1101/2021.10.02.21264267,Year-long COVID-19 infection reveals within-host evolution of SARS-CoV-2 in a patient with B cell depletion,"Nussenblatt, V.; Roder, A.; Das, S.; de Wit, E.; Youn, J.-H.; Banakis, S.; Muchegian, A.; Mederos, C.; Wang, W.; Chung, M.; Perez-Perez, L.; Palmore, T.; Brudno, J.; Kochenderfer, J.; Ghedin, E.",Elodie Ghedin,National Institute of Allergy and Infectious Diseases,2021-10-05,2,PUBLISHAHEADOFPRINT,cc0,infectious diseases,https://www.medrxiv.org/content/early/2021/10/05/2021.10.02.21264267.source.xml,10.1093/infdis/jiab622,medrxiv,10.1101__2021.10.02.21264267_doc.txt
10.1101/2021.10.04.21264434,Acute COVID-19 gene-expression profiles show multiple etiologies of long-term sequelae,"Thompson, R. C.; Simons, N. W.; Wilkins, L.; Cheng, E.; Del-Valle, D. M.; Hoffman, G. E.; Fennessy, B.; Mouskas, K.; Francoeur, N. J.; Johnson, J. S.; Lepow, L.; Le Berichel, J.; Chang, C.; Beckmann, A. G.; Wang, Y.-c.; Nie, K.; Zaki, N.; Tuballes, K.; Barcessat, V.; Cedillo, M. A.; Huckins, L.; Roussos, P.; Marron, T. U.; The Mount Sinai COVID-19 Biobank Team,  ; Glicksberg, B. S.; Nadkarni, G.; Gonzalez-Kozlova, E.; Kim-Schulze, S.; Sebra, R.; Merad, M.; Gnjatic, S.; Schadt, E. E.; Charney, A. W.; Beckmann, N. D.",Noam D. Beckmann,Icahn School of Medicine at Mount Sinai,2021-10-05,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/10/05/2021.10.04.21264434.source.xml,,medrxiv,10.1101__2021.10.04.21264434_doc.txt
10.1101/2021.10.06.21263384,SARS-CoV-2 RNA and antibody dynamics in a Dutch household study with dense sampling frame,"Han, W. G. H.; Swart, A.; Bonacic Marinovic, A.; Eggink, D.; Reimerink, J.; Wijsman, L. A.; van der Veer, B.; van den Brink, S.; van den Brandt, A.-M.; van Tol, S.; Godeke, G.-J.; Brouwer, F.; Hoogerwerf, M.; the Dutch FFX-COVID-19 research group,  ; Reukers, D. F. M.; Rots, N.; Reusken, C.; Meijer, A.",Adam Meijer,"Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands",2021-10-12,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/10/12/2021.10.06.21263384.source.xml,,medrxiv,10.1101__2021.10.06.21263384_doc.txt
10.1101/2021.10.05.21262783,Is the infection of the SARS-CoV-2 Delta variant associated with the outcomes of COVID-19 patients?,"Gunadi,  ; Hakim, M. S.; Wibawa, H.; Marcellus,  ; Setiawaty, V.; Slamet,  ; Trisnawati, I.; Supriyati, E.; Khair, R. E.; Iskandar, K.; Afiahayati,  ; Siswanto,  ; Irene,  ; Anggorowati, N.; Daniwijaya, E. W.; Nugrahaningsih, D. A. A.; Puspadewi, Y.; Puspitarani, D. A.; Tania, I.; Vujira, K. A.; Ardlyamustaqim, M. B.; Gabriela, G. C.; Eryvinka, L. S.; Nirmala, B. C.; Geometri, E. T.; Darutama, A. A.; Kuswandani, A. A.; Lestari,  ; Irianingsih, S. H.; Khoiriyah, S.; Lestari, I.; Ananda, N. R.; Arguni, E.; Nuryastuti, T.; Wibawa, T.; Yogyakarta-Central Java COVID-19 study group,  ",Gunadi,"Pediatric Surgery Division, Department of Surgery/Genetics Working Group, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, I",2021-10-07,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/10/07/2021.10.05.21262783.source.xml,10.3389/fmed.2021.780611,medrxiv,10.1101__2021.10.05.21262783_doc.txt
10.1101/2021.10.08.21262462,Nine-month presence of SARS-CoV-2 in saliva: a case report,"Jansen, G. J.; Wiersma, M.",Marit Wiersma,Biotrack,2021-10-09,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/10/09/2021.10.08.21262462.source.xml,,medrxiv,10.1101__2021.10.08.21262462_doc.txt
10.1101/2021.10.08.21264595,COVID-19 Vaccine Effectiveness by Product and Timing in New York State,"Rosenberg, E.; Dorabwila, V.; Easton, D.; Bauer, U.; Kumar, J.; Hoen, R.; Hoefer, D.; Wu, M.; Lutterloh, E.; Conroy, M. B.; Greene, D.; Zucker, H. A.",Eli Rosenberg,New York State Department of Health,2021-10-09,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/10/09/2021.10.08.21264595.source.xml,,medrxiv,10.1101__2021.10.08.21264595_doc.txt
10.1101/2021.10.11.21264831,SPECIFIC DETECTION OF SARS-COV-2 VARIANTS B.1.1.7 (ALPHA) AND B.1.617.2 (DELTA) USING A ONE-STEP QUANTITATIVE PCR ASSAY,"Erster, O.; Mendelson, E.; Kabat, A.; Levy, V.; Mannasse, B.; Asraf, H.; Azar, R.; Ali, Y.; Bucris, E.; Bar-Ilan, D.; Mor, O.; Elul, M.; Mandelboim, M.; Sofer, D.; Fleishon, S.; Zuckerman, N. S.; Bar-Or, I.",Oran Erster,"Central Virology Laboratory, Public Health Services, Ministry of Health, Chaim Sheba Medical Center, Ramat Gan, Israel",2021-10-26,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/10/26/2021.10.11.21264831.source.xml,,medrxiv,10.1101__2021.10.11.21264831_doc.txt
10.1101/2021.10.13.21264966,"Breakthrough SARS-CoV-2 infections in 620,000 U.S. Veterans, February 1, 2021 to August 13, 2021","Cohn, B. A.; Cirillo, P. M.; Murphy, C. C.; Krigbaum, N. Y.; Wallace, A. W.",Arthur W Wallace,"University of California, San Francisco; Veterans Affairs Medical Center in San Francisco",2021-10-14,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/10/14/2021.10.13.21264966.source.xml,,medrxiv,10.1101__2021.10.13.21264966_doc.txt
10.1101/2021.10.16.21265067,The usefulness of antigen testing in predicting contagiousness in COVID-19,"Lopera, T. J.; Diaz, F. J.; Alzate-Angel, J. C.; Rugeles, M. T.; Aguilar-Jimenez, W.",Wbeimar Aguilar-Jimenez,Universidad de Antioquia,2021-10-18,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/10/18/2021.10.16.21265067.source.xml,,medrxiv,10.1101__2021.10.16.21265067_doc.txt
10.1101/2021.10.20.21264403,Response to Tozinameran (BNT162b2) booster in twice-vaccinated kidney transplant and maintenance dialysis patients,"Ben-Dov, I. Z.; Tzukert, K.; Prichen, H.; Oster, Y.; Oiknine-Djian, E.; Wolf, D. G.; Elhalel, M. D.",Iddo Z. Ben-Dov,Hadassah - Hebrew University Medical Center,2021-10-20,1,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2021/10/20/2021.10.20.21264403.source.xml,,medrxiv,10.1101__2021.10.20.21264403_doc.txt
10.1101/2021.10.26.21265497,Implementation and extended evaluation of the Euroimmun Anti-SARS-CoV-2 IgG assay and its contribution to the United Kingdom's COVID-19 public health response,"Otter, A. D.; Bown, A.; D'Arcangelo, S.; Bailey, D.; Semper, A.; Hewson, J.; Catton, M.; Perumal, P.; Sweed, A.; Jones, J.; Harvala, H.; Lamikanra, A.; Zambon, M.; Andrews, N.; Whitaker, H.; Linley, E.; Mentzer, A. J.; Skelly, D.; Knight, J.; Klenerman, P.; PHE Porton Euroimmun testing group,  ; Amirthalingam, G.; Taylor, S.; Rowe, C.; Vipond, R.; Brooks, T.",Ashley David Otter,"Diagnostics and Genomics, National Infection Service, Public Health England, Porton, SP4 0JG",2021-10-28,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/10/28/2021.10.26.21265497.source.xml,,medrxiv,10.1101__2021.10.26.21265497_doc.txt
10.1101/2021.11.02.21265826,The basic reproduction number of COVID-19 across Africa,"Iyaniwura, S. A.; Musa, M. R.; David, J. F.; Kong, J. D.",Sarafa Adewale Iyaniwura,The University of British Columbia,2021-11-03,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/11/03/2021.11.02.21265826.source.xml,,medrxiv,10.1101__2021.11.02.21265826_doc.txt
10.1101/2021.11.09.21266118,Cellular and Humoral Immunity to Ebola Zaire Glycoprotein and Viral Vector Proteins Following Immunization with Recombinant Vesicular Stomatitis Virus-Based Ebola Vaccine (rVSV{triangleup}G-EBOV-GP),"Raabe, V. N.; Lai, L.; Morales, J.; Xu, Y.; Rouphael, N.; Davey, R. T.; Mulligan, M. J.",Vanessa N Raabe,New York University Grossman School of Medicine,2021-11-10,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/11/10/2021.11.09.21266118.source.xml,,medrxiv,10.1101__2021.11.09.21266118_doc.txt
10.1101/2021.11.09.21265981,"Divergent lineages of pathogenic Leptospira species are widespread and persisting in the environment in Puerto Rico, USA","Stone, N. E.; Hall, C. M.; Ortiz, M.; Hutton, S.; Santana-Propper, E.; Celona, K. R.; Williamson, C. H. D.; Bratsch, N.; Fernandes, L. G. V.; Busch, J. D.; Pearson, T.; Rivera-Garcia, S.; Soltero, F.; Galloway, R.; Sahl, J. W.; Nally, J. E.; Wagner, D. M.",David  M Wagner,Northern Arizona University,2021-11-11,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/11/11/2021.11.09.21265981.source.xml,,medrxiv,10.1101__2021.11.09.21265981_doc.txt
10.1101/2021.11.14.21266318,Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States,"Li, R.; Liu, H.; Fairley, C. K.; Zou, Z.; Xie, L.; Li, X.; Shen, M.; Li, Y.; Zhang, L.",Rui Li,Xi\'an Jiaotong University,2021-11-14,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/11/14/2021.11.14.21266318.source.xml,,medrxiv,10.1101__2021.11.14.21266318_doc.txt
10.1101/2021.11.17.21265553,C-reactive protein and lactate dehydrogenase are useful biomarkers for predicting the requirement for oxygen therapy in outpatients with coronavirus disease 2019,"Suzuki, K.; Ichikawa, T.; Suzuki, S.; Tanino, Y.; Kakinoki, Y.",Keiko Suzuki,Asahikawa City Hospital,2021-11-19,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/11/19/2021.11.17.21265553.source.xml,,medrxiv,10.1101__2021.11.17.21265553_doc.txt
10.1101/2021.11.17.21266297,SARS-CoV-2 testing in the community: Testing positive samples with the TaqMan SARS-CoV-2 Mutation Panel to find variants in real-time,"Ashford, F.; Best, A.; Dunn, S.; Ahmed, Z.; Siddiqui, H.; Melville, J.; Wilkinson, S.; Mirza, J.; Cumley, N.; Stockton, J.; Ferguson, J.; Wheatley, L.; Ratcliffe, E.; Casey, A.; The COVID-19 Genomics UK (COG-UK) Consortium5,  ; Quick, J.; Richter, A.; Loman, N. J.; McNally, A.",Alan McNally,University of Birmingham,2021-11-21,1,PUBLISHAHEADOFPRINT,cc_by,infectious diseases,https://www.medrxiv.org/content/early/2021/11/21/2021.11.17.21266297.source.xml,,medrxiv,10.1101__2021.11.17.21266297_doc.txt
10.1101/2021.11.25.21266298,Management and containment of a SARS-CoV-2 Beta variant outbreak at the Malawi University of Science and Technology,"Bandawe, G. P.; Chigwechokha, P.; Kunyenje, P.; Kazembe, Y.; Mwale, J.; Kamaliza, M.; Mpakati, M.; Nyakanyaka, Y.; Makamo, C.; Kimu, S.; Madanitsa, M.; Bitilinyu-Bangoh, J.; Nyirenda, T.; Luhanga, R.; Sambani, M.; Mvula, B.; Giandhari, J.; Pillay, S.; Naidoo, Y.; Ramphal, U.; San, E. J.; Tegally, H.; Wilkinson, E.; de Oliveira, T.; Malata, A.",Gama Petulo Bandawe,Malawi University of Science and Technology,2021-11-28,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/11/28/2021.11.25.21266298.source.xml,,medrxiv,10.1101__2021.11.25.21266298_doc.txt
10.1101/2021.12.02.21267164,Estimation of heterogeneous instantaneous reproduction numbers with application to characterize SARS-CoV-2 transmission in Massachusetts counties,"Zhou, Z.; Kolaczyk, E.; Thompson, R. N.; White, L. F.",Laura N White,Boston University,2021-12-06,2,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2021/12/06/2021.12.02.21267164.source.xml,,medrxiv,10.1101__2021.12.02.21267164_doc.txt
10.1101/2021.12.06.21267328,Comprehensive Serological Profile and Specificity of Maternal and Neonatal Cord Blood SARS CoV-2 Antibodies,"Boelig, R. C.; Chaudhury, S.; Aghai, Z.; Oliver, E.; Mancuso, F.; Berghella, V.; Bergmann-Leitner, E. C.",Rupsa C Boelig,Thomas Jefferson University,2021-12-07,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/12/07/2021.12.06.21267328.source.xml,10.1016/j.xagr.2021.100046,medrxiv,10.1101__2021.12.06.21267328_doc.txt
10.1101/2021.12.07.21267432,Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and Monoclonal Antibodies,"Wilhelm, A.; Widera, M.; Grikscheit, K.; Toptan, T.; Schenk, B.; Pallas, C.; Metzler, M.; Kohmer, N.; Hoehl, S.; Helfritz, F. A.; Wolf, T.; Goetsch, U.; Ciesek, S.",Marek Widera,"Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, 60596 Frankfurt am Main, Germany",2021-12-13,4,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/12/13/2021.12.07.21267432.source.xml,,medrxiv,10.1101__2021.12.07.21267432_doc.txt
10.1101/2021.12.09.21267539,Food for thought: Eating before saliva collection and interference with SARS-CoV-2 detection,"Hernandez, M. M.; Riollano-Cruz, M.; Boyle, M. C.; Banu, R.; Shrestha, P.; Gray, B.; Cao, L.; Chen, F.; Shi, H.; Paniz-Perez, D. E.; Paniz-Perez, P. A.; Rishi, A. L.; Dubinsky, J.; Dubinsky, D.; Dubinsky, O.; Baine, S.; Baine, L.; Arinsburg, S.; Baine, I.; Ramirez, J. D.; Cordon-Cardo, C.; Sordillo, E. M.; Paniz Mondolfi, A. E.",Matthew M. Hernandez,Icahn School of Medicine at Mount Sinai,2021-12-11,1,PUBLISHAHEADOFPRINT,cc_by_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/12/11/2021.12.09.21267539.source.xml,,medrxiv,10.1101__2021.12.09.21267539_doc.txt
10.1101/2021.12.09.21267278,"Nipah virus outbreak in Kerala state, India amidst of COVID-19 pandemic","Yadav, P.; Sahay, R. R.; B, A.; Mohandas, S.; Radhakrishnan, C.; Gokhale, M. D.; Balasubramaniam, R.; Abraham, P.; Gupta, N.; Sugunan, A.; Khobragade, R.; George, K.; Shete, A.; Patil, S.; Thankappan, U. P.; Dighe, H.; Koshy, J.; Vijay, V.; R, G.; Kumar, P. J.; Rahim, A.; A, N.; Nair, S.; Rajendran, V.; V, J.; Majumdar, T.; Jain, R.; Vishwanathan, P.; Patil, D. Y.; Kumar, A.; Nyayanit, D.; Sarkale, P.; Waghmare, A.; Bedekar, S.; Gawande, P.; Bodake, P.; Kalele, K.; Yemul, J.; Dhaigude, S.; Holepannawar, M.; Gopale, S.; Chopade, G.; Narayan, J.; Mathapati, B.; Kadam, M.; Kumar, A.; Suryawanshi,",Pragya Yadav,"Indian Council of Medical Research-National Institute of Virology, Pune, India",2021-12-11,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/12/11/2021.12.09.21267278.source.xml,,medrxiv,10.1101__2021.12.09.21267278_doc.txt
10.1101/2021.12.13.21267698,Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19,"Shibata, Y.; Minemura, H.; Suzuki, Y.; Nikaido, T.; Tanino, Y.; Fukuhara, A.; Kanno, R.; Saito, H.; Suzuki, S.; Ishii, T.; Inokoshi, Y.; Sando, E.; Sakuma, H.; Kobayashi, T.; Kume, H.; Kamimoto, M.; Aoki, H.; Takama, A.; Kamiyama, T.; Nakayama, M.; Saito, K.; Tanigawa, K.; Sato, M.; Kanbe, T.; Kanzaki, N.; Azuma, T.; Sakamoto, K.; Nakamura, Y.; Otani, H.; Waragai, M.; Maeda, S.; Ishida, T.; Sugino, K.; Inage, M.; Hirama, N.; Furuyama, K.; Fukushima, S.; Saito, H.; Machiya, J.-i.; Machida, H.; Abe, K.; Iwabuchi, K.; Katagiri, Y.; Aida, Y.; Abe, Y.; Ota, T.; Ishizawa, Y.; Tsukada, Y.; Yamada, R.",Yoko Shibata,"Department of Pulmonary Medicine, Fukushima Medical University",2021-12-14,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/12/14/2021.12.13.21267698.source.xml,,medrxiv,10.1101__2021.12.13.21267698_doc.txt
10.1101/2021.12.13.21267729,Interdependencies between cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination,"Hollstein, M. M.; Muensterkoetter, L.; Schoen, M. P.; Bergmann, A.; Husar, T. M.; Abratis, A.; Eidizadeh, A.; Schaffrinski, M.; Zachmann, K.; Schmitz, A.; Holsapple, J. S.; Stanisz-Bogeski, H.; Schanz, J.; Gross, U.; Leha, A.; Zautner, A. E.; Schnelle, M.; Erpenbeck, L.",Luise Erpenbeck,"Department of Dermatology, University of Muenster, Muenster, Germany",2021-12-14,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/12/14/2021.12.13.21267729.source.xml,,medrxiv,10.1101__2021.12.13.21267729_doc.txt
10.1101/2021.12.15.21267805,Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization,"Doria-Rose, N.; Shen, X.; Schmidt, S. D.; O'Dell, S.; McDanal, C.; Feng, W.; Tong, J.; Eaton, A.; Maglinao, M.; Tang, H.; Manning, K. E.; Edara, V.-V.; Lai, L.; Ellis, M.; Moore, K.; Floyd, K.; Foster, S. L.; Atmar, R. L.; Lyke, K. E.; Zhou, T.; Wang, L.; Zhang, y.; Gaudinski, M. R.; Black, W. P.; Gordon, I.; Guech, M.; Ledgerwood, J. E.; Misasi, J. N.; Widge, A.; Roberts, P. C.; Beigel, J.; Korber, B.; Pajon, R.; Mascola, J. R.; Suthar, M. S.; Montefiori, D. C.",David C Montefiori,Duke University Medical Center,2021-12-20,2,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/12/20/2021.12.15.21267805.source.xml,,medrxiv,10.1101__2021.12.15.21267805_doc.txt
10.1101/2021.12.14.21267418,COVID-19 vaccination and Guillain-Barre syndrome: analyses using the National Immunoglobulin Database,"Keh, R. Y. S.; Scanlon, S.; Datta-Nemdharry, P.; Donegan, K.; Cavanagh, S.; Foster, M.; Skelland, D.; Palmer, J.; Machado, P.; Carr, A.; Lunn, M.; BPNS/ABN COVID-19 Vaccine GBS Study Group,  ",Ryan Yann Shern Keh,National Hospital for Neurology and Neurosurgery,2021-12-15,1,PUBLISHAHEADOFPRINT,cc_no,neurology,https://www.medrxiv.org/content/early/2021/12/15/2021.12.14.21267418.source.xml,,medrxiv,10.1101__2021.12.14.21267418_doc.txt
10.1101/2021.12.14.21267804,"Emerging from the COVID-19 pandemic: impacts of variants, vaccines, and duration of immunity","Newcomb, K.; Michael, E.",Edwin Michael,University of South Florida,2021-12-15,1,PUBLISHAHEADOFPRINT,cc_by_nc,infectious diseases,https://www.medrxiv.org/content/early/2021/12/15/2021.12.14.21267804.source.xml,,medrxiv,10.1101__2021.12.14.21267804_doc.txt
10.1101/2021.12.14.21267714,Hepatitis C subtyping assay failure in UK patients born in Sub-Saharan Africa: implications for global treatment and elimination,"Adeboyejo, K.; King, B. J.; Tsoleridis, T.; Tarr, A. W.; McLauchlan, J.; Irving, W. L.; Ball, J. K.; McClure, C. P.",C Patrick McClure,University of Nottingham,2021-12-15,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/12/15/2021.12.14.21267714.source.xml,,medrxiv,10.1101__2021.12.14.21267714_doc.txt
10.1101/2021.12.17.21267976,Sputnik Light booster after Sputnik V vaccination induces robust neutralizing antibody response to B.1.1.529 (Omicron) SARS-CoV-2 variant,"Dolzhikova, I. V.; Iliukhina, A. A.; Kovyrshina, A. V.; Kuzina, A. V.; Gushchin, V. A.; Siniavin, A. E.; Pochtovyi, A. A.; Shidlovskaya, E. V.; Kuznetsova, N. A.; Megeryan, M. M.; Dzharullaeva, A. S.; Erokhova, A. S.; Izhaeva, F. M.; Grousova, D. M.; Botikov, A. G.; Shcheblyakov, D. V.; Tukhvatulin, A. I.; Zubkova, O. V.; Logunov, D. Y.; Gintsburg, A. L.",Denis Y Logunov,Gamaleya NRCEM,2021-12-21,1,PUBLISHAHEADOFPRINT,cc_no,infectious diseases,https://www.medrxiv.org/content/early/2021/12/21/2021.12.17.21267976.source.xml,,medrxiv,10.1101__2021.12.17.21267976_doc.txt
10.1101/2021.12.19.21268037,Superior immunogenicity and effectiveness of the 3rd BNT162b2 vaccine dose,"Lustig, Y.; Gonen, T.; Meltzer, L.; Gilboa, M.; Indenbaum, V.; Cohen, C.; Amit, S.; Jaber, H.; Doolman, R.; Asraf, K.; Rubin, C.; Fluss, R.; Mendelson, E.; Freedman, L.; Regev-Yochay, G.; Kreiss, Y.",Gili Regev-Yochay,Sheba Medical Center,2021-12-21,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/12/21/2021.12.19.21268037.source.xml,,medrxiv,10.1101__2021.12.19.21268037_doc.txt
10.1101/2021.12.22.21268274,"SARS-CoV-2 Antigen Tests Predict Infectivity Based on Viral Culture: Comparison of Antigen, PCR Viral Load, and Viral Culture Testing on a Large Sample Cohort","Kirby, J. E.; Riedel, S.; Dutta, S.; Arnaout, R.; Cheng, A.; Ditelberg, S.; Hamel, D. J.; Chang, C. A.; Kanki, P. J.",James E Kirby,Beth Israel Deaconess Medical Center,2021-12-23,1,PUBLISHAHEADOFPRINT,cc_by_nc_nd,infectious diseases,https://www.medrxiv.org/content/early/2021/12/23/2021.12.22.21268274.source.xml,,medrxiv,10.1101__2021.12.22.21268274_doc.txt
10.1101/2021.12.22.21268288,"Elevation of cell-associated HIV-1 RNA transcripts in CSF CD4+ T cells, despite suppressive antiretroviral therapy, is linked to in vivo brain injury","Suzuki, K.; Zaunders, J.; Gates, T. M.; Levert, A.; Butterly, S.; Liu, Z.; Ishida, T.; Huang, C.-S.; Palmer, S.; Rae, C. D.; Juge, L.; Cysique, L. A.; Brew, B. J.",John Zaunders,"Centre for Applied Medical Research, St Vincent\'s Hospital, Sydney, NSW, Australia",2021-12-27,1,PUBLISHAHEADOFPRINT,cc_no,hiv aids,https://www.medrxiv.org/content/early/2021/12/27/2021.12.22.21268288.source.xml,,medrxiv,10.1101__2021.12.22.21268288_doc.txt
10.1101/2021.12.25.21268206,Topological data analysis identifies distinct biomarker phenotypes during the inflammatory phase of COVID-19,"Blair, P. W.; Brandsma, J.; Chenoweth, J. G.; Richard, S. A.; Epsi, N. J.; Mehta, R.; Striegel, D. A.; Clemens, E. G.; Lindholm, D. A.; Maves, R. C.; Larson, D. T.; Mende, K.; Colombo, R. E.; Ganesan, A.; Lalani, T.; Colombo, C. J.; Malloy, A. A.; Snow, A. L.; Schully, K. L.; Lanteri, C.; Simons, M. P.; Dumler, J. S.; Tribble, D.; Burgess, T.; Pollett, S.; Agan, B. K.; Clark, D. V.; EPICC COVID-19 Cohort Study Group,  ",Paul W Blair,"The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD",2021-12-29,1,PUBLISHAHEADOFPRINT,cc0,infectious diseases,https://www.medrxiv.org/content/early/2021/12/29/2021.12.25.21268206.source.xml,,medrxiv,10.1101__2021.12.25.21268206_doc.txt
